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Abstract 
Leishmania major is a protozoan parasite and infection in the human host causes severe 
cutaneous Leishmaniasis.  The study aims to determine how signaling via the IL-4Rα on 
CD4+Tcells causes susceptibility to L. major.  We compared gene expression patterns early 
during infection in CD4+ T cells in the absence or presence of IL-4Rα signaling.  Non-healer 
BALB/c mice with a deletion of the IL-4Rα on all cells (IL-4Rα-/-) or CD4+ T cells only 
(iLCKcreIL-4Rαlox/-) and their controls (wild-type (WT) C57BL/6, WT BALB/c and littermate 
IL-4Rαlox/-) were subcutaneously infected with L. major.  As expected, the C57BL/6 “healer” 
mice produced a predominant TH1 response, whereas the iLCKcreIL-4Rα-/lox mice and 
susceptible BALB/c mice produced a TH2 response.  No significant differences in footpad 
swelling or parasite burden was observed amongst the groups at this early time point, 
except for the BALB/c mice which had a higher number of parasites.  Activated CD4+ T cells 
were successfully isolated to greater than 99% purity by FACS sorting, and high quality 
RNA extracted with no genomic DNA contamination.  Activated T cell and regulatory T cell 
marker expression on linearly amplified RNA from three independent biological 
experiments was evaluated by RT-PCR to confirm conformity to expected profiles given the 
genotype of mice and samples were hybridized to Affymetrix Exon arrays at the Centre for 
Proteomic and Genomic Research (CPGR) and Illumina Bead chip® arrays at the RIKEN 
Omics Science Centre, Japan.  Lists of significantly differentially expressed (DE) genes were 
generated by comparing expression data from the IL-4Rα-/- groups to wild type groups’ 
expression data.  The DE gene lists were considered to be biologically relevant as 
determined by the appearance of many expected genes for this particular study (e.g. CCR5 
and H2-T10).  Forty novel candidate genes either associated with cell proliferation, 
differentiation and immune response were identified using various bioinformatics tools 
such as network analysis.  Confirmation of the DE gene expression of candidate genes of 
interest was done using RT-PCR.  This study provides possible targets for manipulation as a 
foundation for potentially novel therapeutic targets in Leishmaniasis in humans. 
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Introduction 
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1.1 Innate and Adaptive Immunity 
The body’s defense against infectious organisms and other invaders is called the immune 
system (Roitt et al., 2001). During an immune response the immune system, in a series of 
steps attacks organisms and foreign substances that invade the body to cause disease. The 
immune system is divided into two categories, namely innate and adaptive immunity 
(Figure 1).  Innate immunity refers to the body’s nonspecific defense mechanisms 
immediately or within hours of an antigen’s appearance in the body (C A Janeway, 1992).  
These include physical barriers such as skin, immune cells that attack foreign cells or 
chemicals in the blood.  Adaptive (acquired) immunity is antigen-specific and a more 
complex response than the innate response and it is orchestrated by B and T cells (Roitt et 
al., 2001).  When the antigen has been processed and recognized, the immune system 
creates an army of immune cells specifically designed to attack.  An adaptive immune 
response also results in immunological memory, which confers lifelong protective 
immunity to reinfection with the same pathogen (Male et al., 2006).   
Both innate and adaptive immune responses depend upon the activities of leukocytes, 
which develop and mature in the bone marrow, where they then migrate and guard the 
peripheral tissues.  Lymphocytes are the key players in the immune system, and are found 
in the lymphoid organs positioned throughout the body.  Bone marrow is the ultimate 
source of all blood cells, including lymphocytes.  The thymus is a lymphoid organ where T 
lymphocytes or T cells mature, and then migrates to other tissues.  B lymphocytes or B cells 
become activated in peripheral lymphoid organs and mature into plasma cells which make 
and release antigen-specific antibodies such as IgM, IgG, IgE, IgA or IgD antibodies. B-cells 
can function as antigen presenting cells (APCs) as they can process and present antigens on 
MHC-II molecules to CD4+ T-cells and possess APC co-stimulatory molecules (Rothenberg 
et al., 2006). The spleen contains specialized compartments and serves as a meeting 
ground where immune defense confronts antigens.  Figure 1 is an illustration depicting the 
main difference between the innate and adaptive immune system as well as the interface 
between the two arms. 
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Figure 1 The Innate and adaptive Immune system 
The immune system is the body’s mechanism of protection against invaders such as viruses, 
bacteria and parasites and comprises of two parts, namely innate and adaptive.  The first line of 
defense against infection is called the innate response and consists of many cellular components 
including granulocytes, macrophages, dendritic cells, natural killer cells and mast cells.  The second 
arm is called the adaptive immune response which is orchestrated by lymphocytes (T and B cells) 
and is defined by specificity and memory.  The interface between the two arms of immunity 
consists of the natural killer T cells and γδT cells.  Illustration taken from previous publication, 
Nature Reviews Cancer 2004. 
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1.1.1. Cytokines 
Cytokines are chemical messengers that play a key role in modulation of immune 
responses.  Cells communicate with one another by releasing and responding to cytokines, 
and they are essential for the regulation of the cells of both innate and adaptive immune 
responses (Male D et al., 2006).   These proteins are secreted by immune and non-immune 
cells  and act on other cells to coordinate appropriate immune responses such as regulation 
of lymphocyte turnover, differentiation and activation.  Cytokines include a diverse 
assortment of interleukins, interferons, and growth factors, and can have multiple effects 
on various different cells.   
The production of cytokines is transient and it contributes to many roles in the cell 
including activation, proliferation, cell differentiation, cell recruitment and release of 
effector molecules (Brombacher 2012 and Tato, C.M. & O'Shea, J.J, 2006). The host’s 
immune response depends on the cytokines that are produced and are therefore indicators 
of disease progression.  Cytokines can be produced by a variety of cell types and often have 
overlapping functions on effector cells (Brombacher 2012).  A cytokine cascade can also 
result in an increase or decrease of other cytokines.  Some receptor subunits  are shared by 
cytokines, hence their functional redundancy (Durum et al., 1998).  Therefore, 
understanding the role of cytokines and the importance of their expression profiles are 
important.  Research has indicated that the use of gene-deficient (knockout) and transgenic 
mice strains provide an essential tool in our understanding of cytokine function (Durum et 
al., 1998).  However, in the absence of a specific gene, compensatory mechanism not 
normally present may be activated (Louis et al., 1998).  We now make use of mice that are 
deficient for cytokines or their receptor subunits and more recently, mice with cell-specific 
deletions or transgenes to study specific diseases. 
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1.1.2. T cell differentiation 
The immune system’s response to any foreign substance, or antigen, involves a cascade of 
events orchestrated by specialized immune cells.  T cells play central roles in cell-mediated 
and humoral immunity.  Several different subsets of T cells have been discovered, each 
with distinct functions.  For a long time it was believed that TH1 / TH2 paradigm 
dominated. 
The major lineages for CD4+ T helper cells are TH1 and TH2; however other subsets have 
been identified.  These subsets include TH17, TfH and CD4+CD25+ regulatory T cells and 
they regulate immune responses and play a crucial role in preventing autoimmunity and 
excessive effector responses to pathogens (Figure 2).  Additional effector T cell subsets may 
include TH5 and TH9, which produce IL-5 and IL-9 respectively (Zhu et al., 2010). TH17 
cells are IL-17 producing effector CD4+ T cells that require TGF-β, IL-6 and IL-23 for 
development.  The TH17 lineage has a role in autoimmunity and defence against 
extracellular bacteria (Bettelli et al., 2006; Mangan et al., 2006) and the crucial 
transcription factor for this lineage is the orphan nuclear receptor (RORγt) (Ivanov et al., 
2006).  TH17 cells play a crucial role in clearing extracellular microbes (Huang et al., 2004), 
autoimmunity (Koenders et al., 2005), and certain asthmatic symptoms (Kolls et al., 2003). 
 
TfH cells assists in the formation of germinal centers, affinity maturation and promote 
immunoglogulin class switch recombination.  The primary function of TfH cells is to assist 
the B cells make antibody responses to T cell-dependent antigens.  Bcl6 is a transcriptional 
repressor that is expressed by TfH cells.  These cells may produce TH1 or TH2 cytokines 
depending on the conditions of their activation (Zhou et al., 2009, Fazileau et al., 2009).  
 
Regulatory T cells are a specialized subpopulation of T cells that are essential for 
maintaining peripheral tolerance as well as acting to suppress activation of the immune 
system and thereby maintain homeostasis of the immune system and tolerance to self 
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antigens (Zhu & Paul, 2008).  The critical role that regulatory T cells play within the 
immune system is evidence by the severe autoimmune syndrome that results from genetic 
deficiency in regulatory T cells (Sakaguchi et al., 2006; Sakaguchi et al., 2008, Belkaid et al., 
2009 and Yamaguchi et al., 2006).  Regulatory T cells develop in the thymus and are 
defined by the expression of the forkhead family transcription factor FoxP3 (forkhead box 
p3).  Expression of this ‘master regulator,’ FoxP3 is required for regulatory T cells 
development and appear to control a genetic program specifying this cell fate.  Functions of 
these cells include, maintaining tolerance to self and control deviation, prevention of 
runaway responses to pathogens or allergens, they help with the maintenance of the 
balance with microbial flora and facilitate tumors escape from immune monitoring 
(Feuerer et al., 2009).  A study has shown that deficiencies in FoxP3 underlie the 
lymphoproliferation and multiorgan autoimmunity of scurvy mutant mice and human 
patients with immunodysregulation polyendocrinopathy and enteropathy, X-linked (IPEX) 
syndrome (Ziegler, 2006). 
 
A large majority of FoxP3 expressing regulatory T cells are found within the MHC-II 
restricted CD4+ T helper cell population and express high levels of the IL-2Rα chain (CD25) 
(Belkaid et al., 2002).  To identify and monitor regulatory T cells, a number of different 
methods have been employed.  Initially, high expression of CD4 and CD25 surface markers 
was used (ie. CD4+CD25+cells). However, it is known that CD25 is also expressed on non 
regulatory T cells.  The additional expression of FoxP3 allowed for a more specific analysis 
of regulatory T cells (CD4+CD25 cells) (Vignali et al., 2008).  The high level of expression of 
CD25 (IL-2Rα) on regulatory T cells suggests the importance of IL-2 for these cells.  The 
immunosuppressive cytokines TGF-β and IL-10 have also been implicated in regulatory T 
cells function.  TGF-β plays a major role in regulatory T cell differentiation and 
development and it induces FoxP3 expression (Chen et al., 2003).  IL-2- mediated Stat5 
activation is also a requirement for the induction of FoxP3 expression.  Therefore, both 
TGF-β and IL-2 are a prerequisite for the function and survival of regulatory T cells even 
after they have differentiated.   
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In addition, Regulatory T cells include three distinct subtypes of CD4+ T cells that are 
termed inducible regulatory T cells. These subtypes are distinct in the following manner. T 
regulatory 1 (TR1) cells secrete high levels of IL-10, no IL-4 and no or low levels of IFN-γ.  T 
helper 3 (TH3) cells secrete high levels of TGF-β and CD8+ regulatory T cells, although CD8+ 
T cells are normally associated with cytotoxic T-lymphocyte function and IFN-  
production, a subtype of these cells secrete IL-10 (Mills 2004). 
 
 
 
Figure 2 Summary of the different T helper cell differentiation  
Differentiation into different effector CD4+ T cell lineages, T helper (TH) 1, TH2, TH17, TfH (T 
follicular helper cells) and regulatory T cells is initiated through an interaction of dendritic cells 
with uncommitted (naïve) CD4+ T helper cells.  The effector cell types are characterized by their 
synthesis of specific cytokines and their immune-regulatory functions, as indicated on the right.  
Illustration adapted from a previous publication (O'Shea and Paul, 2010). 
Extracellular bacteria, 
Fungi and Autoimmunity 
Intracellular pathogens 
and Autoimmunity 
Immune tolerance 
Lymphocyte homeostasis 
Regulation of immune 
responses 
Extracellular parasites, 
Allergy and asthma 
Development of germinal 
centers, Promotes 
immunoglobulin class 
switch recombination 
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The mechanism of how regulatory T cells function is important and has been grouped into 
four basic modes of action. Firstly, suppression by inhibitory cytokines, secondly, 
suppression by cytolysis, thirdly, suppression by metabolic disruption and fourthly, 
suppression by modulation of dendritic cell (DC) maturation or function (Vignali et al., 
2008).  IL-10, IL-35 and TGF-β form part of the inhibitory cytokines.  Cytolysis includes 
granzyme-A- and granzyme-B-dependent and perforin-dependent killing mechanisms. 
Metabolic disruption includes high affinity CD25-dependent cytokine-deprivation-
mediated apoptosis, cyclic AMP (cAMP)-mediated inhibition amongst others.  Targeting 
dendritic cells includes mechanisms that modulate DC maturation and/or function such as 
lymphocyte activation gene-3 (LAG3)–MHC-class-II-mediated suppression of DC 
maturation, and cytotoxic T lymphocyte antigen-4 (CTLA4)–CD80/CD86-mediated 
induction of indoleamine 2,3-dioxygenase (IDO), which is an immunosuppressive molecule, 
by DCs.  Figure 3A illustrates the four mechanisms used by regulatory T cells.   
 
For a number of years it was believed that only a TH1 / TH2 paradigm dominated and that 
the immune system’s response to any foreign substance, or antigen, involves a cascade of 
events orchestrated by specialized immune cells, leading to either a TH1 or a TH2 
response.  However, other lineages for CD4+ T helper cells have been identified (Zhu et al., 
2010).   Dendritic cells, a type of immune cell, have two key functions in the initial, innate 
immune response.  First, they produce cytokines that help to kill viruses and bacteria and 
secondly, they ensure that pathogens and other foreign substances are highly visible to 
specialized helper T cells which coordinate the longer-term adaptive immune response 
(Scott & Hunter, 2002).  Dendritic cells recognize different types of offending substances 
and are able to guide the immune system to make the most appropriate response.   
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TH1 cells mediate immune responses against intracellular pathogens (Mosmann, 1989 and 
Paul, 1994).  TH1 related cytokines production is important for host control of parasite 
burden in Leishmaniasis. In addition, these cells play an important role in resistance to 
mycobacterial infections and may induce some autoimmune diseases.  Specific cytokines, 
IFN-γ, lymphotoxin α (LT α) and IL-2 are a few of the cytokines that are produced by the 
body during a TH1 response (Kelso, 1995).  Protective IgG antibodies are also generated to 
help rid the body of foreign antigens and allergens (Mohammadi et al., 2006).  The primary 
function of IFN-γ produced by the TH1 cells is the activation of macrophages to increase 
their microbiocidal activity (Suzuki Y, 1988).  IL-2 production is important for CD4 T-cell 
memory as well as the stimulation of CD8 cells during the priming phase (Williams MA et 
al, 2006). 
 
Host defense against extracellular pathogens are mediated by TH2 cells (Mosmann et al., 
1986).  These cells produce IL-4, IL-5, IL-9, IL-10, IL-13, IL-25 and amphiregulin and are 
important in the induction and persistence of asthma and other allergic diseases.  The 
positive feedback cytokine for TH2 is IL-4 (Le Gros et al., 1990) and is also the major 
mediator of IgE class switching in B cells (Kopf M et al., 1993).  IgE binds to FcєRI on 
basophils and mast cells and leads to the production of several cytokines including IL-4, IL-
13 and tumor necrosis factor (TNF).  Recruitment of eosinophils is mediated by IL-5 which 
also has an effect of mast cells and lymphocytes.  During an allergic reaction, IL-9 induces 
the production of mucin on epithelial cells (Longphre M et al., 1999).  The IL-10 that is 
produced by TH2 cells, suppresses TH1 cell proliferation as well as dendritic cell function 
(Moore KW et al., 2001).  The expulsion of helminthes and the induction of airway 
hypersensitivity are mediated by the cytokine IL-13 (Wynn TA et al., 2003 and Urban JF et 
al., 1992). 
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The TH1 / TH2 paradigm is of relevance to this study as the differentiation has been shown 
to play a role during L. major infection (Radwanska et al., 2007) (Figure 3B).  Typically, IL-
12 causes the activation of naïve CD4+ T cells to differentiate into TH1 via the Stat4 
pathway to activate the transcription factor T-bet.  As mentioned earlier, these cells 
produce IFN-γ as the hallmark cytokine.  Conversely, IL-4 leads to the activation of naïve 
CD4+ T cells to activate the transcription factor GATA3 via the STAT6 pathway to drive the 
TH2 differentiation.  This leads to the production of IL-4, IL-13 and IL-5 amongst other TH2 
cytokines.  IL-4 is needed for the induction of most Th2 responses (Forbes, et al., 2010 and 
Van Panhuys, et al., 2008).  These subsets, TH1 and TH2 can also be negatively regulated by 
the cytokines IFN-γ and IL-4, which suppress differentiation of TH2 and TH1 respectively.  
Table 1 lists the major differences between mouse TH1 and TH2 cells and Figure 2 
illustrates the different effector CD4+ T cell lineages.    
 
Table 1 TH1 vs TH2 Major differences 
 TH1 TH2 
Response to Microbial and intracellular 
pathogens 
Extracellular parasites 
and allergic reactions 
Initiating cytokines IL-12, IL-18 IL-4 
Antibodies IgG2a 
IgG2b 
IgE 
IgG1 
Transcription factors T-bet , STAT-4 GATA3, STAT-6 
Cytokines produced IFN-γ (IL-2) IL-4 (IL-2), IL-13, IL-5. 
Inhibited by cytokines IL-4, IL-10, TGF-β IFN-γ, TGF-β 
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  B 
 
 
 
 
 
 
 
Figure 3 Regulatory T cell mechanism and TH1 / TH2 differentiation 
A. Basic mechanism used by regulatory T cells. Illustration of the various regulatory T cell 
mechanisms centered on the four basic modes of action.  These include inhibitory cytokines, 
cytolysis, metabolic disruption and targeting dendritic cells.  B. TH1 / TH2 lineages.  Illustration of 
TH1 and TH2 cell differentiation, antigen presentation and its interaction with its co-stimulatory 
molecules.  Illustrations were taken from Vignali et al., 2008 and Sacks et al., 2002. 
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1.2. IL-4 Receptor alpha (IL-4Rα) 
   
Interleukin 4 (IL-4) is a cytokine that induces differentiation of naive helper T cells to TH2 
cells and was originally identified in 1982.  The gene for IL-4 together with the genes for IL-
5 and IL-13 are localized of chromosome 11 (Morgan et al., 1992).  It has been shown that 
basophils (Min et al., 2004), mast cells (Plaut et al., 1989), γδT cells (Ferrick et al,. 1995), 
NK1.1+ T cells (Yoshinoto and Paul 1994), eosinophils (Sabin et al., 1996) and conventional 
T cells (Launois et al., 1995; Noben-trauth et al., 2000) are all sources of IL-4 and these cells 
have been shown to initiate TH2 differentiation.  IL-4-independent TH2 differentiation has 
also been previously described (Mohrs et al., 2000). 
 
IL-13 is a cytokine secreted by many cell types, but especially TH2 cells.  This cytokine is 
produced by many cell types including dendritic cells, NK cells, mast cells, basophils and T 
cells (McKenzie et al., 1993; de Saint-Vis et al., 1998; Hoshino et al., 1999; Heller et al., 
2005).  It has been shown in studies by Noben-Trauth et a.l in 1999 that IL-13 plays a role 
in the susceptibility of BALB/c mice during Leishmania major infection.     
 
These two cytokines (IL-4 and IL-13) are closely related and has similar functions in that 
they play a role in the induction of TH2 responses and the inhibition of TH1-associated 
cytokines such as IFN-γ and TNF (Paul, 2010).  Both share a common receptor subunit, the 
interleukin-4 receptor alpha (IL-4Rα) (Duschl & Sebald, 1996) (Figure 4) through which 
they signal.  
 
The mouse IL-4Rα gene is located on chromosome 7 (accession number M29854) and is 
encoded by 12 exons (Mosley et al., 1989).  The IL-4Rα chain consists of two separate 
chains, the 140kDa IL-4-binding chain and the common gamma chain, γc.  There are two 
types of IL-4 receptor complexes that function as heterodimers.  Firstly, the type I receptor 
consists of the IL-4Rα and the γc, which is also a component of the receptors for IL-2, IL-7, 
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IL-9, IL-15 and IL-21 (Leonard and Lin 2000; Hershey, 2003) while the type II receptor 
consists of the IL-4Rα and the IL-13Rα. 
This receptor (IL-4Rα) is very closely linked to the activities of IL-4, in that it plays a major 
role in the regulation of the differentiation of naïve CD4+ T cells into a TH2 phenotype as 
well as a role in class switching to IgG1 and IgE (Coffman et al., 1986). 
 
The components of the IL-4Rα complexes are constitutively associated with the Janus 
tyrosine kinases (JAKs).  JAK1 associates with IL-4Rα (Yin et al. 1994) while JAK3 
associates with the γc (Russell et al., 1994; Nelms et al., 1999).  Upon ligand binding the 
receptor subunits dimerize leading to the activation of JAKs.  Activated JAKs phosphorylate 
tyrosine residues in the cytoplasmic domain of the IL-4Rα, which can in their 
phosphorylated state act as docking sites for signaling molecules.  The IL-4Rα dedicated 
signal transducer and activator of transcription 6 (STAT6) is recruited to the 
phosphorylated IL-4Rα where it also becomes phosphorylated by JAKs (Tadeka et al., 
1996).  Phosphorylated STAT6 monomers dimerize and translocate to the nucleus to bind 
STAT6 binding elements in promoters of IL-4 or IL-13 responsive genes (Tadeka et al., 
1996).  The cytoplasmic domain of IL-13Rα1 also binds to STAT3 and IL-4 or IL-13 binding 
leads to the phosphorylation of this transcription factor.  Recently, it was discovered that 
IL-4Rα could also signal through Syk kinase to enhance phagocytosis and cell adhesion 
(Ennaciri and Girard, 2009).  The roles of IL-4, IL-13 and their receptors in type II 
immunity forms a central part of the studies presented here and is therefore discussed 
further in the following section. 
 
In order to further characterize the role of these cytokines, mice lacking the IL-4Rα globally 
as well as on specific cell types using the Cre-loxP system were generated in our lab 
(Dewals et al., 2009; Herbert et al., 2004; Horsnell et al., 2007; Mohrs et al., 1999; 
Radwanska et al., 2007). 
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Figure 4   IL-4 and IL-13 receptor complexes 
 
IL-4 interacts with the IL-4Rα subunit in combination with either γc (Type I) or IL-13Rα1 (Type II).  
IL-13 interacts with IL-13Rα1 in combination with IL-4Rα or with IL-13Rα2.  Illustration adapted 
from previous publication, Holgate, 2012. 
This strategy employed to generate these cell-specific IL-4Rα knockout mice is illustrated 
in Figure 5.  Using these IL-4Rα knockout mice, a role for IL-4 and IL-13 was established 
during Leishmania major infection (Radwanska et al., 2007), Nippostrongylus brasiliensis 
infection (Horsnell et al., 2011; Horsnell et al., 2007), Schistosoma mansoni infection 
(Dewals et al., 2010; Dewals et al., 2009; Herbert et al., 2004; Leeto et al., 2006; Marillier et 
al., 2010) and allergy (Kirstein et al., 2010).  For the purpose of this study, we investigated 
the role of CD4+T cells host protective responses against cutaneous leishmaniasis using 
30 
 
genome-wide transcriptomics with specific interest in the absence of IL-4Rα on CD4+T 
cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 Breeding  strategy to generate IL-4Rα knockout mice. 
IL-4Rα-/- mice were mated with transgenic mice possessing an LCK promoter driving Cre 
recombinase, resulting in iLCKcreIL-4Rα-/- offspring.  These offspring were mated with mice 
containing IL-4Rα flanked by loxP sites (IL-4Rαlox/lox) to produce mice with iLCK driven cre-
mediated deletion of IL-4Rα (iLCKcreIL-4Rα-/lox).  Illustration adapted from Radwanska et al., 2007. 
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1.3. Leishmania major / Leishmaniasis 
1.3.1 Background 
Leishmaniasis is a disease caused by a protozoan parasite that is transmitted by the bite of 
the Phlebotomus genus of sand fly. Leishmaniasis is found mainly in the subtropics and 
tropics. Various forms of Leishmaniasis are determined by which part of the body is 
affected (Table 2). In visceral leishmaniasis, the parasite affects the organs of the body.  The 
most common form is cutaneous leishmaniasis, where the skin is the predominate site of 
infection. Cutaneous leishmainiasis can involve the mucocutaneous membranes, a 
condition called mucocutatneous leishmaniasis. 
 
Table 2 Etiological agents of the various forms of Leishmaniasis 
Type Etiological species 
Cutaneous  Americas – L. tropica mexicana, L. braziliensis, and  
L. amazonensis 
Old World (Europe, Asia, and Africa) – L. tropica, L. major, 
 L. infantum, and L. aethiopica 
Mucocutaneous  Americas – L. braziliensis 
Old World (Europe, Asia, and Africa) – L. aethiopica 
Visceral  India, Kenya – L. donovani 
South Europe and North Africa – L .infantum 
Americas – L. chagasi 
 
The global impact of leishmaniasis has been severely underestimated, and the scope of 
endemic areas and number of recorded cases of the disease are on the increase (Dujardin et 
al., 2008).  Leishmaniasis is listed by the World Health Organisation as one of the top six 
diseases, with an estimated 12 million people infected that is endemic in 88 countries 
(http://www.who.int/leishmaniasis/cutaneous_leishmaniasis/en/).Cutaneous 
leishmaniasis currently affects approximately 1.5 million people annually (Desjeux, 2001).  
Despite the disease not being fatal it is important to study diseases of poverty, like 
leishmaniasis.  They often cause high morbidity however low mortality.  Therefore, the 
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burden of disease becomes largely invisible.  Those that are affected by the disease are 
often isolated due to the social stigma associated with the disease.   
1.3.2 Leishmania/HIV co-infection 
It is increasingly more important to study Leishmania due to the increase in HIV infections.  
Leishmaniasis is one of the opportunistic infections which affects HIV-infected individuals.  
The visceral form of the disease appears to be the most common form associated with co-
infection with HIV (Ezra et al., 2010).  Figure 6 illustrates the global distribution of 
reported cases of Leishmania / HIV co-infection and the distribution of leishmaniasis cases.  
Approximately 31 countries have reported Leishmania / HIV co-infection in 1999.  Having 
both pathogens concomitantly in the same system, the macrophage enhances the effects 
that influence the expression and multiplication of either one or both pathogens (Cruz et 
al., 2008).   
 
A vicious circle is established whereby the protozoan parasite Leishmania induces a more 
robust HIV-1 production and the virus mediates a greater parasitic replication.  In co-
infected patients there is a depletion of both the cellular and humoral responses to 
Leishmania, this further increases the risk of disease progression (Moreno et al., 2000).  
HIV-infected individuals have nonfunctional T lymphocytes and this is problematic for 
Leishmania infections (Cruz et al., 2008).   
 
The overlap in the geographical areas with high risk of both HIV and leishmaniasis is 
increasing, with the spread of leishmaniasis (typically a rural disease) into urban areas and 
the increased spread of HIV into rural areas.  Leishmaniasis accelerates the onset of AIDS 
by cumulative immuno-suppression and by stimulation of the replication of the virus. In 
addition, since visceral leishmaniasis can be spread intravenously, sharing of needles by 
intravenous drug users is a direct way of spreading leishmaniasis. 
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Figure 6 Global distributions of reported cases of leishmaniasis and Leishmania/HIV 
co-infection. 
WHO-compiled a depiction of endemic regions of Leishmaniasis (light blue) and those areas were 
HIV co- infection has significantly complicated the clinical outcome. Illustration was taken from 
http://www.who.int/csr/resources/publications/CSR_ISR_2000_1leish/en/index.html. 
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1.3.3. Life cycle 
Infection begins with metacyclic promastigote parasites being transmitted to the host 
during a blood meal of the sandfly vector (Phlebotomus papatasi) (Figures 7 and 8). The 
parasites are phagocytosed by phagocytes including neutrophils, macrophages and 
dendritic cells and survive in phagolysosomes, where they differentiate into amastigotes. 
These amastigotes grow and divide, infecting other macrophages while waiting to be 
ingested by a feeding sandfly.  
 
 
 
 
 
 
 
 
 
 
 
Figure 7 Life cycle of Leishmania parasites. 
Parasites are transferred between hosts by a sandfly vector during blood meals (step 1), they then 
become phagocytosed by macrophages (step 3) where they reside within the phagosome and 
replicate as amastigotes (step 4) and develop the disease phenotype. Infected macrophages may 
then be taken up by a naive sandfly (step 5-8) to repeat the cycle.  Illustration taken from 
http://en.wikipedia.org/wiki/File:Leishmania_LifeCycle.gif. 
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Figure 8 Leishmania major infection and resulting immunity 
The immune response in brief after the parasite has been taken up by the resident macrophages in 
the skin. Once the uptake occurs, the promastigotes transforms into obligate amastigotes where 
they replicate.  These macrophages lyse and release the amastigotes which then infect dendritic 
cells.  This lead to its activation and that of the T cells to differentiate into IFN-γ producing TH1 cells 
which in turn induce the macrophages to upregulate iNOS to eliminate the intracellular organism. 
The metacyclic promastigotes can be transmitted when the sand fly takes another blood meal.  This 
illustration was taken from Barral-Netto et al., 2007. 
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1.3.4. Immune response to L. major  
It is generally accepted that protective immunity against L. major is dependent on an IL-12-
driven type-1 response mainly characterized by the production of interferon-gamma (IFN-
γ) by CD4+ TH1 cells (Gorak, Engwerda, & Kaye, 1998; Sypek et al., 1993; Walker et al., 
1999).  IFN-γ in turn mediates protection by inducing NOS-2 expression and nitric oxide 
(NO) production in classically activated macrophages (Liew and O'Donnell, 1993).  In 
contrast, conventional opinion and early studies with L. major (Heinzel et al., 1989; Leal et 
al., 1993.) would suggest than an IL-4 driven TH2 response and associated cytokines like 
IL-13 counter-regulate TH1 responses and consequently it would be expected that a TH2 
response would be detrimental to the outcome of disease.  Indeed susceptible BALB/c mice 
deficient for IL-4 (Kopf et al., 1996a), IL-13 (Matthews et al., 2000), the IL-4 receptor-alpha 
(IL-4Rα) (Mohrs et al., 1999), or STAT6 (Stamm et al., 1998) are able to contain infection 
with L. major.   
 
TH2 cytokines like IL-4, IL-9, IL-10 and IL-13 are susceptible factors as identified by fellow 
researchers from our group and others during the last few years (Arendse et al., 2005; Kopf 
et al., 1996; Mohrs et al., 1999; Stamm et al., 1998; Alexander et al., 2002).  Even though, 
Leishmania major is the organism that has been most intensely studied and from which the 
original TH1 / TH2 paradigm of immunological development during infectious disease was 
determined, the exact role of IL-4 and IL-13 is still not clear.  Firstly, TH2 differentiation 
can be independent of IL-4 (Mohrs et al., 2000).  Secondly, both cytokines can have 
beneficial functions (Mohrs et al., 1999) and are needed for effective drug therapy and 
vaccination (Alexander et al,. 2000; Stäger et al., 2003).  Thirdly, the IL-4/IL-13 
dependency for susceptibility is reliant on the Leishmania strain used (Noben-Trauth et al., 
1996 and Noben-Trauth, 2000) and possibly on the chronicity of the disease (Mohrs et al., 
1999), as summarized in the literature (Alexander J and Brombacher F, 2012).  Recent 
evidence shows that IL-4Rα responsive non-T cells are critical for transforming from a non-
healer to a healer strain in cutaneous leishmaniasis (Radwanska et al., 2007).  
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The murine model of infection for Leishmania major (L. major) has been used extensively to 
unravel mechanisms underlying T cell differentiation into TH1 or TH2 cells (Sacks & 
Noben-Trauth, 2002).  Essentially, most laboratory mouse strains (such as C57BL/6 mice) 
are able to control L. major infection, raising a polarised TH1 response following infection 
this is driven by IL-12 and the production of IFN-γ (Sacks & Anderson, 2004; Sacks & 
Noben-trauth, 2002).  These resistant C57BL/6 mice was also found to produce IL-4 early 
during infection, however they still developed and unimpaired TH1 biased response (Scott 
et al., 1996).  Due to a genetic predisposition, BALB/c mice develop a TH2 response (with 
the production of IL-4 and IL-13) following infection with L. major and are susceptible to 
infection with the development of progressive lesions and systemic disease.  The L. major 
mouse model has been a useful tool, not only in identifying the importance of TH1 
polarisation in resistance to the disease, but also in identifying the processes involved in 
controlling TH1 differentiation in vivo (Sacks and Anderson 2004).   Studies have shown 
that global IL-4Rα deficient mice showed resistance to L. major infection during the acute 
phase of infection however, the mice continued to develop necrotic lesions during the 
chronic phase.  In contrast, the T cell-specific IL-4Rα KO (knock out) mice developed 
resistance to L. major infection during the acute as well as chronic phases of infection 
(Mohrs et al., 2000 and Radwanska et al., 2007). 
Studies using CD4+T cell specific IL-4Rα deficient mice on a susceptible BALB/c 
background, demonstrated that loss of IL-4R responsiveness on CD4+T cells together with 
the presence of IL-4R responsiveness on other non-CD4+ cell types, lead to clinical 
immunity in “non-healer” BALB/c mice infected with L. major (Radwanska et al., 2007).  
This suggests that during L. major infection, signaling via the IL-4R on CD4+T cells induces 
a cascade of events that ultimately results in susceptibility and disease progression.  These 
studies have highlighted that IL-4Rα signaling on cells other than T cells may have a 
protective role during L. major infection.   
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Thus, the aim of this study is to identify the gene expression patterns in activated CD4+T 
cells and regulatory T cells that are associated with resistance or susceptibility to L. major, 
with the long term goal that these genes (and their encoding protein products) can serve as 
targets for rational drug design.  To do this we will use DNA microarrays to analyze the 
gene expression profiles of IL-4R responsive and non-responsive CD4+ T cells (activated 
and regulatory) isolated from the draining lymph nodes of susceptible WT BALB/c mice 
and resistant mice CD4+T cell-specific IL-4R KO BALB/c (iLCKcreIL-4Rαlox/-) mice 
respectively at three weeks after infection with L. major.  Control mouse groups will 
include WT C57BL/6, global IL-4R KO (IL-4Rα-/-) and IL-4Rαlox/- mice.  This differential 
microarray strategy comparing genetically resistant and susceptible mice was used 
previously by researchers from our group to identify genes as potential drug targets with a 
low false positive rate during listeria monocytogenes infection (Schwegmann et al., 2007). 
 
 
1.3.5 The role of regulatory T cells in Leishmaniasis  
 
CD4+CD25+ Regulatory T cells are a major source of IL-10 and play an important role in the 
regulation of immune responses.  Regulatory T cells are essential for the suppression of 
detrimental pathogenic responses especially to self antigens, however, they may also lead 
to the suppression of beneficial responses.  In C57BL/6 mice infected with L. major, the 
regulatory T cells are recruited to the site of infection.  Here the regulatory T cells function 
in a way to suppress the effector cells to eliminate the parasites (Belkaid et al., 2000).  The 
depletion of CD25+ cells in this mouse strain enhances the production of IFN-γ by CD4+ T 
cells in the lesions.  This resulted in clearance of the parasites.  Similarly, in a susceptible 
BALB/c mouse strain, treatment with anti-CD25 increases resistance to L. major infection 
(Gray et al., 2006).  By regulating the biased TH2 response in susceptible BALB/c mice 
infected with L. major, the CD4+CD25+ regulatory T cells play a significant disease 
controlling role (Xu et al., 2003).  Other studies demonstrated that the transfer of naïve 
CD4+CD25+T cells in SCID mice reconstituted with CD4+CD25- T cells, suppressed L. major 
disease development.  This suggests that CD4+CD25+ T cells also inhibit TH2 responses and 
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susceptibility to L. major infection (Xu et al., 2003).  Therefore, this study is aimed at 
identifying the role of regulatory T cells in Leishmania infection as current evidence 
suggests that the balance between regulatory T cells and effector cells is critical for 
immunity to Leishmania. 
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Aims of the project  
The key goal of this project is to identify the transcriptional differences in activated CD4+ T 
cells and regulatory T cells that do or do not express IL-4Rα that results in either a 
protective or non-protective immune response during leishmaniasis. Comparative gene 
expression profiling of activated CD4+ T cells and regulatory T cells will identify genes that 
are important for host protection or disease progression and will help us elucidate the 
molecular mechanisms of how these activated T cell subsets are primed to guide the 
immune response to be either protective or non-protective.  A deeper understanding of 
these mechanisms may result in rational approaches for effective drug and vaccine 
development as a long-term goal.  This aim was to be achieved by performing comparative 
L.major infections in mice lacking IL-4Rα on CD4+ T cells (Radwanska et al., 2007) and 
assessing the transcriptional profile of the popliteal lymph node T cells at three weeks post 
infection. 
 
Specific objectives 
 Complete a minimum of three comparative L. major infections comprising from 
iLCKcreIL-4Rαlox/-, IL-4Rαlox/-, IL-4Rα-/-, BALB/c and C57BL/6 mice at 3 weeks post 
infection.  
 Isolate activated and regulatory T cells at three weeks post infection. 
 Purify total RNA isolated from activated and regulatory T cells  and profile the gene 
expression of these by DNA microarray 
 Analyze the microarray using bioinformatics to identify genes and pathways important 
for host protection or disease progression 
 Validate the microarray results by quantitative RT- PCR 
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Chapter 2 
Materials and Methods 
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2.1 Ethics statement.  
This study was performed in strict accordance with the recommendations of the South 
African national guidelines and University of Cape Town of practice for laboratory animal 
procedures. All mouse experiments were performed according to protocols approved by 
the Animal Research Ethics Committee of the Health Sciences Faculty, University of Cape 
Town (Permit Number: 012/033). All efforts were made to minimize suffering of the 
animals. 
 
2.2 Mice 
Mice with a global (IL-4Rα -/-) (Mohrs et al., 1999) or T cell specific (iLCKcreIL-4R α -/lox) 
(Radwanska et al., 2007) deletion of IL-4Rα, together with its littermate control (IL-4Rα -
/lox) and experimental controls (BALB/c and C57BL/6) were used for this project (Sacks et 
al., 2002).  All mice were bred and housed under specific-pathogen-free conditions at the 
University of Cape Town, South Africa and experiments were approved by the University’s 
Animal Ethics Committee.  The mice were matched for age and gender and were 
maintained under barrier conditions in the biosafety level 2 facilities in individually 
ventilated cages. Prior to experiment, the mice were genotyped by PCR. 
 
2.3 Tail vein bleed 
After restraining the mouse, the tail was heated under an infrared fluorescent lamp to 
dilate the veins. The tail was extended and an incision was made across the lateral tail vein 
with a disposable scalpel blade (Swann-Morton). From the incised site approximately 
200µl of blood was collected in microtainer serum separator tube. Gentle pressure was 
then applied to the wound to ensure hemostasis. The serum from this blood was used for 
antibody titers. 
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2.4 CD4+ T cell-specific IL-4Rα deletion in iLCKcre IL-4Rα-/lox BALB/c mice 
 
The IL-4Rα is found on haematopoietic, endothelial, epithelial, muscle, fibroblast, 
hepatocyte and brain tissue (Nelms et al. 1999). In order to study the effects of IL-4 on 
specific cell types it is necessary to target the IL-4Rα gene specifically, this is accomplished 
by using Cre/loxP recombination (see Figure 9). Cyclization recombinase (Cre) inserted 
downstream of the promoter recognises a pair of loxP binding sites flanking the gene of 
interest (Exon 7 through 9 of IL-4Rα). Cre-recombinase brings the two loxP sites together, 
removing the intervening DNA which encodes the transmembrane, soluble and extra 
cellular membrane proximal regions (Nagy 2000). To specifically target IL-4Rα deletion on 
CD4+T cells (iLCkcreIL-4Rα-/lox), Cre-recombinase expression was driven using the T cell-
specific LCK promoter (Gu et al., 1994; Radwanska et al., 2007). LCK protein tyrosine is a 
kinase involved in the T cell signal transduction pathway (Janeway and Travers 1996 and 
Chiang et al., 2001). Introduction of a neo/tk selection cassette flanked by two loxP sites 
(yellow arrowhead), and one loxP site 5’ of exon 10 resulted in the generation of the 
conditional “floxed” mouse after Cre-mediated recombination. An intercross between the 
floxed strain and LCKcre, knockin strain facilitated the generation of CD4+T cell-specific IL-
4Rα-deficient mice. Numbers indicate exons of the IL-4Rα; B, E and X, restriction sites for 
BamHI, EcoRI and XhoI (Herbert et al., 2004). 
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Figure 9 IL-4Rα gene locus and targeted deletion 
Introduction of a neo/tk selection cassette flanked by two loxP sites (yellow arrowhead), and one 
loxP site 5’ of exon 10 resulted in the generation of the conditional “floxed” mouse after Cre-
mediated recombination. An intercross between the floxed strain and LCKcre, knock-in strain 
facilitated the generation of T cell-specific IL-4Rα-deficient mice. Numbers indicate exons of the IL-
4Rα; B, E and X, restriction sites for BamHI, EcoRI and XhoI (Herbert et al., 2004). 
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Table 3 Primers for genotyping IL-4Rα knockout mice 
Target Primer Product size (bp) 
WT forward 5’-TGACCTACAAGGAACCCAGGC-3’ 600 
WT reverse 5’-CTCGGCGCACTGACCCATCT-3’ 
KO forward 5’-GCTGCTGACCTGGAATAACC-3’ 471 
KO reverse 5’-CCTTTGAGAACTGCGGGCT-3’ 
loxP forward 5’-CCCTTCCTGGCCCTGAATTT-3’ 188 
loxP reverse 5’-GTTTCCTCCTACCGCTGATT-3’ 
iLCKCre forward 5’-CAGGTATGCTCAGAAAACGCCTGG-3’ 450 
iLCKcre reverse 5’-GAGGGTGGAATGAAACTCTCGGT-3’ 
 
 
2.5 Culturing and preparation of Leishmania major 
After 5-6 weeks post infection, passage BALB/c mice infected with 2x106 L. major 
MRHO/SU/59/P was sacrificed by cervical dislocation and infected footpads and the 
draining popliteal lymph nodes were harvested and placed in 5ml Schneider’s medium 
(Sigma) supplemented with 20% FCS in a tissue culture flask. The flask was then incubated 
at room temperature in a humidified chamber for 7 days.  From days 3-4, motile parasites 
become apparent. Parasites were counted daily to determine the growth curve in 0.1% 
glutaraldehyde in Neubauer chamber with depth of 0.05mm (conversion factor 2x104).  At 
days 6 -7, parasites should be at ~ 108/ml in the stationary phase. To prepare parasites for 
infection, supernatants were transferred from the culture flask to a 50ml falcon tube and 
centrifuged at 500 rpm for 5 minutes to pellet the debris.  The supernatant was then 
transferred to a new 50 ml falcon tube and centrifuged at 3000 rpm to pellet the parasites. 
Parasites were then washed twice in HBSS with protein inhibitor (see appendix) and 
counted as described above.  Finally the parasites were resuspended in the required 
volume for infection. 
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2.6 Leishmania major infection 
Prior to infection, mice were bled to access naïve antibody titers by ELISA. L. major LV 39 
(MRHO/SU/59/P) strain was maintained by continuous passage in BALB/c mice and 
cultured in vitro as previously described (Radwanska et al., 2007).  Six mice per group were 
anesthetized and infected with 50 µl of 2x106 stationary phase metacyclic promastigote 
stage L. major, subcutaneously into the left hind footpad.  Infected footpad swelling was 
measured weekly as an indication of disease progression using a pocket thickness gauge 
(Mitutoyo, Japan) until mice were to be sacrificed. Necrosis was also noted and recorded.  
Mice with a footpad swelling measurement of greater than 5mm were euthanized in 
accordance with the animal ethics regulations. 
 
2.7 Quantification of parasite burden  
Parasite burden was determined from infected organs by the limiting dilution assay (LDA) 
and quantitative real-time PCR (Nicolas, Prina, Lang, & Milon, 2002).  At three weeks post 
infection, the mice were sacrificed by cervical dislocation and sterilized by spraying 
liberally with 70% ethanol.  The infected footpads and draining popliteal lymph nodes 
were harvested and placed in 2ml Schneider’s medium supplemented with 20% FCS and 
DMEM supplemented with 10% FCS respectively.  The footpad was homogenized and a 
single cell suspension was prepared from the lymph node to a final volume of 6.4 ml.  Two-
fold serial dilutions were prepared in Schneider’s medium (Sigma) with 20% FCS in a flat 
bottomed tissue culture grade 96 well plate, and the cultures were examined for parasites 
after 7 days at room temperature.  The number of parasites per footpad or draining lymph 
node  was calculated as follows: parasite burden = (geometric mean of titre from 
quadruplicate cultures) × (reciprocal fraction of the homogenized footpad inoculated into 
the first well). The titre was the reciprocal of the last dilution in which parasites were 
observed (Carrion et al., 2011).  
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2.8 Lymphocyte isolation 
Post sacrifice the draining popliteal lymph nodes was harvested from the mice and placed 
in ice cold DMEM supplemented with 5% FCS.  Single cell suspensions were made from the 
pooled lymph nodes per group, by teasing lymph nodes through a 40µM filter (Becton 
Dickinson) or metal sieve using the plunger of a syringe into a 5.0 ml falcon tube.  Single 
cell suspension was collected by centrifugation at 1600 rpm for 5 minutes at 4°C in a 50ml 
falcon tube.  Cells were washed twice in media.  The pelleted cells were resuspended in 
10ml media and stained with Trypan blue (1 in 10 dilution) (Sigma-Aldrich, Irwine, UK) to 
assess the number of cells per group.  Cells were counted using a Neubauer counting 
chamber (Surface: 0.0025 mm2, Tiefe: 0.1 mm).   
 
2.9 Extracellular Surface staining 
Extracelluar surface staining was performed to set up gating strategy for FACS sorting of 
the activated T cells and regulatory T cells.  Lymphocytes were isolated as described above 
and resuspended in FACS buffer (PBS supplemented with 0.1% BSA and 0.05% Sodium 
Azide).  Activated T cells (CD4+CD44med-hiCD62Llo) and regulatory T cells (CD4+CD25+) were 
quantified in the lymph node using fluorescein isothiocyanate (FITC), phycoerythrin (PE) 
and allophycocyanin (APC) monoclonal antibodies A list of the specific dilution and 
catalogue numbers are listed in the appendix. Cells from one of the control groups 
(BALB/c) were used for this part of the experiment.  A volume of 500 µl popliteal lymph 
node cells (1x107 cells /ml) from the BALB/c control group was aliquoted into each FACS 
tube and centrifuged at 1600 rpm at 4°C for 10 minutes to pellet the cells. These cells 
where then incubated with 2% rat serum diluted in FACS buffer on ice for 5 minutes to 
prevent non specific binding.  Cells were stained for the surface markers for 15 minutes at 
4°C in the dark and were resuspended in FACS buffer containing 7AAD (1:1000) (Sigma, St. 
Louis, USA) and acquired using the FACS Calibur (BD Biosciences, San Jose, CA, USA) and 
data was analyzed using FlowJo v7.2 (Tree Star, Inc., Ashland, Oregon, USA)   
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2.10 FACS Sorting of CD4+ T cells and CD4+CD25+ regulatory T cells from popliteal 
lymphnodes 
2.10.1  Activated T cell Isolation using CD4 Microbeads 
Lymph node CD4+ T cells were positively selected using anti-CD4 coupled to microbeads   
(MACS, Miltenyi Biotec). Single cell suspensions prepared from lymph nodes were 
incubated with anti-CD4 microbeads and passed through an LS separation column (max 
108 cells). The magnetically labeled CD4+ cells were retained in the column while unlabeled 
cells ran through. After removal from the magnetic field, CD4+ cells were eluted. These cells 
were then stained for surface marker expression for activated T cells (CD4+CD44med-
hiCD62Llo) supplemented with 4% rat serum then resuspended in 7AAD and FACS Sorted 
using the FACS Vantage.  A purity of >98% was obtained, which was confirmed by FACS. 
2.10.2  Regulatory T cells isolation using CD4+CD25+ regulatory T cell Isolation 
Kit (MACS Miltenyi Biotec)  
Lymph node CD4+CD25+ regulatory T cells were isolated in a two-step procedure. First, 
CD4+ T cells were pre-enriched by depletion of unwanted cells. Then, CD25+ cells were 
positively selected from the enriched CD4+ T cell fraction.  For the isolation of CD4+ T cells, 
non-CD4 T cells were indirectly magnetically labeled with a cocktail of Biotin-conjugated 
antibodies and Anti-Biotin microbeads. In parallel, the cells were labeled with CD25-PE. 
The cell suspension was then loaded onto a MACS column (LD), which was placed in the 
magnetic field of a MACS Separator. The magnetically labeled non-CD4+ T cells were 
retained in the column, while the unlabelled, CD4+ T cells ran through.  For the isolation of 
CD4+CD25+ cells, the CD25+ PE labeled cells in the enriched CD4+ T cell fraction were 
magnetically labeled with Anti-PE microbeads. The cell suspension was loaded onto a 
column which was placed in the magnetic field of the MACS Separator. The magnetically 
labeled CD4+CD25+ cells were retained in the column, while the unlabelled cells ran 
through. After removal of the column from the magnetic field, the retained CD4+CD25+ cells 
were eluted as the positively selected cell fraction and once again separated over a new 
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column, to achieve highest purities.  The cells were resuspended in 7AAD and FACS Sorted 
using the FACSVantage.  A purity of >98% was obtained, which was confirmed by FACS. 
 
2.11 Flow cytometry 
The following antibodies were used for flow cytometry: CD3-FITC, CD4-PerCP, CD8-PE, 
CD19-biotin, CD86-FITC, CD11c-PE, MHCII-APC, CD44-FITC, CD62L-APC, CD4-FITC and 
CD25-PE (all BD Bioscience Erembodegem, Belgium). For intracellular cytokine staining, 
popliteal lymph node cells from L.major infected mice were seeded at 2x106 cells/well and 
stimulated at 37° C for 4 hours with phorbal myristate acetate (Sigma-Aldrich) (50ng/ml), 
ionomycin (Sigma-Aldrich) (250ng/ml) and monensin (Sigma-Aldrich) (200µM) in 
DMEM/10% FCS. Cells were stained, fixed and permeabilized, and intracellular cytokines 
were stained with anti-IL-10, anti-IL-12, anti-IFNγ, and anti-IL-13 and isotype controls (BD 
Bioscience) (all PE-labelled). Cells were acquired on a FACS Calibur machine (BD 
Immunocytometry systems, San Jose, CA, USA) and data were analyzed using Flowjo 
software (Treestar, Ashland, OR, USA). 
2.12 Antibody detection by Enzyme-linked Immunosorbent Assays (ELISA) 
Blood samples were taken by tail vein bleeding at day zero and three weeks post infection 
in gel separation tubes (Microtainer, BD, USA).  Samples were centrifuged at 8000 rpm for 
15 minutes at 4°C.  Leishmania-specific IgG1, IgG2a and IgG2b were measured by indirect 
ELISA using 5μg/ml Soluble Leishmania Antigen (SLA) for coating (overnight at 4°C) on 
nunc maxisorb ELISA plates (Nunc, Reskilde Denmark). The plates were blocked for 3 
hours at 37°C, washed 3 x, serum added in serial dilutions and incubated overnight at 4°C.  
Alkaline Phosphatase (AP)-labelled goat-anti-mouse isotype-specific Abs (Southern 
Biotechnology, Birmingham, USA) were added for 1 hour at 37°C.  Total IgE was measured 
by sandwich ELISA using clone 84.1C as a coat and anti-mouse IgE (Southern 
Biotechnology, USA) for detection (Nieuwenhuizen et al., 2007). Total IgE, IgG1, IgG2a and 
IgG2b levels were measured for naïve and L. major treated mice (days 0 and 21) by 
sandwich ELISA. Anti-mouse IgE (84.1C), IgG1, IgG2a and IgG2b mAbs were used for 
coating, purified recombinant mouse IgE, IgG1, IgG2a and IgG2b (BD Pharmingen) were 
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used as standards and anti-mouse isotype-specific Abs (Southern Biotechnology, USA) for 
detection. 4-Nitrophenylphosphate (PNP, Fluka, Switzerland) dissolved at 1mg/ml in 
substrate buffer was added to all samples and the absorbance measured at 405nm on a 
Versamax microplate spectrophotometer (Molecular Devices, Germany). 
 
2.13 RNA Preparation from FACS sorted Cells 
Sorted activated and regulatory T cells were lysed in 500 µl TriReagent® (Molecular Research, 
USA) and stored at -80°C. To extract the RNA, thawed samples were incubated at room temperature 
for 5 min to ensure complete dissociation of nucleoproteins. To each sample, 0.1 ml of chloroform 
was added and samples were vortexed for 15 seconds and incubated at room temperature for a 
further 15 min prior to centrifugation at 12000 rpm for 15 min at 4°C. The RNA contained in the 
upper aqueous layer was purified using the miRNeasy Mini Kit (Cat. No. 217004, Qiagen, USA), 
RNeasy MinElute Cleanup Kit (Cat. No. 74204, Qiagen, USA) and the RNase-Free DNase Set (Cat. No. 
79254, Qiagen, USA). RNA quantity was determined using a Nanodrop ND1000 (Thermo Scientific, 
USA) and the integrity was determined using the Agilent RNA 6000 Pico Kit (Cat. No. 5067-1513, 
Agilent Technologies, USA) on an Agilent 2100 Bioanalyzer (Agilent Technologies, USA). The Agilent 
assays were performed by the Centre for Proteomic and Genomic Research, Cape Town.  
2.14 cDNA Synthesis 
For each sample, 20 ng of extracted RNA (>200 nt fraction) was converted to cDNA via a poly-A and 
random priming method and linearly amplified and purified using the Ovation Pico WTA System 
(Cat. No. 3300, Nugen, USA) in conjunction with the DNA Clean & Concentrator Kit (Cat. No. D4005, 
Zymo Research, USA). The purity, concentration and yields were assessed using the Nanodrop. 
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2.15 Quantitative Real-time Polymerase Chain Reaction  
The transcription level of selected genes (Type 1 and Type 2) was confirmed by 
quantitative real-time RT-PCR. This was performed on cDNA samples to determine gene 
expression levels of marker genes. Each reaction contained SYBR® Green Master Mix (Cat. 
No. 04913850001, Roche, Germany), primers and cDNA template. Reactions were prepared 
in 96- or 384-well plates (Roche, Germany) using a QIAgility robot (Qiagen, USA) and PCRs 
were performed in a LightCycler® 480 (Roche, Germany). To generate PCR standards, PCR 
products from each amplified gene were purified using the QIAquick PCR Purification Kit 
(Cat. No. 28104, Qiagen, USA) and subsequently quantified on a Nanodrop ND1000 
(Thermo Scientific, USA). Using the formula: pmoles of ds DNA = (ug of ds DNA) x 1515 ÷ 
(product size in bp), the concentration to which the purified sample had to be diluted to 
obtain 1 x 106 molecules/µl was determined. Standard curves were prepared using serial 
ten-fold dilutions of the known amounts of starting material for each gene. Gene expression 
levels were normalized to either the rs12 or HPRT house-keeping gene. PCR specificity was 
confirmed via melt-curve analysis (a single sharp peak indicated a single homogenous 
product). 2-ΔΔCt method was used as the relative quantification algorithm in real-time RT-
PCR of a target transcript in comparison to a reference gene. The threshold cycle (CT), 
defined as the cycle at which PCR amplification reached a significant value, was given as the 
mean value. The relative expression of each mRNA was calculated by ΔCT method (where 
ΔCT was the value obtained by subtracting the CT value of the endogenous control gene 
from the CT value of the target gene).  All PCR reactions were done in triplicate. The fold 
change in the transcription level of target genes was calculated using the 2-ΔΔCt method. 
Primer sequences and PCR conditions are indicated in Table 4.  
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Table 4   Primers used for the quantitative real-time PCR Pre-microarray 
validation 
No Genes Sequences Primer 
length 
Product 
length 
Anne
aling 
Temp 
Ext 
Time   
(sec) 
Acquis
ition 
Temp 
1 
IL-4-
Forward 
5’-TCG GCA TTT TGA ACG 
AGG TC-3’ 
20 216 60 9 80 
1 
IL-4-
Reverse 
5’-GAA AAG CCC GAA AGA 
GTC TC-3’ 
20 
    
2 
IFN-γ-
Forward 
5’-GCT CTG AGA CAA TGA 
ACG CT-3’ 
20 227 60 10 82 
2 
IFN-γ-
Reverse 
5’-AAA GAG ATA ATC TGG 
CTC TGC-3’ 
21 
    
3 
GAPDH-
Forward 
5’-TTC ACC ACC ATG GAG 
AAG GC-3’ 
20 236 60 9 80 
3 
GAPDH-
Reverse 
5’-GGC ATG GAC TGT GGT 
CAT GA-3’ 
20 
    
4 
Rs12-
Forward 
5’-GGA AGG CAT AGC TGC 
TGG AGG T-3’ 
22 365 60 10 80 
4 
Rs12-
Reverse 
5’-CGA TGA CAT CCT TGG 
CCT GA-3’ 
20 
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2.16 Microarray design and overview 
Amplification of RNA was performed using the WT-Ovation Pico assay.  The purified cDNA 
was fragmented and subsequently labeled using the FL-Ovation™ cDNA Biotin Module. The 
fragmentation step is an enzymatic process producing single stranded cDNA fragments 
ranging from 50 – 100 bases. To ensure that the fragmentation step was successful, the 
samples were analysed using the Agilent Bioanalyser. The samples were labeled using an 
enzymatic process where a biotin-labeled nucleotide is attached to the 3-hydroxyl end of 
the fragmented cDNA.  
 
2.16.1  For Activated T cell microarray 
2 µg of amplified cDNA was labeled and hybridized to GeneChip Mouse Exon 1.0 ST Arrays 
for 18 hours in accordance with the Affymetrix protocol. After hybridization, the arrays 
were washed and stained using the GeneChip® Fluidics Station 450 and scanned using the 
GeneChip® Scanner 3000 7G.  The above steps were performed by the Centre for 
Proteomic and Genomic Research, Cape Town. 
 
2.16.2  For Regulatory T cell microarray 
2 µg of amplified cDNA was biotin-labeled using the Encore™ BiotinIL Module (Cat No. 
4210, Nugen, USA) and purified using the Qiagen Mini Elute Spin Column (Cat. No. 28004, 
Qiagen, USA). Samples were then hybridized to Illumina® MouseWG-6 v2.0 Expression 
BeadChips (Illumina, San Diego, CA, USA) as per the manufacturer’s  indications. BeadChips 
were scanned with the Illumina® BeadArray Reader and signal intensities were recorded 
as iDAT (image data) files for each chip. The above steps were performed by Dr. Roy Sugata 
at the RIKEN Omics Science Centre, Japan.  
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2.17 Microarray data analysis 
For both the Affymetrix exon array (activated T cells) and Illumina bead array (regulatory 
T cells), the iDAT files were converted to data tables using Affymetrix Expression Console™ 
Software (goo.gl/QnfMw) and Illumina® Genome Studio Version 3 software 
(www.illumina.com). Quality control of the data was also done using this software. Samples 
were normalized by the quantile normalization method using the Bioconductor package, 
Limma (Smyth & Speed, 2003) and clustered via the hierarchical clustering method using 
Spotfire® software (spotfire.tibco.com). The above steps were also performed by the 
Centre for Proteomic and Genomic Research, Cape Town (activated T cells) and Dr. Roy 
Sugata at the RIKEN Omics Science Centre, Japan (regulatory T cells).  A python program 
was written by a fellow lab member, Mr Andrew Einhorn, to generate lists of differentially 
expressed genes from the normalized data using user-defined criteria for fold-change and 
p-value cut-offs. Significance of differential expression was determined using a two-tailed 
Student’s t-test. The python program required an input of a minimum expression cut off-
value which was calculated by determining the expression level at which genes were 
classified as 90 % ‘present’ by the Genome Studio software (www.affymetrix.com and 
www.illumina.com). Including a minimum cut-off reduced the amount of noise in the list of 
differentially expressed genes. Genes were only excluded if expression values in both 
datasets being compared fell below the minimum. The python program also appended 
annotations to each gene using the Affymetrix and Illumina annotation files 
(www.affymetrix.com and www.illumina.com). Annotated gene lists were loaded onto 
Ingenuity Pathway Anaysis (IPA) software (Ingenuity® Systems, www.ingenuity.com) and 
Babelomics (http://babelomics.bioinfo.cipf.es) for network, pathway and functional 
analyses. Automated literature searches using user-defined search terms were performed 
using MILANO online software (Rubinstein & Simon, 2005).  Figure 10 depicts the 
experimental approach to obtain the lists of differentially expressed genes. 
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Figure 10 Experimental approach to obtain list of differentially expressed genes
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2.18 Statistical analysis 
Values are shown as mean ± SD or SEM and significant differences were determined using 
the unpaired one or two-tailed Student’s t-test or one-way ANOVA  using a Dunnett's 
Multiple Comparison post test. *, ** and *** indicate p<0.05, p<0.01 and p<0.001 
respectively (Graphpad Prism™). 
 
2.19 Calculating the fold change from the microarrays 
Activated T cell Microarray was performed using affymetrix platform. The expression 
values received were log transformed values. Firstly, data was converted to linear, then 
triplicate values were averaged, data was then normalized to a control, BALB/c. The 
normalized individual values were then plotted using Graphpad prism to perform 
statistical analysis. 
For the regulatory T cell microarray was performed using Illumina platform. The 
expression values received were linear values. This data was already linear. Triplicate 
values were averaged; data was then normalized to a control, BALB/c.  The normalized 
individual values were then plotted using Graphpad prism to perform statistical analysis. 
 
2.20 Validation of candidate genes using quantitative RT-PCR 
To confirm the differential expression of the candidate genes, quantitative RT-PCR using 
the same RNA samples used in the microarray, was performed.  The method used was as 
described above. All PCR reactions were done in triplicate. The fold change in the 
transcription level of target genes was calculated using the 2-ΔΔCt method. Primer 
sequences and PCR conditions are indicated in Table 5. 
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Table 5  Primers used for the quantitative real-time PCR- Validation Post-
microarray validation 
No Genes Sequences Primer 
length 
Product 
length 
Annea
ling 
Temp 
Ext 
Time   
(sec) 
Acquisit
ion 
Temp 
1 
IL-18r1-
Forward 
5'-
GGCCAGGTGCAGTCTGTA
GCAA-3' 
22 275 60 11 78 
1 
IL-18r1-
Reverse 
5'-
TGAGATGCTTGGTGGGAA
ACCTGAT-3' 
25 
    
2 
STAT4-
Forward 
5'-
GCTGCAGCCAACATGCCTA
TCCAG-3' 
24 322 60 13 77 
2 
STAT4-
Reverse 
5'-
GGTGGGAGGTTCTCGTAA
GCAAGA-3' 
24 
    
3 
Rnf130-
Forward 
5'-
GGACAGGAACCAGCGTCG
TC-3' 
20 444 60 18 82 
3 
Rnf130-
Reverse 
5'-
GTGCGAGGAGTGAGCTCC
CCA-3' 
21 
    
4 
Rapgef4-
Forward 
5'-
ACATCTGAAGTGCCCAGA
GTGATGT-3' 
25 257 60 11 84 
4 
Rapgef4-
Reverse 
5'-
GGTGCTGGCGTGCCAACA
ATG-3' 
21 
    
5 
CCR5-
Forward 
5'-
GCAGTTTCGGAGCAGTGT
TGCTT-3' 
23 355 60 14 79 
5 
CCR5-
Reverse 
5'-
AAGCTGGGGCTGTAGCAG
ACTGA-3' 
23 
    
6 
CCL5-
Forward 
5'-
CCTCACCATATGGCTCGGA
CACCA-3' 
24 79 60 3 80 
6 
CCL5-
Reverse 
5'-
TCCTTGACGTGGGCACGA
GG-3' 
20 
    
7 
B2M-
Forward 
5'-
TCACGCCACCCACCGGAGA
A-3' 
20 265 60 11 80 
7 
B2M-
Reverse 
5'-
TGTCTCGATCCCAGTAGAC
GGTC-3' 
23 
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Results 
3.1.1 Comparative L. major infection 
In order to investigate the role of IL-4Rα-responsive T cells during cutaneous Leishmaniasis, 
comparative L. major infection experiments were done in non-healer BALB/c mice with a 
deletion of the IL-4Rα on all cells (IL-4Rα-/-) or T cells only (iLCKcreIL-4Rαlox/-), their littermate 
controls (wild-type (WT) BALB/c and IL-4Rαlox/-) and healer C57BL/6 mice. Six mice per group 
were infected subcutaneously in the hind footpad with 2 × 10
6
 stationary phase metacyclic 
promastigotes of L. major LV39 (MRHO/SV/59/P). Disease progression was monitored by 
measuring the footpad swelling, parasite burden and systemic antibody responses. Three 
independent biological experiments were carried out.  
 
3.1.2 Footpad swelling and Parasite burden 
Footpad swelling was monitored weekly using a pocket thickness gauge (Mitutoyo, Japan) 
until the end point of the experiment. At three weeks post-infection parasite burden in 
footpads was determined by the limiting dilution method. Significant differences in footpad 
swelling were observed for the iLCKcreIL-4Rαlox/- and IL-4Rα-/- groups when compared to 
the BALB/c mice at the last time point (Figure 11A). Parasite burden in footpads was 
similar among all the mouse groups, with the susceptible BALB/c mice displaying a small 
but significant higher parasite burden as compared to the iLCKcreIL-4Rαlox/-, IL-4Rα-/- and 
C57BL/6 mice (Figure 11B).  
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Figure 11  Footpad swelling and parasite burden during acute L. major infection 
Six mice per strain were infected subcutaneously in the hind footpad with 2 × 106 stationary phase 
metacyclic promastigotes of L. major LV39 (MRHO/SV/59/P). A. Footpad swelling was monitored 
weekly using a pocket thickness gauge (Mitutoyo, Japan). Pooled data of three experiments. 
Statistics: BALB/c vs. iLCKcreIL-4Rα-/lox p< 0.01 **, BALB/c vs. IL-4Rα-/- p<0.05 *. B. At three 
weeks post-infection parasite burden in footpads was determined by the limiting dilution method. 
A representative of one of three experiments is shown. Statistical significance was determined by 
comparing all groups to the BALB/c control group ** P<0.01 (Anova) 
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3.1.3 Antibody responses to L. major infection 
In order to assess TH1 or TH2 differentiation and the development of the type 1 or type 2 
immune responses during the acute phase of leishmaniasis, the levels of antigen–specific 
IgG2b and total IgE was measured in the sera of each mouse group by sandwich ELISA and 
using SLA.  Total IgE was detected at significantly higher levels in both the susceptible 
BALB/c mice and the IL-4Rαlox/- littermate controls as compared to the iLCKcreIL-4Rαlox/-, 
IL-4Rα-/- and C57BL/6 mouse groups. The levels of total IgE were equivalent between the 
iLCKcreIL-4Rαlox/- and C57BL/6 mice, whereas in the IL-4Rα-/- mice the total IgE level was 
significantly impaired and was at the detection level of the ELISA (Figure 12). This is as 
previously reported, as the presence of IL-4Rα on B cells is needed to produce IgE 
(Radwanska et al., 2007).  Since IgE production is strictly dependent on IL-4 signaling 
(Shimoda et al., 1996) this data indicates very strong signaling via the IL-4Rα in the BALB/c 
and the IL-4Rαlox/- mice during the acute phase of L. major infection, which is associated 
with TH2 associated type 2 immune responses. Similarly, since C57BL/6 mice are known to 
mount a TH1 associated immune response to L. major infection and that the SLA-specific 
IgE levels were equivalent between the iLCKcreIL-4Rαlox/- and C57BL/6 mice, this data 
suggested that the iLCKcreIL-4Rαlox/- may also have developed TH1 associated immune 
response despite its susceptible BALB/c genetic background. It was therefore expected that 
the iLCKcreIL-4Rαlox/- and C57BL/6 mice have high SLA-specific IgG2b levels, which is 
indicative of a type 1 response (Mohrs et al., 1999). However, no clear type 1 immune 
response was observed between the various mouse groups (Figure 13).  
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Figure 12 Total IgE production. 
Six mice per strain were infected with 2x106 L. major LV39 (MRHO/SV/59/P) metacyclic 
promastigotes parasites and the serum levels of total IgE from individual mice were analysed at 
three weeks post infection by ELISA. Pooled data of three experiments is shown. All strains were 
compared to the BALB/c strain to determine statistical significance. *P<0.05 and *** P<0.001 
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SLA-specific IgG2b 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13 Soluble Leishmania antigen-specific IgG2b productions.  
Six mice per strain were infected with 2x106 L. major LV39 (MRHO/SV/59/P) metacyclic 
promastigotes parasites and the serum levels of SLA-specific IgG2b from individual mice were 
analysed at three weeks post infection by ELISA. Each graph (A-C) represents an independent 
biological experiment.  
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3.1.4 Popliteal Lymph node T cell isolation 
 
At three weeks post-infection, CD4
+
 CD44
med
-
hi
CD62L
lo
 activated T cells and CD4
+
 CD25
+
 
regulatory T cells were isolated from the draining lymph nodes of iLCK
cre
IL-4Rαlox/-, IL-4Rαlox/-, 
IL-4Rα-/-, BALB/c and C57BL/6 mice that were infected L. major LV39 (MRHO/SV/59/P).  
 
A single round of FACs sorting using the strategy depicted in Figures 14 yielded a cell purity of 
>99% for the CD4
+
CD44
med-hi
CD62L
lo
 activated T cells (Table 6). Two rounds of FACs sorting 
was needed to isolate the CD4
+
CD25
+
 regulatory T cells to a cell purity of >97%. It is important 
to note that one limitation of this study was that it was not possible to isolate a 100% pure 
regulatory T cell population. This was because it would require that the isolated CD4
+
 T cells be 
stained for both FoxP3 in addition to CD25. FoxP3 is a transcription factor that act as the 
master regulator for natural regulatory T cells and its detection by FACs analysis would 
require intracellular staining, which would result in the loss of RNA from the cells. In order to 
obtain RNA from the FACs sorted cells for microarray and quantitative RT-PCR, the cells 
needed to be viable. To determine the percentage of true CD4
+
CD25
+
FoxP3
+ 
T cells within the 
FACS sorted CD4
+
CD25
+ 
regulatory T cells, an aliquot of the CD4
+
CD25
+ 
regulatory T cells 
were intracellularly stained for FoxP3.  
 
On average 75% - 85% of the the CD4+CD25+ regulatory T cells were FoxP3+ (Figure 15). 
For the CD4+CD25+ regulatory T cells isolated from iLCKcreIL-4Rαlox/-, IL-4Rαlox/-, IL-4Rα-/- 
and BALB/c mice, greater than 80% were FoxP3+. However for the CD4+CD25+ regulatory T 
cells isolated from C57BL/6 mice, only 74% were FoxP3+ cells.  
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Figure 14 Flow cytometry gating strategy to isolate CD4+ CD44med-hi CD62Llo activated T 
cells as well as expression of CCR5 (see p152) .  
Mice were infected with 2x106 L. major LV39 (MRHO/SV/59/P) metacyclic promastigotes parasites. 
At three weeks post-infection, mice were killed and CD4+CD44med_hiCD62Llo activated T cells were 
isolated. 
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Figure 15 Flow cytometry strategy to obtain regulatory T cells as well as expression of 
CCR5 (see p152).  
Mice were infected with 2x106 L. major LV39 (MRHO/SV/59/P) metacyclic promastigotes parasites. 
At three weeks pot-infection, mice were killed and CD4+CD25+ regulatory T cells were isolated  
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Figure 16 Percentage of CD4+ CD25+ regulatory T cells that are FoxP3+. 
CD4+CD25+ Regulatory T cells from A. iLCKcreIL-4Rαlox/-, B. IL-4Rαlox/-, C. IL-4Rα-/-, D. BALB/c 
and E. C57BL/6 mice were stained intracelluarly for the transcription factor, FoxP3. The 
percentages obtained are illustrated in the box on the right of this figure.
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Table 6 Summary of yield and purity of sorted CD4+CD44med-hiCD62Llo activated 
T cells 
Experiment Sample Yield (no of cells) Purity (%) 
A 
iLCKcreIL-4Rαlox/- 89225 99.68 
IL-4Rα lox/- 110887 99.81 
IL-4Rα -/- 210596 99.61 
BALB/c 125430 99.86 
C57BL/6 70002 99.70 
B 
iLCKcreIL-4Rαlox/- 132161 99.83 
IL-4Rα lox/- 113565 99.49 
IL-4Rα -/- 147745 99.36 
BALB/c 266488 99.93 
C57BL/6 169255 99.81 
C 
iLCKcreIL-4Rαlox/- 205116 99.83 
IL-4Rα lox/- 427970 99.91 
IL-4Rα -/- 254514 99.87 
BALB/c 216640 99.88 
C57BL/6 142106 99.87 
 
Table 7 Summary of yield and purity of sorted CD4+CD25+ regulatory T cells 
Experiment Sample Yield (no of cells) Purity (%) 
A 
iLCKcreIL-4Rαlox/- 131378 99.66 
IL-4Rα lox/- 203879 99.73 
IL-4Rα -/- 489951 99.83 
BALB/c 360343 99.77 
C57BL/6 143770 99.64 
B 
iLCKcreIL-4Rαlox/- 302681 99.01 
IL-4Rα lox/- 284165 99.31 
IL-4Rα -/- 403907 99.50 
BALB/c 349880 99.19 
C57BL/6 249199 99.22 
C 
iLCKcreIL-4Rαlox/- 78754 98.33 
IL-4Rα lox/- 132363 98.86 
IL-4Rα -/- 173470 98.6 
BALB/c 188130 98.95 
C57BL/6 58755 97.23 
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3.1.5 Purification of RNA from activated and regulatory T cells  
Six mice per group were infected with 2x10
6
 stationery phase L major LV39 (MRHO/SV/59/P) 
metacyclic promastigotes into the hind footpad. At 3 weeks post-infection, CD4
+
CD44
med-
hi
CD62L
lo
 activated T cells and CD4
+
CD25
+
 regulatory T cells were isolated from the draining 
lymph nodes and FACS sorted to >98% purity. Total RNA was extracted using the Qiagen 
RNeasy Plus Micro Kit which contains proprietary “gDNA Eliminator” spin columns that 
efficiently removes any contaminating genomic DNA.  
The quality and quantity of the RNA was checked by BioAnalyzer analysis and no 
contaminating genomic DNA was detected (Figure 17). The RNA Integrity Number (RIN) for 
the RNA samples values ranged from 7.5 - 9.6 for the activated T cells (Table 8) and 6.6 - 9.3 for 
the regulatory T cells (Table 9).  The RIN values for two samples, iLCKcreIL-4Rαlox/- 
(experiment B) and BALB/c (experiment C), was not calculated due to an error in the 
BioAnalyzer software. Good quality RNA is indicated by 2 distinct peaks corresponding to the 
28S and 18S rRNA whereas degradation is indicated by decreased signal intensities for both 
rRNA peaks. The electropherograms for both these samples displayed prominent peaks that were 
comparable to the other samples. Hence, it was assumed that the quality was equivalent to the 
other samples. The BioAnalyzer analysis for these two samples was not repeated, in order to 
conserve as much RNA for the downstream microarray and PCR analyses. The 
electropherograms for these two samples displayed prominent peaks that were comparable to the 
other samples. Therefore it was assumed that the quality was equivalent to the other samples. 
The RIN is an indication of the level of RNA degradation (Schroeder et al., 2006) and a RIN of 
≥ 7 is considered acceptable for microarray. This meant that the RNA isolated from IL-4Rα lox/- 
regulatory T cells (experiment A) and potentially iLCKcreIL-4Rαlox/- activated T cells 
(experiment B) and BALB/c activated T cells (experiment C) may not be of high enough 
quality for efficient cDNA conversion and microarray analysis. However, since the method of 
cDNA synthesis and linear amplification used a whole transcriptome approach, transcripts with a 
compromised poly-A tail can be successfully amplified (Tariq et al., 2011). This allows for RNA 
samples that are partially degraded, to be successfully converted to cDNA, linearly amplified and 
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then successfully used in downstream gene expression analyses including microarrays 
(www.nugeninc.com).  
The yield of RNA for each sample isolated from activated T cells or regulatory T cells ranged 
from 6.7 to 13µg and 7.1 to 12.6µg respectively. The RNA was successfully converted to cDNA 
and linearly amplified using the Ovation Whole Transcriptome Amplification System (Nugen, 
USA), and yields exceeding 3ug were obtained for all of the samples (Tables 8 and 9). Since 
minimum cDNA yield of approximately 3ug was required for each microarray, and 
electrophoerograms indicated pure cDNA with no genomic DNA contamination (data not 
shown), the cDNA was considered to be of sufficient high quality and purity for use in the 
microarray as well as the validation quantitative RT-PCR experiments. 
 
Table 8 Summary of the RNA yields from activated T cells 
Experiment Sample 
Yield (no of 
cells) 
RNA yield 
(pg/ul) 
RIN* 
cDNA yield 
(ug) 
 
A 
iLCKcreIL-4Rαlox/- 89225 4802 8.1 10.401  
IL-4Rα lox/- 110887 4682 8.8 9.036  
IL-4Rα -/- 210596 8346 9.6 7.242  
BALB/c 125430 7078 7.7 6.705  
C57BL/6 70002 3660 7.6 8.964  
B 
iLCKcreIL-4Rαlox/- 132161 3702 N/A 13.011  
IL-4Rα lox/- 113565 4799 8.5 12.159  
IL-4Rα -/- 147745 6800 8.9 11.145  
BALB/c 266488 7853 8.5 11.949  
C57BL/6 169255 6527 9.0 11.625  
C 
iLCKcreIL-4Rαlox/- 205116 9630 8.4 11.721  
IL-4Rα lox/- 427970 14418 8.4 12.228  
IL-4Rα -/- 254514 9456 8.5 10.479  
BALB/c 216640 2737 N/A 12.927  
C57BL/6 142106 6107 8.7 11.652  
* RNA Integrity Number 
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Figure 17  Representative Bioanalyzer electropherograms of RNA Samples. The integrity 
of RNA extracted from sorted T cells was assessed using a capillary electrophoretic approach. The 
samples displaying the highest (A) and lowest (B) RNA Integrity Numbers (RIN) are shown. Good 
quality RNA is indicated by 2 distinct peaks corresponding to the 28S and 18S rRNA whereas 
degradation is indicated by decreased signal intensities for both rRNA peaks as well as an increase 
in shorter fragments. The RIN scale ranges from 1 to 10. 
A. RIN: 9.6                          B. RIN: 6.6 
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Table 9 Summary of the RNA yields from regulatory T cells  
Experiment Sample 
Yield (no of 
cells) 
RNA yield 
(pg/ul) 
RIN 
cDNA 
yield (ug) 
 
A 
iLCKcreIL-4Rαlox/- 131378 4998 7.7 7.098  
IL-4Rα lox/- 203879 9777 6.6 7.257  
IL-4Rα -/- 489951 15245 6.9 12.576  
BALB/c 360343 11625 7.9 9.72  
C57BL/6 143770 4914 7.1 2.916  
B 
iLCKcreIL-4Rαlox/- 302681 8896 8.8 12.384  
IL-4Rα lox/- 284165 7892 8.9 12.33  
IL-4Rα -/- 403907 9001 8.7 9.972  
BALB/c 349880 10899 8.8 10.932  
C57BL/6 249199 7595 8.7 12.597  
C 
iLCKcreIL-4Rαlox/- 78754 2754 9.1 12.027  
IL-4Rα lox/- 132363 4756 9.1 11.412  
IL-4Rα -/- 173470 5248 8.9 12.033  
BALB/c 188130 6876 9.3 11.655  
C57BL/6 58755 1925 8.9 9.75  
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In order to determine if the RNA isolated from each mouse group was “biologically 
representative” of the observed phenotypic data (Figures 11-13 ) and reported in vivo data 
(Radwanska et al., 2007), the induction of IFN-γ and IL-4 was measured by quantitative 
real-time RT-PCR. C57BL/6 mice are reported to be genetically resistant to L. major, 
characterized by elevated IFN-γ levels and the induction of a strong TH1 response during 
infection. By contrast, susceptible BALB/c mice develop a progressive disease accompanied 
by high levels of IL-4 and TH2-associated cytokines (Radwanska et al., 2007). IFN-γ 
expression is associated with a typical TH1 response, whereas, IL-4 expression is 
associated with a TH2 response (Alexander, Satoskar, & Russell, 1999). An aliquot of the 
RNA that was to be used for microarray analysis was used to make cDNA for the RT-PCR 
analysis. The expression profiles of the IFN-γ and IL-4 for all three independent biological 
experiments are shown in Figures 18 – 19.   
As expected, the level of IFN-γ was the highest in the activated and regulatory T cells 
isolated from C57BL/6 mice, and was on average 5-fold higher as compared to the BALB/c, 
iLCKcreIL-4Rαlox/-, IL-4Rαlox/-, and IL-4Rα-/- mouse groups. The expression of IFN-γ was at 
similar reduced levels in both the activated and regulatory T cells for the WT BALB/c, 
iLCKcreIL-4Rαlox/-, IL-4Rαlox/-, and IL-4Rα-/- mouse groups.  
In contrast, the level of IL-4 was 2-fold higher in the BALB/c activated T cells as compared 
to the iLCKcreIL-4Rαlox/-, IL-4Rαlox/- and IL-4Rα-/- mouse groups, and 4-fold higher than the 
activated T cells from C57BL/6 mice. The expression of IL-4 was equivalent in the activated 
T cells for the iLCKcreIL-4Rαlox/-, IL-4Rαlox/- and IL-4Rα-/- mouse groups.  
The level of IL-4 was almost 5-fold higher in the BALB/c regulatory T cells as compared to 
the iLCKcreIL-4Rαlox/- and IL-4Rα-/- mouse groups, and 2-fold higher than the IL-4Rαlox/- 
regulatory T cells. The expression of IL-4 was 4-fold higher in the BALB/c regulatory T cells 
as compared to the from C57BL/6 regulatory T cells.  
Furthermore, the amplification of the RT-PCR products was very efficient and robust, 
indicating that the quality of the RNA was high and can be confidently used for microarray 
analysis.  
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Figure 18 Expression levels of IL-4 expression in activated (CD4+CD44med-hiCD62Llo) and 
regulatory (CD4+CD25+) T cells isolated from L. major-infected mice at three weeks post 
infection. For each mouse group, T cells were isolated from pooled popliteal lymph nodes of 6 mice 
and sorted to > 98% purity. Total RNA was extracted, converted to cDNA and then linearly 
amplified and used for quantitative RT-PCR. Gene expression data was normalized to the rs12 
housekeeping gene, and then compared to the BALB/c group. Each graph represents the average 
and standard deviation for three independent biological experiments *** P<0.001 
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Figure 19 IFN-γ expression in activated (CD4+CD44med-hiCD62Llo) and regulatory 
(CD4+CD25+) T cells isolated from L. major-infected mice three weeks post infection. For each 
mouse group, T cells were isolated from pooled popliteal lymph nodes of 6 mice and sorted to > 
98% purity. Total RNA was extracted, converted to cDNA and then linearly amplified and used for 
quantitative RT-PCR. Gene expression data was normalized to the rs12 housekeeping gene, and 
then compared to the BALB/c group. Each graph represents the average and standard deviation for 
three independent biological experiments *** P<0.001 
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3.2 Gene expression profiling of popliteal lymph node Activated T cells 
Transcriptional profiling by microarray was used to assess the differences in activated T 
cells isolated from iLCKcreIL-4Rαlox/-, IL-4Rαlox/-, IL-4Rα-/-, BALB/c and C57BL/6 mice at 
three weeks post infection with L. major.  
Transcriptional profiling was performed to identify genes and pathways by which signaling 
via the IL-4Rα on CD4+Tcells confers host protection or susceptibility to L. major. Gene 
expression patterns were compared early during infection in T cells in the absence or 
presence of IL-4Rα signaling. 
 
3.2.1 Quality Control of microarray data 
The activated T cell microarray was performed using a GeneChip Mouse Exon 1.0 ST Array 
on an Affymetrix platform at the Centre for Proteomics and Genomic Research (CPGR) in 
Cape Town, South Africa. Before extracting biologically meaningful results from the 
microarray data, it was necessary to assess the quality of the data using various quality 
control metrics. Before extracting biologically meaningful results from the microarray data, 
it was necessary to assess the quality of the data using various quality control metrics. The 
quality scores for all microarrays were within the required specifications outlined in Table 
10, indicating no technical problems with respect to hybridization, washing, staining and 
specificity. For all microarrays, the individual background was consistently low and 
homogenous within each array, and the signal to noise ratio consistently high. 
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Table 10 Control metrics used to assess quality of microarray data 
Quality Control metric Description  
Sample Quality A sample / hybridization should be flagged 
and possibly removed when several metrics 
are outliers within the distribution of 
samples. If none of these metrics 
consistently denotes an outlier sample, the 
researcher should confidently proceed with 
downstream analysis. 
Pos_vs_neg_auc  This is the “area under the curve” or AUC 
value for a ROC curve which plots the 
detection of positive controls against the 
false detection of negative controls. 
All Probe set Mean  The mean of the signal of all probe sets 
included in the analysis. 
All Probe Set RLE Mean Mean absolute relative log expression (RLE). 
The signal of each probe set is compared to 
the median signal value of this probe set of 
the study. The metric is the mean of these 
differences from all the probe sets. 
 
3.2.2 Identification of differentially expressed genes 
Differentially expressed genes in activated T cells were identified and by performing 
comparative analyses of the microarray data between C57BL/6 versus (vs.) BALB/c and 
iLCKcreIL-4Rαlox/- vs. BALB/c, amongst others. From a previous publication (Radwanska et 
al., 2007), it is known that C57BL/6 mice are resistant and are able to heal during the acute 
and chronic stages of the disease, whereas BALB/c mice are susceptible and succumb to 
infection. Even though iLCKcreIL-4Rαlox/- is on a susceptible BALB/c genetic background, it 
is still able to heal. We sought to investigate how similar the transcriptional response of the 
iLCKcreIL-4Rαlox/- is to the C57BL/6. By comparing the mRNA expression profiles of 
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C57BL/6 to BALB/c and iLCKcreIL-4Rαlox/- to BALB/c, these comparisons will identify genes 
important for mediating protection during L. major infection. 
Historically, a fold change cut-off of 2-fold was considered standard for identifying 
differentially expressed genes in microarray data (DeRisi et al., 1996). However, it has 
emerged that arbitrarily assigning a fold change and p-value cut-off may result in a loss of 
valuable biological information (McCarthy & Smyth, 2009). When using a p-value cut-off of 
<0.05 and a differential gene expression cut-off of >2-fold, marker genes such as IFN-, 
Tbx21 and Stat4 were excluded as being differentially expressed, even though they have 
been published to be differentially regulated in CD4+T cells during TH1/TH2 differentiation 
and Leishmania infection (Zhu & Paul, 2008). Therefore in order to determine the best fold 
cut-off to use when defining differentially expressed genes, different gene lists were 
generated using a p<0.05 and different differential expression fold cut-offs, and the lists 
analyzed. A differential gene expression fold change cut-off of 1.2 combined with a p-value 
< 0.05 was found to be optimal, and was subsequently used for both the C57BL/6 vs. 
BALB/c and iLCKcreIL-4Rαlox/- vs. BALB/c comparative data analyses to identify 
differentially expressed genes (Table 11, and Tables A1 and A2 in appendix). A total of 456 
genes were differentially expressed in activated T cells from C57BL/6 mice as compared to 
BALB/c mice, with 46% being up-regulated and 54% being down-regulated in the C57BL/6 
activated T cells. In contrast, only 17 genes were differentially expressed in activated T 
cells from iLCKcreIL-4Rαlox/- mice as compared to BALB/c mice, with 70% being up-regulated 
and 30% being down-regulated in the iLCKcreIL-4Rαlox/- activated T cells. Interestingly, four 
genes (Gdpd3, Ccr5, Otud6b and H2-T10) were differentially expressed with the same up- 
or down-regulatory patterns in the C57BL/6 and the iLCKcreIL-4Rαlox/- activated T cells as 
compared to BALB/c activated T cells (Figure 20).   
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Table 11 Summary of differentially expressed genes from activated T cell 
microarray. 
  
iLCKcreIL-
4Rαlox/-  vs. 
BALB/c 
C57BL/6 vs. 
BALB/c 
DE genes 
p > 0.05 
Total DE genes 236 487 
DE genes 
p > 0.05 
fold change > ± 1.2 
Total DE genes 17 456 
# DE genes up-regulated 12 209 
# DE genes down-regulated 5 247 
# DE genes with p<0.05 9 349 
# DE genes with p <0.01 4 98 
# DE genes with p <0.05 4 9 
# DE genes located in Lmr loci 7 201 
 
 
 
 
 
 
 
 
 
Figure 20  Activated T cells with a p value <0.05 Fc >1.2  
Overlapping differentially expressed genes in dataset comparisons comprising the BALB/c control 
group. Differentially expressed genes in common in both C57BL/6 vs. BALB/c and iLCKcreIL-4Ra-/lox 
vs. BALB/c dataset comparisons from activated T cell microarray (p-value ≤ 0.05 and Fc > 1.2). 
Expression data from 3 independent biological replicates were used to generate the gene lists. 
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3.2.3 Biological relevance and interpretation of microarray data  
After having generated the lists of differentially expressed genes, the next step was to 
determine if the microarray data was biologically relevant, and to interpret the results 
biologically within the context of the experiment.  
3.2.3.1 Differential expression of IL-4Rα 
Given that activated T cells from L. major-infected from iLCKcreIL-4Rαlox/-, IL-4Rαlox/-, IL-
4Rα-/-, BALB/c and C57BL/6 were used in this microarray study, the expression of the IL-
4Rα gene in each microarray dataset was analyzed for conformity to published data (Figure 
21). In the activated T cells of the littermate control IL-4Rαlox/-, global knockout IL-4Rα-/- 
and iLCKcreIL-4Rαlox/- , the expression of IL-4Rα was significantly reduced as compared to 
the susceptible BALB/c mice. These results are in line with the published gene dosage 
effect of the IL-4Rα alleles, where BALB/c have 2 functioning alleles of the receptor as 
compared to the knockouts that have only one (IL-4Rαlox/-). Surprisingly, in the global 
knockout IL-4Rα-/- mRNA expression of the IL-4Rα receptor was still observed, even 
though the gene is not making a functional IL-4Rα protein.  A possible hypothesis for this 
observation is the detection algorithm used for Affymetrix exon array image analysis, 
which calculated overall gene expression by taking an average across all 12 exons of the IL-
4Rα, even though exons 7, 8 and 9 were deleted.  
 
3.2.3.2 Mapping of Differentially expressed genes to Leishmania major 
response (Lmr) Loci  
Furthermore, 41% of the differentially expressed genes in both C57BL/6 and iLCKcreIL-
4Rαlox/- activated T cells in mapped to Leishmania major response (Lmr) loci (Tables A1 
and A2 in appendix). This enrichment was found to highly statistically significant in 
C57BL/6 vs. BALB/c comparative analysis (Table 12), but not for the iLCKcreIL-4Rαlox/- vs. 
BALB/c analysis (Table 13). 
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Figure 21  Analysis of IL-4Rα expression levels by microarray 
Activated T cells from iLCKcreIL-4Rαlox/-, IL-4Rαlox/-, IL-4Rα-/-, BALB/c and C57BL/6 L. major-
infected mice were subject to transcriptional profiling by microarray at 3 weeks post infection. 
Relative IL-4Rα expression levels post-normalisation of microarray data. All groups were compared 
to the BALB/c control group which was set to 1. Data are representative of three independent 
biological experiments. *P<0.05, ** P<0.01 
82 
 
 Table 12 Activated T cell microarray of C57BL/6 vs. BALB/c comparison  
showing linkage to Lmr loci. A two-tailed Chi-square test with Yates correction was 
used to analyze the 2x2 contingency table below. 
 
Rest of genome DE genes Total 
# genes in Lmr 7091 201 7292 
# gene not in Lmr 16077 286 16363 
Total 23168 487 23655 
 
Result: 
 
2= 24.950 with 1 degrees of freedom 
p < 0.0001  
 
 
 
Table 13 Activated T cell microarray of iLCKcreIL-4Rαlox/- vs. BALB/c comparison  
showing linkage to Lmr loci. A two-tailed Chi-square test with Yates correction was 
used to analyze the 2x2 contingency table below. 
 
Rest of genome DE genes Total 
# genes in Lmr 7091 7 7098 
# genes not in Lmr 16077 10 16087 
Total 23168 17 23185 
 
Result: 
 
2 = 0.893 with 1 degrees of freedom.  
p < 0.3446 
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3.2.3.3 Functional clustering of the differentially expressed genes  
Functional clustering of the differentially expressed genes into common signaling 
pathways, functional networks and molecular functions was done using Babelomics 
(http://babelomics.bioinfo.cipf.es) and Ingenuity Pathway Analysis (IPA) (Ingenuity® 
Systems, www.ingenuity.com).  
The top IPA functional networks that were most significant in both the C57BL/6 vs. BALB/c 
and iLCKcreIL-4Rαlox/- vs. BALB/c comparative analysis were cellular growth and 
proliferation, cell-mediated immune response, cell signaling, inflammatory response, cell-
to-cell signaling and interaction, and cell death (Table 14 and Figures 23 and 24). Each 
network is assigned a score which is derived from the p-value. This score is assigned by IPA 
according to the fit of that network to the user-defined focus genes. The higher the score, 
the more statistically significant the clustering of genes in a network is, and the less 
likelihood that these genes are clustering due to random chance. Similarly, functional 
clustering using Babelomics revealed that the differentially expressed genes were 
significantly enriched for cytokine-cytokine receptor interaction, lysosome, transport of 
synthesized lysosomal enzymes, cell adhesion molecules with interest in the T cell receptor 
signaling pathway, antigen processing and presentation, Hemapoetic cell lineage, Type 1 
diabetes mellitus, Asthma (Jak-STAT signaling), Autoimmune thyroid disease, allograft 
rejection and graft versus host disease (Figure 22).   Babelomics uses a simple enrichment 
analysis.  Once the genes of interest have been selected, the enrichment any type of 
biologically relevant annotation in these genes is compared to the corresponding 
distribution of the annotation in the background.  FatiGo (Al-Shahrour et al., 2004) is one 
such tool that is available that use different functionally relevant annotations, such as GO 
terms and KEGG pathways. 
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Figure 22 Pathways associated with differentially expressed genes from activated T cell 
microarray. Babelomics was used to identify known biological relationships among the 
differentially expressed genes. A) The Jak-STAT signaling and B) Antigen processing and 
presentation pathways were amongst the pathways that were significantly enriched. (Illustrations 
were taken from http://babelomics.bioinfo.cipf.es) 
A 
B 
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Table 14  Summary of the top IPA networks from the activated T cell microarray 
C57BL/6 vs. BALB/c iLCKcreIL-4Rαlox/- vs. BALB/c 
Associated network Score Associated network Score 
Cellular Growth and Proliferation, 
Hematological System Development 
and Function, Cell Death 
 
 
34 
Cellular Function and Maintenance, 
Cellular Development, Hematological 
System Development and Function 
 
 
27 
Cellular Movement, Cell Death, 
Cellular Growth and Proliferation 
 
 
27 
Cell Signaling, Molecular Transport, 
Vitamin and Mineral Metabolism 
 
 
9 
Inflammatory Response, Cell 
Morphology, Hematological System 
Development and Function 
 
 
26 
Embryonic Development, Organ 
Development, Organismal Development 
 
 
3 
Cellular Development, Hematopoiesis, 
Cell-To-Cell Signaling and Interaction 
 
 
24 
    
Cell Cycle, Cellular Development, Cell 
Death 
 
24 
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Figure 23 Network analysis of differentially expressed genes in C57BL/6 vs. BALB/c 
dataset comparisons (FC > 1.2, p < 0.05) from activated T cell microarray.  
Ingenuity Pathway Analysis software (Ingenuity® Systems, www.ingenuity.com) was used to 
identify known biological relationships among the differentially expressed genes. Relationships 
represented may be activation, expression, inhibition, localization, phosphorylation, protein-DNA 
interaction, protein-protein interaction, proteolysis, regulation of binding, RNA-RNA interactions, 
transcription or translocation.  
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Figure 24  Network analysis of differentially expressed genes in iLCKcreIL-4Rαlox/- vs. 
BALB/c dataset comparisons (FC > 1.8, p < 0.05 ) from activated T cell microarray.  
Ingenuity Pathway Analysis software (Ingenuity® Systems, www.ingenuity.com) was used to 
identify known biological relationships among the differentially expressed genes. Relationships 
represented may be activation, expression, inhibition, localization, phosphorylation, protein-DNA 
interaction, protein-protein interaction, proteolysis, regulation of binding, RNA-RNA interactions, 
transcription or translocation.  
88 
 
In order to identify which DE genes were associated with either TH1 or TH2 differentiation 
during Leishmaniasis, intensive literature mining for each DE gene was done using the IPA 
knowledgebase (Ingenuity® Systems, www.ingenuity.com) and the automated literature 
search tool, MILANO (Rubinstein & Simon, 2005). The molecular interaction networks of 
the differentially expressed genes with TH1- or TH2-associated molecules were assessed 
using IPA (Ingenuity ® Systems, www.ingenuity.com). The TH2 molecules assessed were 
IL-4, IL-13 and the TH2-associated transcription factors, STAT6 and GATA3 (Paul, 2010), 
and the DE genes having molecular interactions with these TH2 genes are summarized in 
Table 15. Similarly DE genes having molecular interactions with TH1-assosiated molecules 
such as IFN-γ, TNF, T-bet and STAT4 were identified and are summarized in Table 15 
where, these interactions are depicted by grey shadowing.  
 
Functional annotations such as ‘differentiation’, ‘proliferation’, ‘activation’, ‘presentation’ 
and ‘recruitment’ are regularly used to describe the genes that are important in host 
defense and immunity against L.major. Differentially expressed genes which shared the 
same or similar combination of functional annotations were identified and are shown in 
Table 16, along with their molecular interaction with other molecules already known to be 
associated with TH1/TH2 response.  
The above literature mining strategies present only a limited analysis of the gene lists, but 
were sufficient to identify genes in activated T cells that may be contributing to disease 
protection or progression during L. major infection and / or TH1 / TH2 differentiation. 
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Table 15 Genes associated with known interactions (grey) with TH2, TH1 and regulatory molecules in activated T 
cells (Ingenuity ® Systems). 
 
Gene Gene ID 
TH2 molecules TH1 molecules Regulatory 
Molecules 
IL-4 IL-13 IL-6 IL-2 STAT6 GATA3 IFN-γ TNF IL-12 IL-18 STAT4 IL-10 TGF-β 
                              
GDPD3 6964245                           
CTSE 6753067                           
Gbp1 6901952                           
SCG5 6889893                           
IL4  6788290                           
Ifi202b 6764289                           
ALOX5AP 6935701                           
IL1R1 6748884                           
SELL 6754681                           
CCR9 6993138                           
KYNU 6876735                           
RAMP1 6751535                           
CTSH 6991264                           
HAVCR1 6780570                           
RNF130 6780777                           
GRIA3 7010835                           
Trim30a/Trim30d 6970066                           
CCR5 6993154                           
DNAJC15 6826179                           
IL23R 6954418                           
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CYSLTR2 6825872                           
GBP2 6901957                           
HLA-C 6854990                           
Ly6a 6836728                           
CCL5 6790288                           
IL18R1 6748889                           
IL18RAP 6748893                           
Ly6a 6836728                           
HLA-DRA 6855022                           
CTSL2 6813887                           
RAMP1 6751535                           
CYBB 7015521                           
TLR7 7020802                           
IL4R 6964160                           
A130004G07Rik 6889440                           
H2-T3 6855166                           
CCR5 6993154                           
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Table 16 Candidate genes from activated T cell Microarray with relevant biological function (Ingenuity ® 
Systems). 
 
Gene Gene ID 
Relationship with relevant molecules 
Role in cell 
Regulates Regulated by Binds 
T cell differentiation 
IL4  6788290 STAT6, IFNG, TNF Cd3, CD28, Th2 cells IL4R, IL2RG, Nfat differentiation, proliferation, expression 
HOPX 6939338 
DNA endogenous 
promoter, DNA 
promoter, RNA 
polymerase II NKX2-5, HNF1A SRF, Hdac, Sur1 differentiation 
IL23R 6954418 STAT3, IFNG, STAT4 IL6, IL21, TGFB1 IL23A, IL23, IL12RB1 growth, expression, function 
CCL5 6790288 CCR5, Ca2+, TNF TNF, lipopolysaccharide, IFNG CCR5, CCR1, CCR3 chemotaxis, migration, activation 
CCR5 6993154 CCR5, Ca2+, CCL4 lipopolysaccharide, CCL5, TNF CCL4, CCL5, CCL3 chemotaxis, migration, trafficking 
CTSE 6753067 HTT, IL18, IL1B IL10, EBI3, Bleomycin BAG6 number, degradation and differentiation 
CTSL2 6813887 PENK, HTT, CD74 IFNG , lipopolysaccharide, IL13 CST7, UBC function, number and degradation 
TCF4 6861850 CCND1, reporter 
gene, MYC CTNNB1, WNT3A, APC CTNNB1, ID1, ID2 transcription, expression and apoptosis 
IL4R 6964160 
STAT6, JAK1, JAK3, 
Cd23, IgE, IL4, IL5, 
STAT5A, NOS2, 
IL10, IL13 
IL4, STAT6, Interferon Alpha, TNF, 
TGFB1, Tcr, IL2, TP73, CD40, IFNG 
IL4, STAT6, JAK1, IL13, 
IL2RG, IL13RA1, IRS1, 
PTPN6, JAK2, SHC1, 
DOK2, SIRPA, INPP5D, 
IL13RA2, KAT5 
proliferation, differentiation, development, 
apoptosis, activation, activation in, 
quantity, growth, S phase, cell cycle 
progression 
A130004G07Rik 6889440 STAT6, JAK1, JAK3 IL4, STAT6, Interferon Alpha IL4, STAT6, JAK1 proliferation, activation and development 
Proliferation 
HLA-DRA 6855022 IFNG, MHC II, LYN IFNG ,lipopolysaccharide, IL10 HLA-DRB1, CD74 activation, proliferation 
IL4  6788290 STAT6, IFNG, TNF Cd3, CD28, Th2 cells IL4R, IL2RG, Nfat differentiation, proliferation, expression 
IL1R1 6748884 NFkB, IL6, IL1B IL1B, lipopolysaccharide, IL1 IL1B, IL1RAP, IL1A recruitment, proliferation and infiltration 
CTSH 6991264 SFTPB, Surfactant, 
GS-7119 PRL, IFNG, CTS3 UBC, CSTA activation and degradation 
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HAVCR1 6780570 
IL4, IFNG, IL10 cisplatin, cyclosporin A, Ren2 
TIMD4, UBQLN4, 
HAVCR1 activation, proliferation and function 
Rpl29  6992174 PAPPA ARNT2, SIM1, IL3 UBC, NEDD8, ANXA2 proliferation, cell cycle progression 
MT2A 6978290 
Cu2+ 
heavy metal, triamcinolone acetonide, 
CLDN7 TFAP2A, MTF1, JUN homeostasis, apoptosis, proliferation 
CCR5 6993154 CCR5, Ca2+, CCL4 lipopolysaccharide, CCL5, TNF CCL4, CCL5, CCL3 chemotaxis, migration, trafficking 
HDGFRP3 6968871 
Tubulin fenofibrate, cisplatin 
UBC, Tubulin, Alpha 
tubulin proliferation, stabilization, bundling 
IL23R 6954418 STAT3, IFNG, STAT4 IL6, IL21, TGFB1 IL23A, IL23, IL12RB1 growth, expression, function 
Eef1a1 6857435 
phosphatidylinositol 
4,5-diphosphate, 
GTP , GDP NRG1, cycloheximide, EGF UBC, SUMO2, SNCA proliferation, anoikis and transformation 
Ly6a 6836728 
mineral, 
Immunoglobulin, 
Igg 
Ifn alpha/beta, IFNG (includes 
EG:15978), dexamethasone FGR 
number, proliferation, abnormal 
morphology 
CCL5 6790288 CCR5, Ca2+, TNF TNF, lipopolysaccharide, IFNG CCR5, CCR1, CCR3 chemotaxis, migration, activation 
SLAMF7 6764093 
FLT3LG, TXLNA, 
LTA Bcr, tretinoin, TGM2 SLAMF7, TRIB2, MAK cytolysis, proliferation, killing 
Rpl29  6992174 PAPPA ARNT2, SIM1, IL3 UBC, NEDD8, ANXA2 proliferation, cell cycle progression 
SLAMF7 6764093 
FLT3LG, TXLNA, 
LTA Bcr, tretinoin, TGM2 SLAMF7, TRIB2, MAK cytolysis, proliferation, killing 
DBI 6761691 triacylglycerol  
cholesterol  lipid fenofibrate  APP  Insulin UBC  TSPO  UBXN2A proliferation 
Eef1a1 6857435 
phosphatidylinositol 
4,5-diphosphate, 
GTP , GDP NRG1, cycloheximide, EGF UBC, SUMO2, SNCA proliferation, anoikis and transformation 
HAVCR1 6780570 
IL4, IFNG, IL10 cisplatin, cyclosporin A, Ren2 
TIMD4, UBQLN4, 
HAVCR1 activation, proliferation and function 
IL4R 6964160 
STAT6, JAK1, JAK3, 
IRS2, IRS1, Cd23, 
IgE, IL4 , IL5, 
STAT5A, NOS2, 
IL10, FES, IL13 
IL4, STAT6, Interferon Alpha, TNF, 
TGFB1, Tcr, IL2, TP73, CD40, IFNG 
IL4, STAT6, JAK1, IL13, 
IL2RG, IL13RA1,DOK2, 
IL13RA2 
proliferation, differentiation, development, 
apoptosis, activation, activation in, 
quantity, growth, S phase, cell cycle 
progression 
A130004G07Rik 6889440 
STAT6, JAK1, JAK3 IL4, STAT6, Interferon Alpha IL4, STAT6, JAK1 proliferation, activation and development 
Activation 
HLA-DRA 6855022 IFNG, MHC II, LYN IFNG ,lipopolysaccharide, IL10 HLA-DRB1, CD74 activation, proliferation 
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IL4  6788290 STAT6, IFNG, TNF Cd3, CD28, Th2 cells IL4R, IL2RG, Nfat differentiation, proliferation, expression 
P2RY14 6905408 
Erk1/2, EGFR, 
ITGB2 UDP-D-glucose HNF4A 
activation, tyrosine phosphorylation, 
release 
RAMP1 6751535 
cyclic AMP, CALCRL, 
TNF CALCA, CALC, CALCRL   CALCRL, IAPP, CALCA binding, production and activation 
CTSH 6991264 SFTPB, Surfactant, 
GS-7119 PRL, IFNG, CTS3 UBC, CSTA activation and degradation 
HAVCR1 6780570 
IL4, IFNG, IL10 cisplatin, cyclosporin A, Ren2 
TIMD4, UBQLN4, 
HAVCR1 activation, proliferation and function 
IL23R 6954418 STAT3, IFNG, STAT4 IL6, IL21, TGFB1 IL23A, IL23, IL12RB1 growth, expression, function 
CYSLTR2 6825872 
Ca2+, EGFR, ITGAM leukotriene D4, E4, C4 
eukotriene D4, 
cysteinyl-leukotriene, 
montelukast activation, cell death, release 
GBP2 6901957 
MMP9, Rac, IRF1  IFNG, IFNB1, lipopolysaccharide 
RNA polymerase II, 
IRF1, STAT1 activation, response, cell spreading 
HLA-C 6854990 HLA-B, IFNG, STAT3 IFNG, poly rI:rC-RNA, NEF B2M, KIR2DL3, Klra4 cytotoxicity, activation, number 
CCL5 6790288 CCR5, Ca2+, TNF TNF, lipopolysaccharide, IFNG CCR5, CCR1, CCR3 chemotaxis, migration, activation 
SLAMF7 6764093 
FLT3LG, TXLNA, 
LTA Bcr, tretinoin, TGM2 SLAMF7, TRIB2, MAK cytolysis, proliferation, killing 
IL18RAP 6748893 NFkB, IL18, IL6 Il12, Interferon Alpha, STAT4 IL18, IL18R1, MYD88 function, sequestration, activation 
F2RL2 6809148 
GNA12 F2RL3  
EGFR F2  PROCR  PROTEASE F2R  F2  Jam function  activation in  formation in 
HLA-DRA 6855022 IFNG, MHC II, LYN IFNG ,lipopolysaccharide, IL10 HLA-DRB1, CD74 activation, proliferation 
TLR7 7020802 
TNF  NFkB  Cytokine 
lipopolysaccharide  resiquimod  
ssRNA 
MYD88  resiquimod  
imidazoquinolines production in  activation  maturation 
IL4R 6964160 
STAT6, JAK1, JAK3, 
IRS2, IRS1, Cd23, 
IgE, IL4 , IL5, 
STAT5A, NOS2, 
IL10, FES, IL13, 
IL4 , STAT6, Interferon Alpha, TNF, 
TGFB, Tcr, IL2, TP73, CD40, IFNG  
IL4 , STAT6, JAK1, IL13, 
IL2RG, IL13RA1, IRS1, 
PTPN6, JAK2, DOK2, 
IL13RA2 
proliferation, differentiation, development, 
apoptosis, activation, activation in, 
quantity, growth, S phase, cell cycle 
progression 
A130004G07Rik 6889440 
STAT6, JAK1, JAK3 IL4, STAT6, Interferon Alpha IL4, STAT6, JAK1 proliferation, activation and development 
CHRM2 6945419 
  methoctramine, hyoscyamine   
migration, activation in, transformation, 
inhibition in, apoptosis, survival, cell 
rounding, mitogenesis in, cell movement, 
growth 
94 
 
H2-T3 6855166 
 LCK, Plc gamma, 
VAV1, CD3E, Ca2+, 
1,4,5-IP3, Nfat,  
Ifn type 1, dendritic cells, 
lipopolysaccharide, IL10, IFNG, CD40, 
RELB, IFNB1, Interferon Alpha, TLR4, 
Tcr B2M priming, activation in 
Presentation 
HLA-DRA 6855022 IFNG, MHC II, LYN IFNG ,lipopolysaccharide, IL10 HLA-DRB1, CD74 activation, proliferation 
CTSE 6753067 HTT, IL18, IL1B IL10, EBI3, Bleomycin BAG6 number, degradation and differentiation 
CLEC4M 6980101 
CLEC4M, dextran, 
E2 mannan,CLEC4M, GP GP, CLEC4M,ENV interaction, recognition, binding 
CTSH 6991264 SFTPB, Surfactant, 
GS-7119 PRL, IFNG, CTS3 UBC, CSTA activation and degradation 
H2-T10/H2-T22 6855155 
FYN, LCK, VAV1 
lipopolysaccharide, dendritic cells, ifn 
type 1 TCR gamma delta, B2M priming 
HLA-C 6854990 HLA-B, IFNG, STAT3 IFNG, poly rI:rC-RNA, NEF B2M, KIR2DL3, Klra4 cytotoxicity, activation, number 
CYBB 7015521 
reactive oxygen 
species  superoxide  
TNF 
NCF1  phorbol myristate acetate  
NCF2 CYBA  NCF2  SPI1  production in  generation in  apoptosis 
H2-T10/H2-T22 6855155 
FYN, LCK, VAV1 
lipopolysaccharide, dendritic cells, ifn 
type 1 TCR gamma delta, B2M priming 
Recruitment 
ALOX5AP 6935701 
leukotriene, 
prostaglandin, 
ALOX5 CSF2, TNF, CEBPB CEBPE, CEBPA, CEBPD recruitment 
IL1R1 6748884 NFkB, IL6, IL1B IL1B, lipopolysaccharide, IL1 IL1B, IL1RAP, IL1A recruitment, proliferation and infiltration 
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3.2.4 Identification of candidate genes in activated T cells that may confer host 
protection or susceptibility to L. major 
 
Since the aim of the microarray was to identify differentially expressed (DE) genes 
promoting resistance and or susceptibility during Leishmaniasis, it was hypothesized that 
these genes may (i) be located on known Leishmania resistance or susceptible loci, (ii) be 
involved in TH1 / TH2 differentiation, (iii) be involved in known pathways associated with 
T cell receptor (TCR) signaling, (iv) be involved in the immunological synapse (IS) 
formation, which aids in the differentiation of T helper cells into a protective TH1 response 
and or be involved in cell-to-cell signaling and interaction and cellular growth and 
proliferation etc.  
 
A mining strategy was therefore developed (Figure 25), in which DE genes was identified 
based on a fold change cut-off of 1.2 and a p value of < 0.05. These lists of DE genes was 
then used for data mining of the gene ontology database to extract functional data for each 
differentially expressed gene, describing its cellular location, biological processes and 
molecular functions. In addition, the strategy included literature mining of the PubMed 
database to uncover the roles of the DE genes in resistance and susceptibility in 
Leishmania. After extraction and assignment of functional data, the DE genes were 
clustered into the “focus” groups based on their gene ontology associations, Babelomics / 
IPA analysis and previously published functional roles. Candidate genes belonging to two 
or more of the focus groups were then selected for further analysis. The rationale for 
selecting genes which intersected with two or more (ie >50%) of the focus functional 
groups, was that this strategy may increase the probability of selecting candidate genes 
which have a significant biological impact on the resistance of L. major infections. Indeed, 
the list of differentially expressed genes that intersected with two or more functional 
groups were found to be enriched with genes previously described in the literature to play 
a significant role in resistance to L. major (Table A5). 
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Moreover, the significant biological impact for a number of the DE genes during L. major 
infection has been demonstrated in gene deficient mouse models or cell lines. For example, 
mice deficient for CCR5 displayed skewing towards TH2 differentiation (Wong et al., 2003) 
Therefore, co-clustering of DE genes with these “high biological impact” genes may 
therefore highlight which of the DE genes should be selected for further analysis. Of the 
intersection of DE genes, 9 genes were selected for further analysis (Table A5 in appendix).  
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Figure 25 Differentially expressed genes mining strategy.  
A fold change and p value cut-off of 1.2 and 0.05 was chosen to select the differentially expressed 
genes. Data mining of the Gene Ontology database, Babelomics and Ingenuity Pathway analysis was 
employed to extract data for each DE gene describing its cellular localization, biological processes, 
location on lmr’s and molecular functions. In addition, literature mining of the PubMed database is 
used to uncover the roles of the DE genes in host defense and immunity to intracellular pathogens, 
TH1 / TH2 differentiation, T cell receptor mechanisms and proliferation. After extraction and 
assignment of functional data, the DE genes are clustered into the above “focus” groups based on 
their functional annotations. Genes belonging to more than one focus group were selected for 
further analysis. 
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 3.3 Gene expression profiling of popliteal lymph node Regulatory T cells 
 
Transcriptional profiling by microarray was used to assess the differences in regulatory T 
cells isolated from iLCKcreIL-4Rαlox/-, IL-4Rαlox/-, IL-4Rα-/-, BALB/c and C57BL/6 mice at 
three weeks post infection with L. major.  This was done in order to elucidate the 
mechanisms by which signaling via the IL-4Rα on CD4+Tcells causes susceptibility to L. 
major. Gene expression patterns were compared early during infection in regulatory T cells 
in the absence or presence of IL-4Rα signaling.  
3.3.1 Quality Control of microarray data 
The Regulatory T cell microarray was performed using Illumina® MouseWG-6 v2.0 
Expression BeadChips on an Illumina Bead array at the RIKEN Omics Science Centre in 
Japan. Before extracting biologically meaningful results from the microarray data, the 
quality of the data was assessed using various quality control metrics.  
Quality control of all the regulatory T cell RNA samples was performed by Dr Roy Sugata at 
the RIKEN Omics Science Centre in Japan and all samples performed well in terms of the QC 
metrics listed in Table 17. 
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Table 17 Control metrics used to assess quality of microarray data 
Quality Control metric Description  
Hybridization controls Sample-independent metric. Control 
oligonucleotides were spiked into the 
sample and their hybridization efficiency 
assessed so as to analyse problems with 
hybridization, washing and staining (Oeser 
et al., 2009).  
Perfect match (PM) versus Mismatch 
(MM)  
Sample-independent metric. Signal 
intensities of PM probes should be higher 
than MM probes. Deviations point to 
problems with specificity (Oeser et al., 
2009).  
Housekeeping vs. Background  Sample-dependent metric. Signal intensities 
of housekeeping genes should be consistent 
across the arrays and above the background 
signal(Oeser et al., 2009). 
Negative controls (Background and 
Noise) 
Sample-dependent metric. The signal 
intensities for the negative controls should 
be consistently low (Oeser et al., 2009). 
 
 
Prior to the identification of outlier experiments by clustering (data not shown), interarray 
normalization was done to adjust for variation in the microarray experiment itself as 
opposed to biological differences in the samples (Smyth & Speed, 2003). Figure 26 as an 
example indicating how, post normalization, the intensity distributions were adjusted to be 
equivalent (and thus comparable) for all samples. 
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Figure 26 Quantile normalization of gene expression data from regulatory T cells isolated 
from iLCKcreIL-4Rαlox/-, IL-4Rαlox/-, IL-4Rα-/-, BALB/c and C57BL/6 mice at 3 weeks post infection 
with L. major. Samples 1 – 15 represent each of the samples from the above mouse strains from 3 
independent biological experiments. For each experiment, 6 mice were used per strain. Raw 
intensity values (A) were adjusted by quantile normalization so that intensity distributions were 
equivalent among all samples (B) as indicated in the box plots. The black line in the middle of each 
101 
 
box represents the median gene expression value and the upper and lower limit of the box 
represents the 0.75 and 0.25 quantile respectively. 
3.3.2 Identification of differentially expressed genes 
 
As previously discussed, one aim of this study was to identify genes and pathways 
associated with IL-4Rα-induced TH1 and TH2 differentiation and how these genes may 
contribute to susceptibility or resistance during L. major infection at three weeks post 
infection. Thus far the pre-microarray quantitative RT-PCR has shown that the susceptible 
BALB/c produces more IL-4 (Figure 18) and the resistant C57BL/6 produces more IFN-γ 
(Figure 19) as compared to all other mouse groups, which produced intermediate levels of 
these classical TH1 and TH2 cytokines. 
CD4+CD25+ Regulatory T cells are a major source of IL-10 and play an important role in the 
regulation of immune responses. Regulatory T cells are essential for the suppression of 
detrimental pathogenic responses especially to self-antigens, however, they may also lead 
to the suppression of beneficial responses. In C57BL/6 mice infected with L. major, the 
regulatory T cells are recruited to the site of infection, where they function in a way to 
suppress the effector cells to eliminate the parasites (Belkaid et al., 2000). The depletion of 
CD25+ cells in this mouse strain enhances the production of IFN-γ by CD4+ T cells in the 
lesions. This resulted in clearance of the parasites. Similarly, in a susceptible BALB/c 
mouse strain, treatment with anti-CD25 increases resistance to L. major infection (Heinzel 
et al., 1993). By regulating the biased TH2 response in susceptible BALB/c mice infected 
with L. major, the CD4+CD25+ regulatory T cells play a significant disease controlling role 
(Xu et al., 2003). Other studies demonstrated that the transfer of naïve CD4+CD25+T cells in 
SCID mice reconstituted with CD4+CD25- T cells, suppressed L. major disease development. 
This suggests that CD4+CD25+ T cells also inhibit TH2 responses and susceptibility to L. 
major infection (Xu et al., 2003). Therefore, this study is aimed at identifying the role of 
regulatory T cells in Leishmania infection as current evidence suggests that the balance 
between regulatory T cells and effector cells is critical for immunity to Leishmania. 
 
102 
 
Differentially expressed genes in regulatory T cells were identified by comparative 
analyses between C57BL/6 vs. BALB/c and iLCKcreIL-4Rαlox/- vs. BALB/c, amongst others, 
using the same comparative analyses and criteria (fold change cut-off of >1.2 and a p-value 
< 0.05) as for the activated T cell microarray (Table 18, A3 and A4 in appendix). A total of 
485 genes were differentially expressed in regulatory T cells from C57BL/6 mice as 
compared to BALB/c mice, with 53% being up-regulated and 47% being down-regulated in 
the C57BL/6 regulatory T cells. In contrast, 103 genes were differentially expressed in 
regulatory T cells from iLCKcreIL-4Rαlox/- mice as compared to BALB/c mice, with 52% 
being up-regulated and 48% being down-regulated in the iLCKcreIL-4Rαlox/- regulatory T 
cells. Interestingly, seven genes (A130002I06RIK, C530038F07RIK, FAM115C, GDPD3, 
HIP1, IL4, PSG19) were differentially expressed with the same up- or down-regulatory 
patterns in both the C57BL/6 and the iLCKcreIL-4Rαlox/- regulatory T cells as compared to 
BALB/c regulatory T cells (Figure 27). 
 
Table 18 Summary of differentially expressed genes from regulatory T cell 
microarray. 
  
Regulatory T cell 
microarray 
  
iLCKcreIL-
4Rαlox/-  vs. 
BALB/c 
C57BL/6 vs. 
BALB/c 
DE genes 
p > 0.05 
Total DE genes 1054 1135 
DE genes 
p > 0.05 
fold change > ± 1.2 
Total DE genes 103 485 
# DE genes up-regulated 53 256 
# DE genes down-regulated 50 229 
# DE genes with p<0.05 93 361 
# DE genes with p <0.01 10 111 
# DE genes with p <0.05 0 13 
# DE genes located in Lmr loci 32 147 
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Figure 27  Regulatory T cells p value <0.05 Fc, 1.2  
Overlapping differentially expressed genes in dataset comparisons comprising the BALB/c control 
group. Differentially expressed genes in common in both C57BL/6 vs. BALB/c and iLCKcreIL-4Rα-/lox 
vs. BALB/c dataset comparisons from regulatory T cell microarray (p-value ≤ 0.05 and Fc < 1.2). 
Expression data from 3 independent biological replicates were used to generate the gene lists. 
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3.3.3 Biological relevance and interpretation of microarray data 
 
After having generated the lists of differentially expressed genes, the next step was to 
determine if the microarray data was biologically relevant, and to interpret the results 
biologically within the context of the experiment.  
 
3.3.3.1 Differential expression of IL-4Rα 
Given that regulatory T cells from L. major-infected from iLCKcreIL-4Rαlox/-, IL-4Rαlox/-, IL-
4Rα-/-, BALB/c and C57BL/6 were used in this microarray study, the expression of the IL-
4Rα gene for each dataset was analysed for conformity to expected profiles. This analysis is 
shown in Figure 28A. Unexpectedly, no significant differences in IL-4Rα expression were 
obtained among the strains for the regulatory T cells. This result was further investigated 
by performing a BLAST analysis (Altschul et al., 1997) to determine the region of 
hybridization of the microarray probe to the IL-4Rα transcript (Figure 28B). This revealed 
that the probed used in the Illumina array mapped to exon 11 of IL-4Rα (Mohrs et al., 
1999), an exon that is unaffected by the IL-4Rα deletion process. Based on this, the lack of 
significant differential IL-4Rα expression in the microarray among the strains was not a 
cause for concern as it could be reliably explained. 
 
3.3.3.2 Mapping of differentially expressed genes to Leishmania major 
response (Lmr) Loci  
Furthermore, 30% of the differentially expressed genes in C57BL/6 and 31% in iLCKcreIL-
4Rαlox/- regulatory T cells mapped to Leishmania major response (Lmr) loci (Tables A3 and 
A4 in appendix). This enrichment was found to highly statistically significant in C57BL/6 
vs. BALB/c comparative analysis (Table 19), but not for the iLCKcreIL-4Rαlox/- vs. BALB/c 
analysis (Table 20). 
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Figure 28 Analysis of IL-4Rα expression levels by microarray 
A. Regulatory T cells from iLCKcreIL-4Rαlox/-, IL-4Rαlox/-, IL-4Rα-/-, BALB/c and C57BL/6 L. major-
infected mice were subject to transcriptional profiling by microarray at three weeks post infection. 
Relative IL-4Rα expression levels post-normalisation of microarray data. All groups were compared 
to the BALB/c control group which was set to 1. Data are representative of three independent 
biological experiments. B. Location of probe used to detect IL-4Rα expression in the microarray. 
BLAST analysis revealed that the probe used for determining IL-4Rα expression levels mapped to 
exon 11 which is unaffected during the IL-4Rα deletion process. (Figure 26B illustration taken from 
Ms Umeshree Govender, MSc, 2012) 
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Table 19 Regulatory T cell microarray of C57BL/6 vs. BALB/c comparison  
showing linkage to Lmr loci. A two-tailed Chi-square test with Yates correction was 
used to analyze the 2x2 contingency table below. 
 
Rest of genome DE genes Total 
# genes in Lmr 11278 147 11425 
# gene not in Lmr 34003 338 34341 
Total 45281 485 45766 
 
Result: 
 
2= 7.191 with 1 degrees of freedom 
p < 0.0073  
 
 
Table 20 Regulatory T cell microarray of iLCKcreIL-4Rαlox/- vs. BALB/c comparison  
showing linkage to Lmr loci. A two-tailed Chi-square test with Yates correction was 
used to analyze the 2x2 contingency table below. 
 
Rest of genome DE genes Total 
# genes in Lmr 11278 32 11310 
# genes not in Lmr 34003 71 34074 
Total 45281 103 45384 
 
Result: 
 
2 = 1.769 with 1 degrees of freedom.  
p < 0.1835 
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3.3.3.3 Functional clustering of the differentially expressed genes  
Functional clustering of the differentially expressed genes into common signaling 
pathways, functional networks and molecular functions was done using Babelomics 
(http://babelomics.bioinfo.cipf.es) and Ingenuity Pathway Analysis (IPA) (Ingenuity® 
Systems, www.ingenuity.com).  
 
The top IPA functional networks that were most significant in both the C57BL/6 vs. BALB/c 
and iLCKcreIL-4Rαlox/- vs. BALB/c comparative analysis were cellular growth and 
proliferation, cell-mediated immune response, cell signaling, inflammatory response, cell-
to-cell signaling and interaction, and cell death (Table 21 and Figures 29 and 30). 
Functional clustering using Babelomics (refer to 3.2.3.3) revealed that the differentially 
expressed genes from the regulatory T cell microarray was not as significantly enriched as 
compared to the analysis from the activated T cell microarray. When comparing the 
C57BL/6 vs. BALB/c gene IDs, two biological processes were significantly enriched. These 
biological processes were cell activation and immune response.  Similar enrichment 
analysis used for the activated T cell microarray, using Babelomics was applied. 
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Table 21  Summary of the top networks from the Regulatory T cell microarray 
C57BL/6 vs. BALB/c iLCKcreIL-4Rαlox/- vs. BALB/c 
Associated network Score Associated network Score 
Gene Expression, Antimicrobial Response, 
Inflammatory Response 37 
 
 
37 
Cell-mediated Immune Response, 
Cellular Development, Cellular 
Function and Maintenance 
 
 
40 
Cell-To-Cell Signaling and Interaction, 
Hematological System Development and 
Function, Immune Cell Trafficking  
 
 
35 
Cell-mediated Immune Response, 
Cellular Development, Cellular 
Function and Maintenance 
 
 
17 
Cell-To-Cell Signaling and Interaction, 
Hematological System Development and 
Function, Cell Death 
 
 
31 
Cellular Response to Therapeutics, 
Cell Cycle, Nervous System 
Development and Function 
 
 
16 
Cell Death, Cellular Movement, Immune 
Cell Trafficking 
 
 
27 
Cell Death, Cellular Function and 
Maintenance, Reproductive System 
Development and Function 
 
 
3 
Gene Expression, Cellular Growth and 
Proliferation, Cell Cycle 
 
 
24 
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Figure 29 Network analysis of differentially expressed genes in C57BL/6 vs. BALB/c 
dataset comparisons (FC > 1.2, p < 0.05) from regulatory T cell microarray.  
Ingenuity Pathway Analysis software (Ingenuity® Systems, www.ingenuity.com) was used to 
identify known biological relationships among the differentially expressed genes. Relationships 
represented may be activation, expression, inhibition, localization, phosphorylation, protein-DNA 
interaction, protein-protein interaction, proteolysis, regulation of binding, RNA-RNA interactions, 
transcription or translocation.  
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Figure 30 Network analysis of differentially expressed genes in iLCKcreIL-4Rαlox/- vs. 
BALB/c dataset comparisons (FC > 1.2, p < 0.05) from regulatory T cell microarray.  
Ingenuity Pathway Analysis software (Ingenuity® Systems, www.ingenuity.com) was used to 
identify known biological relationships among the differentially expressed genes. Relationships 
represented may be activation, expression, inhibition, localization, phosphorylation, protein-DNA 
interaction, protein-protein interaction, proteolysis, regulation of binding, RNA-RNA interactions, 
transcription or translocation. 
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In order to identify which DE genes were associated either with TH1 or TH2 differentiation 
during Leishmaniasis, intensive literature mining for each DE gene was done using the IPA 
knowledgebase (Ingenuity ® Systems, www.ingenuity.com) and the automated literature 
search tool, MILANO (Rubinstein & Simon, 2005). The molecular interaction networks of 
the differentially expressed genes with TH1- or TH2-associated molecules were assessed 
using IPA (Ingenuity ® Systems, www.ingenuity.com). The TH2 molecules assessed were 
IL-4, IL-13 and the TH2-associated transcription factors, STAT6 and GATA3 (Paul, 2010) 
and the DE genes having molecular interactions with these TH2 genes are summarized in 
Table 22. Similarly DE genes having molecular interactions with TH1-assosiated molecules 
such as IFN-γ, TNF, T-bet and STAT4 were identified and are summarized in Table 22. In 
Table 22, these interactions are depicted by grey shadowing.  
 
Functional annotations such as ‘differentiation’, ‘proliferation’, ‘activation’, ‘presentation,’ 
‘recruitment’ and ‘homeostasis’ are regularly used to describe the genes that are important 
in host defense and immunity against L. major. Differentially expressed genes which shared 
the same or similar combination of functional annotations were identified and are shown in 
Table 23 along with their molecular interaction with other molecules already known to be 
associated with TH1/TH2 response. 
The above literature mining strategies present only a limited analysis of the gene lists, but 
were sufficient to identify genes in regulatory T cells that may be contributing to disease 
protection or progression during L. major infection.  
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Table 22 Genes associated with known interactions (grey) with TH2, TH1 and regulatory molecules in regulatory 
T cells (Ingenuity® Systems) 
 
Gene Gene ID Regulatory Molecules TH2 molecules TH1 molecules 
IL-10 TGF-β FoxP3 IL-4 IL-13 IL-6 IL-2 STAT6 IFN-γ TNF IL-12 IL-18 STAT4 
                              
HLA-C ILMN_196741                           
CTSE ILMN_253611                           
Ifi202b ILMN_210704                           
H2-Q5 ILMN_196752                           
SCG5 ILMN_209144                           
SFI1  ILMN_220674                           
ADI1  ILMN_223121                           
HLA-B ILMN_247624                           
TLR4 ILMN_217521                           
GPR83 ILMN_189915                           
IL4  ILMN_218517                           
ZFP36L1 ILMN_185448                           
CTSC ILMN_214875                           
B2M ILMN_209318                           
STX11 ILMN_215582                           
PDRG1 ILMN_210839                           
GPNMB ILMN_211323                           
ODC1 ILMN_219842                           
BHLHE40 ILMN_211922                           
Art2a-
ps/Art2b ILMN_221345                           
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CCL4 ILMN_222651                           
ZNF330 ILMN_187056                           
B2M ILMN_209318                           
PDRG1 ILMN_210839                           
STX11 ILMN_215582                           
XPO7 ILMN_204705                           
ODC1 ILMN_219842                           
Gbp1 ILMN_216856                           
RNASE4 ILMN_210173                           
ITGAE ILMN_216214                           
AIM2  ILMN_235623                           
ITGAE ILMN_212653                           
CASP9  ILMN_212974                           
IL4 ILMN_218517                           
ITGAL ILMN_218502                           
RTP4 ILMN_253388                           
NOP2 ILMN_210691                           
CCR2 ILMN_213602                           
FBXW5 ILMN_208949                           
MIA ILMN_194804                           
RGS1 ILMN_191801                           
IFNGR1 ILMN_214754                           
TRAF1 ILMN_207421                           
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Table 23 Candidate genes from regulatory T cell Microarray with relevant biological function (Ingenuity® 
Systems) 
Gene 
Gene ID 
Relationship with relevant molecules 
Role in cell 
Regulates Regulated by Binds 
Differentiation 
CTSE ILMN_253611 HTT, IL18, IL1B IL10, EBI3, Bleomycin BAG6 number, degradation and differentiation 
TLR4 
ILMN_217521 
TNF, NFkB, IL6, 
Il12, IL8, Cytokine, 
IFNB1, IL10, IL1B, 
IL12B, P38 MAPK, 
CD86, MYD88, 
CXCL10, IRF3 
Lipopolysaccharide, TNF, IFNG , LY96 
, MYD88, IL1B, CpG oligonucleotide, 
HSP90B1 LY96 , MYD88, CD14 
activation, production, maturation, 
apoptosis, induction, upregulation, 
response, recruitment 
INPP4B ILMN_212686 Akt   unknown differentiation, proliferation 
IL4  ILMN_218517 STAT6, IFNG, TNF Cd3, CD28, Th2 cells IL4R, IL2RG, Nfat differentiation, proliferation, expression 
ZFP36L1 ILMN_185448 TNF, HBB, CSF2 IRF4, macrophages,CD40LG, IL15 TNF translation in, proliferation 
GPNMB 
ILMN_211323 IL6, IL12B , TAC1 
IRF7, DNASE2, bone marrow-derived 
macrophages, monocyte-derived 
macrophages, neutrophils 
PLA2G4A, TAC1, 
SMAD4, fucoidin, 
heparin adhesion, proliferation 
ODC1 
ILMN_219842 
 ODC1, SERPINE1, 
CDK2, TLR2, 
phorbol myristate acetate, EGF, nitric 
oxide, IFNG, lipopolysaccharide, 
ODC1 
MYC, CDK9, ZNF148, 
ZNF281, KLF4, 
TNFRSF1A, SMAD3 
growth, proliferation, transformation, cell 
death, apoptosis, morphology, survival, 
invasiveness, differentiation, expression 
B2M 
ILMN_209318 
IFNG, MHC class I, 
Igg, HLA-C, Klra4, 
HLA-DQA1, STAT3, 
TFRC, IGF1R, HLA-
E, Cd8, CD8A, IL6 
IFNG, lipopolysaccharide, TNF, NEF, 
IFNB1, IL10, Interferon Alpha, 
CD40LG, GP, CD40, dendritic cells, 
IFNA2, STAT1, IFNAR1 
HLA-C, HLA-B, HLA-A, 
HFE, CD1D, MHC Class 
I, TFRC, FCGRT, HLA-E, 
HLA-G, Mhc Class1 
Heavy Chain, CD8A, H2-
ld, CALR, TAP1 
development, quantity, differentiation, 
proliferation, activation, apoptosis, 
activity, cytotoxicity, survival, 
accumulation 
GPNMB 
ILMN_211323 IL6, IL12B , TAC1 
IRF7, DNASE2, bone marrow-derived 
macrophages, Enterotoxin B, PRL, 
FGF2, monocyte-derived 
macrophages, neutrophils, FAS 
PLA2G4A, TAC1, 
SMAD4, fucoidin, 
heparin adhesion, proliferation 
ATP2C1 
ILMN_211584 
elemental calcium, 
Ca2+, heavy metal, 
TG, Calpain, TP73 
Sos, FOS, HTT, guanidinopropionic 
acid, megakaryocytes, celecoxib Atp2c2, ORAI1 
homeostasis in, apoptosis, adhesion, 
quantity, morphology, reorganization, 
differentiation, expression in, activation in, 
replication in 
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MTOR 
ILMN_204279 STAT3, MTOR    MTOR,STAT3 
proliferation, growth, phosphorylation in, 
autophagy in, autophagy, differentiation, 
cell cycle progression, size, apoptosis, 
macroautophagy in 
RPS14 
ILMN_219718 RNA polymerase II 
IL3, polyunsaturated fatty acids, 
arachidonic acid, CD28, Cd3 
TAF9, MAPK3, DLG4, 
MAP3K1, LYAR, 
Ns3/4a, EIF1B, RBBP6, 
RIPK2, ANXA2, NFKB2, 
SMYD2, TSC22D1, 
MEPCE, RELB 
translation in, differentiation, replication 
in, processing in 
AREG/AREGB 
ILMN_217903   
AREG/AREGB, Fsh, beta-estradiol, 
phorbol myristate acetate 
EGFR, WT1, Creb, 
BRCA1 
proliferation, growth, maturation, 
apoptosis, differentiation, mitogenesis, 
invasion, recycling, migration, activation 
CCR2 
ILMN_213602 
IFNG , CCL13, TNF, 
IL6, CD40, CXCL3, 
TIMP1, CCL5, CCL4, 
CXCL10, IL10, Il12, 
elemental calcium, 
Ca2+, CCL11 
lipopolysaccharide, IL10, IL2, TNF, 
CCL2, CCL13, Tcr, IL15, IL1B, LDL, 
Immunoglobulin, MOG, dendritic 
cells, Cd3 
CCL2, CCL13, CCL7, 
CCL8, CCR5, CCL, 
STAT3, G protein alpha 
I, CCL16, JAK2, CD4, 
CXCR4, ADRBK1, 
CX3CL1, Chemokine 
recruitment, quantity, chemotaxis, 
migration, infiltration, accumulation, 
response, activation, entrance, 
proliferation 
IFNGR1 
ILMN_214754 
STAT1, TNF, 
CXCL10, JAK2, IRF1 
, NOS2, CCL13, 
MMP9, CCL5, IL1B, 
nitric oxide, JAK1, 
CXCL9, SOCS1, IL6 
IFNG, Il12, TNF, IL2, Tcr, Cd3, phorbol 
myristate acetate, PBMCs, IL4 , IL13, 
CD2, PAEP, T lymphocytes 
IFNG, STAT1, JAK1, 
JAK2, IFNGR1, IFNGR2, 
V ANTIGEN, Jak, Ifn 
gamma 
activation, production, expression, 
quantity, synthesis, apoptosis, 
proliferation, activity, growth, killing 
Proliferation 
HLA-B ILMN_247624 
STAT3, NFkB, HLA-
B,LCK, VAV1, CD3E, 
CBL, GRB2, IFNG 
Igg1 
IFNG NEF, Interferon Alpha, IFNB1 , 
lipopolysaccharide, TNF, GP, IL10, 
CD40, Interferon Beta, Ins1, CD40LG, 
Insulin, dendritic cells 
B2M, VCP,CD8A, Tap 
complex (Antigen-
processing 
transporter), Tcr, HLA-
B 
activation, proliferation, recognition by, 
protection, negative selection, positive 
selection, priming, engagement, 
presentation in, lysis 
TLR4 ILMN_217521 
TNF, NFkB, IL6, 
Il12, IL8, Cytokine, 
IFNB1 , IL10, IL1B, 
IL12B, P38 MAPK, 
CD86, MYD88, 
CXCL10, IRF3 
lipopolysaccharide, TNF, IFNG, poly 
rI:rC-RNA, LY96, MYD88, E. coli B5 
lipopolysaccharide, IL1B, CD14, MIF, 
CSF2, hyaluronic acid, CpG 
oligonucleotide, HSP90B1 
LY96, MYD88, TIRAP, 
lipopolysaccharide, 
CD14, TICAM2, HMGB1, 
TICAM1, F, HSPD1, Env, 
TOLLIP, Hsp70, Hsp, 
HSP90B1 
activation in, expression in, activation, 
production in, maturation, apoptosis, 
induction in, upregulation in, response, 
recruitment 
INPP4B ILMN_212686 
Akt 
LY294002, MITF, beta-estradiol, (+)-
MK-801, methylselenic acid, AR unknown differentiation, proliferation 
IL4  ILMN_218517 STAT6, IFNG, TNF Cd3, CD28, Th2 cells IL4R, IL2RG, Nfat differentiation, proliferation, expression 
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ZFP36L1 ILMN_185448 
TNF, HBB, CSF2 
butyric acid, PDGF-BB, ARNT2, SIM1 
(includes EG:20464), camptothecin, 
SU6656, methotrexate, MS4A1, Igm, 
IRF4, WR 1065, macrophages, THP-1 
cells, CD40LG, IL15 
PCBD1, MAPK14, 
PAFAH1B2, YWHAZ, 
TBP, ZFP36, NSD1, TNF translation, proliferation 
B2M ILMN_209318 
IFNG , MHC class I, 
FCGRT, Igg, HLA-C, 
Klra4, HLA-DQA1, 
STAT3, TFRC, heavy 
metal, IGF1R, HLA-
E, Cd8, CD8A, IL6 
IFNG, lipopolysaccharide, poly rI:rC-
RNA, TNF, NEF, IFNB1, IL10, 
Interferon Alpha, CD40LG, GP, CD40, 
dendritic cells, IFNA2, STAT1, 
IFNAR1 
HLA-C, HLA-B, HLA-A, 
HFE, CD1D, MHC Class 
I, TFRC, FCGRT, HLA-E, 
HLA-G, Mhc Class1 
Heavy Chain, CD8A, H2-
ld, CALR, TAP1 
development, quantity, differentiation, 
proliferation, activation, apoptosis, 
activity, cytotoxicity, survival, 
accumulation 
SLAMF7 ILMN_207150 
FLT3LG, TXLNA, 
LTA Bcr, tretinoin, TGM2 SLAMF7, TRIB2, MAK cytolysis, proliferation, killing 
GPNMB ILMN_211323 
IL6, IL12B , TAC1 
MITF, IRF7, DNASE2, bone marrow-
derived macrophages, Enterotoxin B, 
PRL, FGF2, monocyte-derived 
macrophages, neutrophils, FAS 
PLA2G4A, TAC1, 
SMAD4, fucoidin, 
heparin adhesion, proliferation 
Rpl29  ILMN_221019 PAPPA ARNT2, SIM1, IL3 UBC, NEDD8, ANXA2 proliferation, cell cycle progression 
UBE2I ILMN_184358 
 SMAD4,STAT1, 
NFKBIA, SREBF1, 
ZNF146, MYB, 
MDM2, TP53      
sumoylation in, binding in, proliferation, 
expression in, response, contact growth 
inhibition, ligation in, cell death, 
transactivation in, migration 
ODC1 ILMN_219842 
ODC1, Cdc2, TLR2 
phorbol myristate acetate, nitric 
oxide, IFNG , lipopolysaccharide, 
cyclosporin A, tretinoin, ODC1  SMAD3 
growth, proliferation, transformation, cell 
death, apoptosis, morphology, survival, 
invasiveness, differentiation, expression in 
BHLHE40 ILMN_211922 
DNA endogenous 
promoter, DNA 
promoter, RNA 
polymerase II TGFB1, CLOCK, beta-estradiol UBC, SUMO2, BHLHE40 expression in, number, proliferation 
MTOR ILMN_204279 
EIF4EBP1, 
RPS6KB1, p70 s6k, 
Akt, STAT3, S6K1, 
HIF1A, MTOR, 
ULK1, EIF4E, IRS1, 
Pp2a, AKT1, Pkc, 
EIF4EBP2 
sirolimus, Akt, amino acids, RHEB, 
TSC2, AKT1, Insulin, INS, Ins1, 
LY294002, D-glucose, everolimus, 
RPTOR, IGF1, pi3k 
RPTOR, RICTOR, 
RPS6KB1, FKBP1A, 
MLST8, EIF4EBP1, 
MAPKAP1, RHEB, 
AKT1, MTOR, AKT1S1, 
STAT3, RHEBP1, Akt, 
TRRAP 
proliferation, growth, phosphorylation, 
autophagy, autophagy, differentiation, cell 
cycle progression, size, apoptosis, 
macroautophagy 
INPP4B ILMN_212686 
Akt 
LY294002, MITF, beta-estradiol, (+)-
MK-801, methylselenic acid, AR unknown differentiation, proliferation 
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ITGAL ILMN_218502 
ICAM1, FN1, THBS1, 
ITGAL, ITGB2, Pkc, 
APP, ITGB3, PTK2B 
MAPK1, JUN, Alpha 
tubulin, 
ITGB2, ITGAL, Tcr, Lmp1, TNF, 
ICAM1, heavy metal, Pertussis toxin, 
phorbol myristate acetate, protein-
protein complex, IL8, MYC, 
IFNG,glucocorticoid 
ICAM1, ITGB2, ICAM3, 
ICAM2, CAV1, Integrin 
beta, CD226, Cd3, 
ITGB7, C3, ITGAM 
adhesion, binding, migration, proliferation, 
cell-cell adhesion, activation, aggregation, 
attachment, cell spreading, chemotaxis 
NOP2 ILMN_210691 
unknown IL2,  
CCNB1, MAP3K1, TAT, 
MYBBP1A, MCRS1, 
SUMO2, RNU11 proliferation 
Activation 
HLA-C ILMN_196741 HLA-B, IFNG, STAT3 IFNG, NEF B2M, KIR2DL3, Klra4 cytotoxicity, activation, number 
H2-Q5 ILMN_196752 
ZAP70, FYN, LAT, 
LCK, Plc gamma, 
VAV1, CD3E, CBL, 
GRB2, elemental 
calcium, Ca2+, 1,4,5-
IP3, peptide, Nfat, 
Itpr 
lipopolysaccharide, Ifn type 1, 
dendritic cells, IFNG , IL10, 
Langerhans cells, RELB, Interferon 
Alpha, phosphatidylserine, IFNB1 , 
CD40, Ifn alpha/beta unknown activation in, priming 
HLA-B ILMN_247624 
STAT3, NFkB, HLA-
B, ZAP70, FYN, LAT, 
LCK, Plc gamma, 
VAV1, CD3E, CBL, 
GRB2, IFNG 
(includes 
EG:15978), Lilrb3 
(includes others), 
Igg1 
IFNG , NEF, Interferon Alpha, IFNB1, 
lipopolysaccharide, TNF, GP, poly 
rI:rC-RNA, IL10, CD40, Interferon 
Beta, Ins1, CD40LG, Insulin, dendritic 
cells 
B2M, LILRB1, LILRB2, 
KIR3DL1, VCP, Kir, 
CD8A, Tap, Tap 
complex (Antigen-
processing 
transporter), CANX, 
PDIA3, TAPBP, NP, Tcr, 
HLA-B 
activation, proliferation, recognition, 
protection, negative selection, positive 
selection, priming, engagement, 
presentation, lysis 
TLR4 ILMN_217521 
TNF, NFkB, IL6, 
Il12, IL8, Cytokine, 
IFNB1 , IL10, IL1B, 
IL12B, P38 MAPK, 
CD86, MYD88, 
CXCL10, IRF3 
lipopolysaccharide, TNF, IFNG, poly 
rI:rC-RNA, LY96, MYD88, E. coli B5 
lipopolysaccharide, IL1B, CD14, MIF, 
CSF2, hyaluronic acid, CpG 
oligonucleotide, HSP90B1 
LY96, MYD88, TIRAP, 
lipopolysaccharide, 
CD14, TICAM2, HMGB1, 
TICAM1, F, HSPD1, Env, 
TOLLIP, Hsp70, Hsp, 
HSP90B1 
activation,production in, maturation, 
apoptosis, induction in, upregulation in, 
response, recruitment 
GPR83 ILMN_189915 
EGFR, GSK3B, FYN, 
ITGB2, Erk1/2, 
AREG/AREGB, 
ITGAM, ICAM1, Akt 
CBFB, FOXP3, SMARCA4, 
amphetamine LY86, INSR 
activation in, tyrosine phosphorylation in, 
release in, molecular cleavage in, 
inhibition in, calcium response in, contact 
growth inhibition, apoptosis 
IL4  ILMN_218517 STAT6, IFNG, TNF Cd3, CD28, Th2 cells IL4R, IL2RG, Nfat differentiation, proliferation, expression 
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B2M ILMN_209318 
IFNG, MHC class I, 
Igg, HLA-C, Klra4, 
HLA-DQA1, STAT3, 
TFRC, IGF1R, HLA-
E, Cd8, CD8A, IL6 
IFNG, lipopolysaccharide, TNF, NEF, 
IFNB1, IL10, Interferon Alpha, 
CD40LG, GP, CD40, dendritic cells, 
IFNA2, STAT1, IFNAR1 
HLA-C, HLA-B, HLA-A, 
HFE, CD1D, MHC Class 
I, TFRC, FCGRT, HLA-E, 
HLA-G, Mhc Class1 
Heavy Chain, CD8A, H2-
ld, CALR, TAP1 
development, quantity, differentiation, 
proliferation, activation, apoptosis, 
activity, cytotoxicity, survival, 
accumulation 
SLAMF7 ILMN_207150 
FLT3LG, TXLNA, 
LTA   SLAMF7, TRIB2, MAK cytolysis, proliferation, killing 
UBE2I ILMN_184358 
SMAD4, DHX9, 
MAPK7, SUMO1, 
SREBF2, CHADL, 
STAT1, NFKBIA, 
SREBF1, ZNF146, 
MYB, MDM2, TP53  
 MAPK1, KRAS, lipopolysaccharide, 
norepinephrine, UBE2I, 3C 
SMAD4, SUMO3, DAXX, 
MITF, SP100, UBE2I, 
UBA2 
sumoylation in, binding in, proliferation, 
expression in, response, contact growth 
inhibition, ligation in, cell death, 
transactivation in, migration 
CASP9  ILMN_212974 
CASP3, CASP7, HTT, 
PARP1, CASP9 
CASP6, BID, 
CASP3/6/7, BCL2, 
MCL1, RB1, 
Caspase, STK4, 
MAP3K1, PAK2 
TNFSF10, FAS, TNF, APAF1, CYCS, 
Cytochrome C, BCL2, CASP9, 
doxorubicin, BCL2L1, HTT, dATP 
APAF1, XIAP, CYCS, 
BIRC2, BCL2L1, IAP, 
HTT, BIRC7, BIRC6, 
DCC, BIRC3, BIRC5, 
NLRP1, CASP8, PARP1 
apoptosis, cell death, molecular cleavage 
in, activation in, transmembrane potential, 
blebbing, DNA damage response, quantity, 
morphology, cleavage in 
UBE2I ILMN_184358 
 SMAD4, DHX9, 
MAPK7, SUMO1, 
SREBF2, CHADL, 
STAT1, NFKBIA, 
SREBF1, ZNF146, 
MYB, MDM2, TP53  
APP, CEBPA, ERG, trovafloxacin, 
ETV1, FLI1, EWSR1, Yersinia pestis, E. 
coli B5 lipopolysaccharide, MAPK1, 
KRAS, lipopolysaccharide, 
norepinephrine, UBE2I, 3C 
SMAD4, SUMO3, DAXX, 
MITF, SP100, UBE2I, 
UBA2 
binding, proliferation, expression, 
response, contact growth inhibition, 
ligation, cell death, transactivation, 
migration 
ATP2C1 ILMN_211584 
      
homeostasis, apoptosis, adhesion, 
quantity, morphology, reorganization, 
differentiation, expression, activation, 
replication 
RNASE4 ILMN_210173 
GAG, Interferon 
Alpha, Cytokine, 
Chemokine, IL6,  
HNF1A, NKX2-1, HOXA10, ERG, FLI1, 
ETV1, EWSR1, PRL, SUMO2, SUMO3, 
KRAS, progesterone, IFNB1 
 RNASE4, sorbitol, AMP, 
HNF1B, HNF1A, HNF4A 
binding, dissociation, cell viability, binding 
in, production in, activation 
AIM2  ILMN_235623 IL1B, IL18, CASP1 IFNG, decitabine, Influenza A virus Ifi202b activation in, cell death, maturation 
MTOR ILMN_204279 
EIF4EBP1, 
RPS6KB1, p70 s6k, 
Akt, STAT3, S6K1, 
HIF1A, MTOR, 
ULK1, EIF4E, IRS1, 
Pp2a, AKT1, Pkc, 
sirolimus, Akt, amino acids, RHEB, 
TSC2, AKT1, Insulin, INS, Ins1, 
LY294002, D-glucose, everolimus, 
RPTOR, IGF1, pi3k 
RPTOR, RICTOR, 
RPS6KB1, FKBP1A, 
MLST8, EIF4EBP1, 
MAPKAP1, RHEB, 
AKT1, MTOR, AKT1S1, 
STAT3, RHEBP1, Akt, 
proliferation, growth, phosphorylation in, 
autophagy in, autophagy, differentiation, 
cell cycle progression, size, apoptosis, 
macroautophagy in 
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EIF4EBP2 TRRAP 
ITGAL ILMN_218502 
ICAM1, FN1, THBS1, 
ITGAL, ITGB2, Pkc, 
APP, ITGB3, PTK2B 
MAPK1, JUN, Alpha 
tubulin, 
ITGB2, ITGAL, Tcr, Lmp1, TNF, 
ICAM1, heavy metal, Pertussis toxin, 
phorbol myristate acetate, protein-
protein complex, IL8, MYC, 
IFNG,glucocorticoid 
ICAM1, ITGB2, ICAM3, 
ICAM2, CAV1, Integrin 
beta, CD226, Cd3, 
ITGB7, C3, ITGAM 
adhesion, binding, migration, proliferation, 
cell-cell adhesion, activation, aggregation, 
attachment, cell spreading, chemotaxis 
AREG/AREGB ILMN_217903 
  
AREG/AREGB, Fsh, beta-estradiol, 
phorbol myristate acetate 
EGFR, WT1, Creb, 
BRCA1 
proliferation, growth, maturation, 
apoptosis, differentiation, mitogenesis in, 
invasion, recycling in, migration, activation 
in 
CCR2 ILMN_213602 
IFNG , CCL13, TNF, 
IL6, CD40, CXCL3, 
TIMP1, CCL5, CCL4, 
CXCL10, IL10, Il12, 
elemental calcium, 
Ca2+, CCL11 
lipopolysaccharide, IL10, IL2, TNF, 
CCL2, CCL13, Tcr, IL15, IL1B, LDL, 
Immunoglobulin, MOG, dendritic 
cells, Cd3 
CCL2, CCL13, CCL7, 
CCL8, CCR5, CCL, 
STAT3, G protein alpha 
I, CCL16, JAK2, CD4, 
CXCR4, ADRBK1, 
CX3CL1, Chemokine 
recruitment, quantity, chemotaxis, 
migration, infiltration by, accumulation, 
response, activation, entrance, 
proliferation 
IFNGR1 ILMN_214754 
STAT1, TNF, 
CXCL10, JAK2, IRF1 
, NOS2, CCL13, 
MMP9, CCL5, IL1B, 
nitric oxide, JAK1, 
CXCL9, SOCS1, IL6 
IFNG, Il12, TNF, IL2, Tcr, Cd3, phorbol 
myristate acetate, PBMCs, IL4 , IL13, 
CD2, PAEP, T lymphocytes 
IFNG, STAT1, JAK1, 
JAK2, IFNGR1, IFNGR2, 
V ANTIGEN, Jak, Ifn 
gamma 
activation, production in, expression in, 
quantity, synthesis in, apoptosis, 
proliferation, activity, growth in, killing 
Presentation 
HLA-C ILMN_196741 HLA-B, IFNG, STAT3 IFNG, NEF B2M, KIR2DL3, Klra4 cytotoxicity, activation, number 
CTSE ILMN_253611 HTT, IL18, IL1B IL10, EBI3, Bleomycin BAG6 number, degradation and differentiation 
HLA-B ILMN_247624 
STAT3, NFkB, HLA-
B, ZAP70, FYN, LAT, 
LCK, Plc gamma, 
VAV1, CD3E, CBL, 
GRB2, IFNG 
(includes 
EG:15978), Lilrb3 
(includes others), 
Igg1 
IFNG , NEF, Interferon Alpha, IFNB1, 
lipopolysaccharide, TNF, GP, poly 
rI:rC-RNA, IL10, CD40, Interferon 
Beta, Ins1, CD40LG, Insulin, dendritic 
cells 
B2M, LILRB1, LILRB2, 
KIR3DL1, VCP, Kir, 
CD8A, Tap, Tap 
complex (Antigen-
processing 
transporter), CANX, 
PDIA3, TAPBP, NP, Tcr, 
HLA-B 
activation, proliferation, recognition by, 
protection, negative selection, positive 
selection, priming, engagement, 
presentation in, lysis 
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B2M ILMN_209318 
IFNG, MHC class I, 
Igg, HLA-C, Klra4, 
HLA-DQA1, STAT3, 
TFRC, IGF1R, HLA-
E, Cd8, CD8A, IL6 
IFNG, lipopolysaccharide, TNF, NEF, 
IFNB1, IL10, Interferon Alpha, 
CD40LG, GP, CD40, dendritic cells, 
IFNA2, STAT1, IFNAR1 
HLA-C, HLA-B, HLA-A, 
HFE, CD1D, MHC Class 
I, TFRC, FCGRT, HLA-E, 
HLA-G, Mhc Class1 
Heavy Chain, CD8A, H2-
ld, CALR, TAP1 
development, quantity, differentiation, 
proliferation, activation, apoptosis, 
activity, cytotoxicity, survival, 
accumulation 
H2-T10/H2-
T22 
ILMN_215923 
FYN, LCK, VAV1 
lipopolysaccharide, dendritic cells, ifn 
type 1 TCR gamma delta, B2M priming 
Recruitment 
TLR4 ILMN_217521 
TNF, NFkB, IL6, 
Il12, IL8, Cytokine, 
IFNB1 , IL10, IL1B, 
IL12B, P38 MAPK, 
CD86, MYD88, 
CXCL10, IRF3 
lipopolysaccharide, TNF, IFNG, LY96, 
MYD88, IL1B, CD14, MIF, CSF2, 
hyaluronic acid, CpG oligonucleotide 
LY96, MYD88, TIRAP, 
lipopolysaccharide, 
CD14, TICAM2, HMGB1, 
TICAM1, F, HSPD1, Env, 
TOLLIP, Hsp70, Hsp, 
HSP90B1 
activation in, expression in, activation, 
production in, maturation, apoptosis, 
induction in, upregulation in, response, 
recruitment 
CTSC ILMN_214875 
ELANE, PRTN3, 
CTSG TGFB1, HRAS CTSC, UBC, YPO0870 recruitment, accumulation, function 
CCL4 ILMN_222651 
CCR5, Ca2+, P38 
MAPK lipopolysaccharide, TNF, IFNG CCR5, CCR1, CCBP2 chemotaxis, migration , recruitment 
CCR2 ILMN_213602 
IFNG , CCL13, TNF, 
IL6, CD40, CXCL3, 
TIMP1, CCL5, CCL4, 
CXCL10, IL10, Il12, 
elemental calcium, 
Ca2+, CCL11 
lipopolysaccharide, IL10, IL2, TNF, 
CCL2, CCL13, Tcr, IL15, IL1B, LDL, 
Immunoglobulin, MOG, dendritic 
cells, Cd3 
CCL2, CCL13, CCL7, 
CCL8, CCR5, CCL, 
STAT3, G protein alpha 
I, CCL16, JAK2, CD4, 
CXCR4, ADRBK1, 
CX3CL1, Chemokine 
recruitment, quantity, chemotaxis, 
migration, infiltration by, accumulation, 
response, activation, entrance, 
proliferation 
Homeostasis 
ATP2C1 ILMN_211584 
    Atp2c2, ORAI1 
homeostasis in, apoptosis, adhesion, 
quantity, morphology, reorganization, 
differentiation, expression in, activation in, 
replication in 
CCR2 ILMN_213602 
IFNG , CCL13, TNF, 
IL6, CD40, CXCL3, 
TIMP1, CCL5, CCL4, 
CXCL10, IL10, Il12, 
elemental calcium, 
Ca2+, CCL11 
lipopolysaccharide, IL10, IL2, TNF, 
CCL2, CCL13, Tcr, IL15, IL1B, LDL, 
Immunoglobulin, MOG, dendritic 
cells, Cd3 
CCL2, CCL13, CCL7, 
CCL8, CCR5, CCL, 
STAT3, G protein alpha 
I, CCL16, JAK2, CD4, 
CXCR4, ADRBK1, 
CX3CL1, Chemokine 
recruitment, quantity, chemotaxis, 
migration, infiltration by, accumulation, 
response, activation, entrance, 
proliferation 
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3.3.4 Identification of candidate genes in regulatory T cells that may confer 
protection or susceptibility to L. major 
A similar mining strategy used for the activated T cell microarray to identify which 
differentially expressed genes in the regulatory T cells may be conferring protection or 
susceptibility to L. major (Figure 25). As expected, the resulting list of candidate genes that 
intersected with two or more functional groups were found to be enriched with genes 
previously described in the literature to play a role in the outcome of Leishmaniasis (Table 
A5) and18 genes were selected for further analysis.  
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3.4 Validation of differential expression of candidate genes 
Following identification of candidate genes, standard procedure requires confirmation of 
the differential expression of the genes using quantitative RT-PCR on the original RNA 
sample. If indeed the microarray and qPCR results are in agreement, the differential 
expression of the genes can then be validated .Based on the focused functional clustering 
strategy (Figure 25), the differential expression of IL-18r1, STAT4, Rnf130, Rapgef4, CCR5 
and CCL5 in the microarray and quantitative real-time RT-PCR experiments were 
compared (Figures 31 – 36).  
 
IL-18r1 is a transmembrane receptor located on the plasma membrane that binds IL-18, IL-
18RAP and IL-37. It is selectively expressed on murine TH1 cells but not TH2 cells (Xu et 
al., 1998) and can thus be used as a surface marker to distinguish TH1 cells from TH2 cells. 
IL-18r1 is involved in the T helper cell differentiation pathway. IL-18r1 has primary roles 
in cell inflammation, function and activation as well as immune response and signal 
transduction. This receptor regulates NFk-β, IFN-γ and Jnk and it is regulated by IL-12, 
STAT4 and IL-4 (Smeltz, Chen, Hu-Li, & Shevach, 2001). In the activated T cell microarray, 
IL18r1 was significantly up regulated in C57BL/6 mice as compared to the BALB/c mice; 
whereas similar levels of IL-18r1 expression was observed amongst the various knockout 
groups (iLCKcreIL-4Rαlox/-, IL-4Rαlox/-, IL-4Rα-/-) and the BALB/c control. Quantitative real-
time RT-PCR showed that the level of IL-18r1 expression was slightly elevated in activated 
T cells of the resistant C57BL/6 mice as compared to the susceptible BALB/c mice, 
however this elevation was not statistically significantly (Figure 31). In contrast, no 
differential expression was observed for IL-18r1 in the regulatory T cell microarray data 
amongst all the mouse groups, which was confirmed by quantitative RT-PCR (Figure 31).  
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STAT4 (Signal transducer and activator of transcription 4) is a transcription factor that 
binds IFN-γ and also plays a role in the T helper cell differentiation pathway. Its biological 
function is cell proliferation, differentiation and cell development (Hoey et al., 2003). This 
transcription regulator regulates IFN-γ, TNF, IL-18r1, IL-10 and is regulated by IL-12, IL-2, 
IL-12rb2, IFN-γ and IL-6 (Kaplan, 2005). Pathways that are associated with STAT4 
includes, IL-12 signaling and production in macrophages, JAK/Stat signaling, dendritic cell 
maturation and T helper cell differentiation. In the microarray data, STAT4 is significantly 
up regulated in C57BL/6 activated T cells as compared to the BALB/c activated T cells, 
whereas similar levels of STAT4 was observed amongst the iLCKcreIL-4Rαlox/-, IL-4Rαlox/-, 
IL-4Rα-/- and BALB/c control activated T cells (Figure 32). However, this up regulation was 
not confirmed by quantitative real-time RT-PCR. No differential expression was observed 
for STAT4 in the regulatory T cell microarray data amongst all the mouse groups, which 
was confirmed by quantitative RT-PCR (Figure 32).  
 
Rnf130 (ring finger protein 130) is a protein located on the cellular membrane and forms 
part of the cytoplasm and nucleus. It is regulated by STAT4 and its biological functions 
include apoptosis, programmed cell death and protein ubiquitination (Stelzl et al., 2005). A 
significantly decreased level of Rnf130 was observed in the activated T cells of resistant 
C57BL/6 mice as compared to the susceptible BALB/c control mice, whereas levels of 
Rnf130 was equivalent in the activated T cells of among the iLCKcreIL-4Rαlox/-, IL-4Rαlox/-, 
IL-4Rα-/- and BALB/c control mouse groups (Figure 33). No differential expression was 
observed for Rnf130 in the regulatory T cell microarray data amongst all the mouse groups, 
which was confirmed by quantitative RT-PCR (Figure 33). The regulatory T cell microarray 
shows a significant down regulation of this gene in the T cell specific iLCKcreIL-4Rαlox/- mice 
when compared to the susceptible BALB/c and the other mouse groups. 
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Rapgef4 (Rap guanine nucleotide exchange factor) also known as Epac2 (exchange protein 
directly impacted by cAMP) is located in the cytoplasm and its biological activities include 
regulation of protein phosphorylation and energy reserve metabolic process. Rapgef4 
forms part of the G-protein coupled receptor protein signaling pathway (Oldenburger et al., 
2012). Rapgef4 was significantly up regulated in activated T cells of C57BL/6 mice as 
compared to the BALB/c mice; but was expressed at similar levels amongst the iLCKcreIL-
4Rαlox/-, IL-4Rαlox/-, IL-4Rα-/- and the BALB/c control activated T cells (Figure 34). 
Quantitative real-time RT-PCR showed that the level of Rapgef4 expression was slightly 
elevated in activated T cells of the resistant C57BL/6 mice as compared to the susceptible 
BALB/c mice, but this elevation was not statistically significantly (Figure 34). No 
differential expression was observed for Rapgef4 in the regulatory T cell microarray data 
amongst all the mouse groups, which was confirmed by qPCR (Figure 34). Although not 
statistically significant, the levels of Rapgef4 tended to be higher in the C57BL/6 and 
iLCKcreIL-4Rαlox/- in both the activated and regulatory T cell populations, suggesting that 
Rapgef4 may provide resistance to L.major, and that the absence of IL-4Rα might play a 
role in the switch from a susceptible TH2 response to a resistant TH1 response. 
Chemokines function in the recruitment, polarization, activation and differentiation of T 
cells (Murphy 1994, Baggiolini et al., 1997, Yoshie et al., 1997 and Rossi 2000).CCR5 
(Chemokine receptor type 5), also known as CD195, is a protein found on the surface of 
white blood cells and acts as a receptor for chemokines. This receptor is predominantly 
expressed on T cells, macrophages, dendritic cells and microglia. It is known that TH1 and 
TH2 cells have different chemokine receptors. TH1 cells express CCR5, whereas TH2 cells 
are known to express CCR3 (also found on eosinophils and basophils) (Wysocki et al., 
2005). CCR5 was significantly up-regulated in both the activated T cells of C57BL/6 and 
iLCKcreIL-4Rα-/lox mice as compared to susceptible BALB/c mice. CCR5 was found to be 
expressed at 4.73 fold higher levels in activated T cells and 2.17 fold higher in regulatory T 
cells from resistant C57BL/6 mice infected with L. major as compared to susceptible 
BALB/c. Similarly, in iLCKcreIL-4Rα-/lox mice infected with L major expressed a 2 fold higher 
level of CCR5 in both activated T cell and regulatory T cell populations as compared to 
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BALB/c (Figure 35). Although not statistically significant, quantitative real-time RT-PCR 
showed that the levels of CCR5 were much higher in in both the activated and regulatory T 
cell populations of C57BL/6 and iLCKcreIL-4Rαlox/- mice as compared to BALB/c controls, 
suggesting that CCR5 is important for providing resistance to L. major. In the activated T 
cell microarray, we observe significance of all the mouse groups when compared to the 
susceptible BALB/c group. 
 
CCL5 (Rantes) is the ligand for CCR5 (Santiago et al., 2004) and was expressed at 2.42 fold 
higher levels in activated T cells and 2.73 fold higher in regulatory T cells from resistant 
C57BL/6 mice infected with L. major as compared to BALB/c. CD4+ T cell specific IL-4Rα 
deficient (iLCKcreIL-4Rα-/lox) mice infected with L major expressed a 1.3 fold higher level of 
CCL5 in activated T cell populations as compared to BALB/c (Figure 36). Once again, 
although not statistically significant, quantitative real-time RT-PCR showed that the levels 
of CCL5 were much higher in the C57BL/6 and iLCKcreIL-4Rαlox/- activated and regulatory T 
cell populations as compared to BALB/c controls, suggesting that CCL5 is important for 
providing resistance to L. major.  
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Figure 31 IL-18r1 expression by quantitative PCR and microarray for activated T cells 
and regulatory T cells. 
A. Activated and regulatory T cells were sorted to greater than 99% purity, the RNA was extracted, 
converted to cDNA and linearly amplified prior to analysis of expression levels by real time 
quantitative PCR. Data was normalized to expression levels of the B2M housekeeping genes and 
values are shown as fold change relative to the BALB/c group. For each strain T cells were isolated 
from pooled popliteal lymph nodes of 6 mice. B. Activated T cells and regulatory T cells from all 
strains L. major-infected mice were subject to transcriptional profiling by microarray at 3 weeks 
post infection. Relative IL-18r1 expression levels post-normalization of microarray data. All groups 
were compared to the BALB/c control group which was set to 1. Each graph represents the average 
values for three independent biological experiments. ** P<0.01 
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Figure 32 STAT4 expression by quantitative PCR and microarray for activated T cells 
and regulatory T cells. 
A. Activated and regulatory T cells were sorted to greater than 99% purity, the RNA was extracted, 
converted to cDNA and linearly amplified prior to analysis of expression levels by real time 
quantitative PCR. Data was normalized to expression levels of the B2M housekeeping genes and 
values are shown as fold change relative to the BALB/c group. For each strain T cells were isolated 
from pooled popliteal lymph nodes of 6 mice. B. Activated T cells and regulatory T cells from all 
strains L. major-infected mice were subject to transcriptional profiling by microarray at 3 weeks 
post infection. Relative STAT4 expression levels post-normalization of microarray data. All groups 
were compared to the BALB/c control group which was set to 1. Each graph represents the average 
values for three independent biological experiments. * P<0.05, ** P<0.01 
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Figure 33 Rnf130 expression by quantitative PCR and microarray for activated T cells 
and regulatory T cells. 
A. Activated and regulatory T cells were sorted to greater than 99% purity, the RNA was extracted, 
converted to cDNA and linearly amplified prior to analysis of expression levels by real time 
quantitative PCR. Data was normalized to expression levels of the B2M housekeeping genes and 
values are shown as fold change relative to the BALB/c group. For each strain T cells were isolated 
from pooled popliteal lymph nodes of 6 mice. B. Activated T cells and regulatory T cells from all 
strains L. major-infected mice were subject to transcriptional profiling by microarray at 3 weeks 
post infection. Relative Rnf130 expression levels post-normalization of microarray data. All groups 
were compared to the BALB/c control group which was set to 1. Each graph represents the average 
values for three independent biological experiments. * P<0.05, ** P<0.01
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Figure 34 Rapgef4 expression by quantitative PCR and microarray for activated T cells 
and regulatory T cells. 
A. Activated and regulatory T cells were sorted to greater than 99% purity, the RNA was extracted, 
converted to cDNA and linearly amplified prior to analysis of expression levels by real time 
quantitative PCR. Data was normalized to expression levels of the B2M housekeeping genes and 
values are shown as fold change relative to the BALB/c group. For each strain T cells were isolated 
from pooled popliteal lymph nodes of 6 mice. B. Activated T cells and regulatory T cells from all 
strains L. major-infected mice were subject to transcriptional profiling by microarray at 3 weeks 
post infection. Relative Rapgef4 expression levels post-normalization of microarray data. All groups 
were compared to the BALB/c control group which was set to 1. Each graph represents the average 
values for three independent biological experiments. ** P<0.01 
 
Normalized Rapgef4 from activated T cells
lo
x 
/-

IL
-4
R
cr
e
iL
C
K
 
lo
x
/-

IL
-4
R
-/
-

IL
-4
R
B
A
L
B
/c
C
57
B
L
/6
0
1
2
3
R
a
p
g
e
f4
 /
 B
2
M
Normalized Rapgef4 from regulatory T cells
lo
x 
/-

IL
-4
R
cr
e
iL
C
K
 lox
/-

IL
-4
R
-/
-

IL
-4
R
B
A
L
B
/c
C
57
B
L
/6
0
1
2
3
R
a
p
g
e
f4
 /
 B
2
M
Rapgef4 From activated T cell microarray (Affymetrix)
lo
x 
/-

IL
-4
R
cr
e
iL
C
K
 lox
/-

IL
-4
R
-/
-

IL
-4
R
B
A
LB
/C
C
57
B
L/
6
0
1
2
3
**
F
o
ld
 D
if
fe
re
n
c
e
 t
o
B
A
L
B
/
c
Rapgef4 From regulatory T cell microarray (Illumina)
lo
x 
/-

IL
-4
R
cr
e
iL
C
K
 lox
/-

IL
-4
R
-/
-

IL
-4
R
B
A
L
B
/C
C
57
B
L
/6
0
1
2
3
F
o
ld
 D
if
fe
re
n
c
e
 t
o
B
A
L
B
/
c
130 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 35 CCR5 expression by quantitative PCR and microarray for activated T cells and 
regulatory T cells. 
A. Activated and regulatory T cells were sorted to greater than 99% purity, the RNA was extracted, 
converted to cDNA and linearly amplified prior to analysis of expression levels by real time 
quantitative PCR. Data was normalized to expression levels of the B2M housekeeping genes and 
values are shown as fold change relative to the BALB/c group. For each strain T cells were isolated 
from pooled popliteal lymph nodes of 6 mice. B. Activated T cells and regulatory T cells from all 
strains L. major-infected mice were subject to transcriptional profiling by microarray at 3 weeks 
post infection. Relative CCR5 expression levels post-normalization of microarray data. All groups 
were compared to the BALB/c control group which was set to 1. Each graph represents the average 
values for three independent biological experiments. ** P<0.01 
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Figure 36 CCL5 expression by quantitative PCR and microarray for activated T cells and 
regulatory T cells. 
A. Activated and regulatory T cells were sorted to greater than 99% purity, the RNA was extracted, 
converted to cDNA and linearly amplified prior to analysis of expression levels by real time 
quantitative PCR. Data was normalized to expression levels of the B2M housekeeping genes and 
values are shown as fold change relative to the BALB/c group. For each strain T cells were isolated 
from pooled popliteal lymph nodes of 6 mice. B. Activated T cells and regulatory T cells from all 
strains L. major-infected mice were subject to transcriptional profiling by microarray at 3 weeks 
post infection. Relative CCL5 expression levels post-normalization of microarray data. All groups 
were compared to the BALB/c control group which was set to 1. Each graph represents the average 
values for three independent biological experiments. * P<0.05 
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3.5 CCR5 expression using FACS for validation 
CCR5 was selected as a lead candidate gene for further study in order to determine if the 
differential expression of CCR5 mRNA correlated to differences in protein expression. 
Therefore iLCKcreIL-4Rαlox/-, IL-4Rαlox/-, IL-4Rα-/-mice together with the susceptible BALB/c 
and resistant C57BL/6 controls, were infected subcutaneously with 2x106 promastigote 
stage L. major into the left hind footpad. After three weeks post-infection the expression of 
CCR5 in activated T cells and regulatory T cells isolated from infected lymph nodes, was 
measured by FACS analysis (Figure 37) using the gating strategy shown in Figures 14 and 
15. The expression levels of CCR5 protein on the surface of activated T cells was 
significantly up-regulated in the C57BL/6 and iLCKcreIL-4Rαlox/- mice as compared to the 
susceptible BALB/c mice, thereby supporting the differential mRNA expression observed in 
the microarray and quantitative real time PCR data. This data strongly suggested that in the 
susceptible BALB/c mice, absence of IL-4Rα on CD4+ T cells results in bias towards a 
resistant TH1 response, and that CCR5 is involved in this TH1 polarization.  
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Figure 37 CCR5 expression in activated and regulatory T cells by FACS. 
FACS analysis of Activated (A) and regulatory (B) T cells of popliteal lymph nodes cells from mice 
infected with 2x106 promastigote stage L. major. The graph represents the average values for five 
mice per group. For statistical significance, all groups were compared to the susceptible BALB/c 
group. * P<0.05 
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In summary, the aim of this study was to identify the gene expression patterns in CD4+ T 
cells that are associated with resistance or susceptibility to L. major, using a 
transcriptomics approach. Firstly, knockout mice, iLCKcreIL-4Rαlox/-, IL-4Rαlox/-, IL-4Rα-/-, 
together with their controls, susceptible BALB/c and resistant C57BL/6, were infected 
subcutaneously with 2x106 promastigote stage L. major into the left hind footpad. Disease 
progression was monitored for three weeks. At the time of euthanasia, activated and 
regulatory T cells were sorted, RNA extracted and linearly amplified to generate cDNA. Pre-
validation quantitative real time PCR was performed to phenotypically characterize the 
known markers for TH1 (resistance) and TH2 (susceptibility). Transcriptional profiling by 
microarray was used to assess the differences in activated and regulatory T cells isolated 
from the various mouse groups (iLCKcreIL-4Rαlox/-, IL-4Rαlox/-, IL-4Rα-/-, BALB/c and 
C57BL/6). DE genes were identified by comparative analyses between C57BL/6 vs. BALB/c 
and iLCKcreIL-4Rαlox/- vs. BALB/c, amongst others, using a fold change cut-off of >1.2 and a 
p-value < 0.05. The lists of differentially expressed genes were then analysed using IPA and 
Babelomics microarray analysis software, and assigned functional annotations. Intensive 
literature mining combined with a focused functional clustering strategy (Figure 25), 
identified differentially expressed genes that belonged to more than one “focus” group. 
Candidate genes belonging to two or more of the focus groups were then selected for 
further analysis. The rationale for selecting genes which intersected with two or more (ie 
>50%) of the focus functional groups, was that this strategy may increase the probability of 
selecting candidate genes which have a significant biological impact on the resistance of L. 
major infections. Indeed differentially expressed genes that intersected with two or more 
functional groups were found to be enriched for these genes which have already been 
described in the literature to play a significant role in resistance to L. major (Table A5 in 
appendix). 
A few genes were selected for further study, and the differential expression for some of the 
candidate genes was confirmed by quantitative RT-PCR on the original RNA sample. Good 
correlation was observed between the quantitative PCR data and the microarray data. The 
strong overlap of the microarray data and the validation quantitative PCR data supports 
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the strength of the microarray experiments and the potential use of the data to identify 
genes important during L. major infection. CCR5 was selected as a possible candidate gene 
for confirmation of the observations seen in the respective microarrays and quantitative 
real time PCR.  
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Chapter 4 
Discussion and Conclusions 
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Discussion 
Experimental Leishmania infections in mice have been widely used to study the control of 
TH1/TH2 differentiation, and to elucidate mechanisms underlying 
susceptibility/resistance to intracellular microbial infection (Radwanska et al., 2007, 
Locksley and Scott, 1991). Resolution of leishmaniasis is dependent on the coordinated 
interactions between components of cell mediated immune response, specifically the 
activation of targeted T-cell populations to secrete appropriate cytokines which in turn 
activate macrophages (Sacks & Noben-Trauth, 2002). Typically in murine models of 
Leishmania infection, resistant C57BL/6 mice are able to control and heal dermal lesions, 
while susceptible BALB/c mice develop severe pathology, manifested by progressive lesion 
development, necrosis, and death (Reiner and Locksley, 1995). Resistance to L. major 
infection is dependent on a sustained IL-12-driven type-1 response mainly characterized 
by the production of IFN-γ by CD4+ TH1 cells (Gorak, Engwerda, & Kaye, 1998; Walker et 
al., 1999), which in turn mediates protection by inducing NOS-2 expression and nitric oxide 
production in classically activated macrophages (Holscher et al., 2006, Guler et al., 1996, 
Park et al., 2002, Liew et al., 1993).  
 
In contrast, non-healing disease in BALB/c mice is associated with a TH2 response 
characterized by secretion of mainly IL-4, IL-5, IL-9, and IL-13 (Kopf et al., 1996; Matthews 
et al., 2000; Mohrs et al., 1999, 2000), high anti-Leishmania antibody titres, arginase-1 
production by macrophages (Holscher et al., 2006, Iniesta et al., 2002) and visceral 
dissemination of parasites (Laskay et al., 1995). Conventional opinion and early studies 
with L. major (Heinzel et al., 1989, Leal et al., 1993) suggested than an IL-4 driven TH2 
response and associated cytokines like IL-13 counter-regulated TH1 responses. 
Consequently, it was expected that a TH2 response would be detrimental to the outcome of 
disease. Indeed, susceptible BALB/c mice deficient for IL-4 (Kopf et al., 1996), IL-13 
(Matthews et al., 2000), the IL-4R (Mohrs et al., 1999), or STAT6 (Hoffmann et al., 2000) 
were able to contain infection with L. major and TH2 cytokines like IL-4, IL-9, IL-10 and IL-
13 were shown to be susceptible factors. However, more recently, new evidence has come 
to light that suggests that the development of effective type-1 immunity can involve the 
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significant involvement of the TH2 cytokines IL-4 and IL-13 (King et al., 2005, Minty et al., 
1997). Both cytokines, IL-4 and IL-13 share a common signaling pathway through the IL-
4R chain. A functional IL-4R (type I) requires assembly of IL-4R with a c chain, while 
interaction of IL-4R with an IL-13R1 subunit leads to formation of a functional IL-13 
receptor (type II) (Kelly-Welch et al., 2003). Mice with a global deletion of the IL-4R on all 
cells (IL-4R-/-) are unable to respond to IL-4 and IL-13. During L. major infection these IL-
4R-/- mice still developed a TH2 response and were able to control infection during the 
acute stage of disease (although with a higher parasite burden). However, during the later 
chronic stages of disease, the IL-4R-/- mice were unable to maintain resistance and 
developed full blown leishmaniasis (Radwanska et al., 2007). This suggested that IL-4R-
mediated mechanisms, other than TH2 responses are responsible for disease progression 
in L. major-infected BALB/c mice. Indeed, the data demonstrated that IL-4R 
responsiveness on macrophages promoted alternative activation of macrophages, which in 
turn contributed to the susceptibility of BALB/c mice. In the absence of alternative 
macrophage activation, protective classical macrophage activation was found to be 
enhanced resulting in increased microbiocidal activity and protective TH1 responses 
(Holscher et al., 2006). 
 
Similarly, studies using CD4+ T cell specific IL-4Rα (iLCKcreIL-4Rαlox/-) deficient mice on a 
susceptible BALB/c background, demonstrated that loss of IL-4R responsiveness on CD4+ 
T cells together with the presence of IL-4R responsiveness on other non-CD4+ cell types, 
lead to clinical immunity in “non-healer” BALB/c mice infected with L. major (Radwanska 
et al., 2007). This suggests that during L. major infection, signaling via the IL-4R on CD4+ T 
cells induces a cascade of events that ultimately results in susceptibility and disease 
progression. In this study, the aim was to identify genes in CD4+ T cells (activated and 
regulatory T cells) that are associated with resistance or susceptibility to L. major, with the 
long term goal that these genes (and their encoding protein products) can serve as targets 
for rational drug design. This was investigated using DNA microarrays, GeneChip Mouse 
Exon 1.0 ST Array on an Affymetrix platform and Illumina ® MouseWG-6 v2.0 Expression 
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BeadChips on an Illumina Bead array to analyze the gene expression profiles of IL-4R 
responsive and non-responsive CD4+ T cells isolated from the draining lymph nodes of 
susceptible WT BALB/c mice and resistant mice CD4+ T cell-specific (iLCKcreIL-4Rαlox/-), 
global IL-4R-/- , littermate control IL-4Rαlox/-, and resistant C57BL/6 mice respectively. 
 
4.1 Comparative L. major infection 
Activated T cells (CD4+CD44+med-hiCD62L+lo) and regulatory T cells (CD4+CD25+) were 
isolated from CD4+ T cell specific (iLCKcreIL-4Rαlox/-), littermate control (IL-4Rα lox/-), global 
knockout (IL-4Rα-/-), susceptible BALB/c control and resistant C57BL/6 mice. The 
activated and regulatory T cells were isolated and the phenotype of the infected mice were 
assessed to confirm that the infection was indeed successful, the biological replicates we all 
reproducible across all experiments and that the infection phenotype was in accordance 
with published data (Mohrs et al., 2000; Radwanska et al., 2007). The C57BL/6 mice 
showed resistance with a healing TH1 phenotype and the BALB/c mice showed 
susceptibility with a non-healing TH2 phenotype at three weeks post infection.   
 
It is known that the early events that lead to the initial development of TH1 or TH2 
response take place within the first two days after infection (Sacks & Noben-Trauth, 2002).  
At three weeks post infection, the acute stage of the disease, there is no distinctive TH1 or 
TH2 phenotype evident, although the total IgE titres in the C57BL/6, IL-4Rα-/-, and 
iLCKcreIL-4Rαlox/- were lower than in the BALB/c, which suggests a predominant type 1 
immune response, the SLA-specific IgG2b responses were equivalent between all the 
mouse groups. 
 
The use of L. major infection is used widely to investigate T helper subset development 
(Radwanska et al., 2007). During L. major infection, BALB/c mice produce type 2 antibodies 
which are significantly reduced in mice that lack IL-4Rα (Mohrs et al., 1999 and Mohrs et al, 
2000). Furthermore, a deletion of IL-4Rα results in a shift towards the production of type 1 
antibodies IgG2a and IgG2b. Production of IgE is dependent on IL-4 signaling (Shimoda et 
al, 1996). In order to assess IL-4Rα-responsiveness in T cells during acute L. major 
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infection, serum antibody levels of IgE and soluble Leishmania antigen (SLA)-specific IgG2b 
were analyzed in the various IL-4Rα-knockout mice, iLCKcreIL-4Rα lox/-, IL-4Rα lox/-, IL-4Rα-
/-, and control BALB/c and C57BL/6. IL-4Rα responsiveness of T cells in the iLCKcre IL-
4Rαlox/- mice, during the acute phase of the disease was demonstrated by assessing the 
levels of total IgE. The levels of total IgE were equivalent between the iLCKcreIL-4Rαlox/- and 
C57BL/6 mice, whereas in the IL-4Rα-/- mice the total IgE level was significantly impaired 
and was at the detection level of the ELISA (Figure 12). This is as previously reported, as 
the presence of IL-4Rα on B cells is needed to produce IgE (Radwanska et al., 2007). Since 
IgE production is strictly dependent on IL-4 signaling (Shimoda et al., 1996) this data 
indicates very strong signaling via the IL-4Rα in the BALB/c and the IL-4Rα lox/- mice 
during the acute phase of L. major infection, which is associated with TH2 associated type 2 
immune responses. Similarly, since C57BL/6 mice are known to mount a TH1 associated 
immune response to L. major infection and that the SLA-specific IgE levels were equivalent 
between the iLCKcreIL-4Rαlox/- and C57BL/6 mice, this data suggested that the iLCKcreIL-
4Rαlox/- may also have developed TH1 associated immune response despite its susceptible 
BALB/c genetic background. High IgG2a levels are indicative of a type 1 response (Mohrs et 
al., 1999). During the acute phase of L. major infection, it is not clear whether it is a definite 
type 1 or type 2 response, as the various knockout groups have similar levels of expression 
for the various TH1 and TH2 markers. However, in experiment C we observe higher levels 
of the antibody for the resistant C57BL/6 when compared to the susceptible BALB/c group. 
This observation from the IgG2a indicates a possible shift towards a type 1 response. 
During the acute phase of disease all the mouse groups appeared phenotypically similar, eg. 
footpad swelling, parasite burden and antibody responses etc.  We observe that the results 
for the biological experiments are reproducible and it corresponds to previously published 
data (Radwanska et al., 2007, Mohrs et al., 1999).  However, a clear phenotype is not 
evident at this selected time point for the experiment. A more powerful experimental 
design would have been to include several time points after infection to detect the very 
early events involved in the induction of TH1 / TH2 differentiation and the establishment 
of type 1 or type 2 immune responses.  These time points could include 1, 2, 7, 14, 21 and 
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28 days post infection.  However, this experiment was not possible due to economic 
constraints. 
 
4.2 Activated and regulatory T cell isolation 
In order to assess the differential gene expression of activated T cells and regulatory T cells 
in the draining popliteal lymph node during acute murine L. major infection, both cell 
populations needed to be isolated at both high purity and yield. For the isolation of the 
activated T cells, a yield and purity of above 99% was obtained. It is important to note that 
one limitation of this study was that it was not possible to isolate a >99% pure regulatory T 
cell population. This would require that the isolated CD4+ T cells be stained for both FoxP3 
in addition to CD25 and FoxP3 would require intracellular staining, which would result in 
the loss of RNA from the cells. However, it was confirmed by intracellular FACS that the 
yield and purity of 99% for the regulatory T cells contained on average above 80% FoxP3+ 
regulatory T cells.  Not having a 100% pure FoxP3+ regulatory T cell population could have 
its pitfalls, in that the regulatory T cell population would contain a 20% contamination of 
activated T cells.  This mixed regulatory T cell population may lead to some of the activated 
T cell genes to be differentially expressed in the regulatory T cell microarray. 
 
Extraction of good quality RNA from the sorted activated and regulatory T cells was 
imperative to be able to assess differential gene expression as accurately as possible. Only 
twenty seven percent of the samples displayed RNA Integrity (RIN) values below 7 – the 
recommended minimum for microarray analysis. However, the method for cDNA synthesis 
from the RNA template used both oligo-dT and random internal primers, ensuring that 
even partially degraded transcripts would be amplified (Tariq et al., 2011). This method 
thus allowed for the samples with RIN values between 6 and 7. The electropherograms 
obtained indicated pure cDNA with no genomic DNA contamination. Despite having 
samples with lower RIN values, all samples were successfully amplified and the cDNA 
quality and yield obtained were sufficient for both the microarray and quantitative RT-PCR 
confirmation studies.  
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To assess whether the cDNA was indeed a reflection of the RNA content and that the 
phenotype of the activated and regulatory T cells was as expected given the genotype, 
quantitative real time PCR was performed on IFN-γ and IL-4, marker genes associated with 
either TH1 or TH2 differentiation respectively (Alexander, Satoskar, & Russell, 1999). The 
IL-4 expression profile for the susceptible BALB/c and C57BL/6 was consistent with what 
is known, where resistant C57BL/6 mice displayed reduced levels of IL-4 when compared 
to susceptible BALB/c mice. This is observed for both activated and regulatory T cells. The 
IFN-γ expression profiles for the controls were in line with what has previously been 
published, where susceptible BALB/c mice have reduced levels of IFN-γ when compared to 
the resistant C57BL/6 mice for both activated and regulatory T cells. The knockout mice 
expressed similar reduced levels of IFN-γ for both the activated and regulatory T cells, 
indicating a bias towards TH2 response, and intermediate levels of IL-4 for the two cell 
populations.  
The quality control analysis of the cDNA therefore indicated the successful preservation of 
the differential expression of good quality mRNA, from the stage of cell isolation to cDNA 
synthesis and amplification, and therefore provided a solid foundation onto which to base 
the microarray analysis.  
 
4.3 Gene expression profiling of activated T cells  
The global transcriptional profile of the activated T cells obtained from draining lymph 
nodes of iLCKcreIL-4Rα lox/-, IL-4Rαlox/-, IL-4Rα-/-, BALB/c and C57BL/6 mice. This was done 
in order to elucidate the mechanisms by which signaling via the IL-4Rα on CD4+ T cells 
causes susceptibility to L. major.  
Gene expression patterns were compared early during infection in T cells in the absence or 
presence of IL-4Rα signaling, with the aim to identify genes and pathways associated with 
IL-4Rα-induced TH1 and TH2 differentiation and how these genes may contribute to 
susceptibility or resistance during L. major infection. The knockout groups, iLCKcreIL-
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4Rαlox/-, IL-4Rαlox/- and IL-4Rα-/- all produced intermediate levels of these classical TH1 and 
TH2 cytokines. Three weeks post infection good correlation amongst the controls from the 
quantitative real time PCR data was observed. The time point chosen for the microarray 
analysis was three weeks post infection.  At this time point all the mouse groups appeared 
phenotypically similar, e.g. footpad swelling, parasite burden etc.  A more powerful 
experimental design would have been to include several time points after infection to 
detect the very early events involved in the induction of TH1 / TH2 differentiation and the 
establishment of type 1 or type 2 immune responses.  These time points could include 1, 2, 
7, 14, 21 and 28 days post infection.  However, this experiment was not possible due to 
economic constraints. Thus we further proceeded to investigate the differentially 
expressed genes amongst the various experimental groups at three weeks post infection. 
This was achieved by identifying genes differentially expressed in activated T cells and 
various comparisons were performed. We sought to investigate how similar the 
transcriptional response of the iLCKcreIL-4Rαlox/- is to the C57BL/6. By comparing the 
mRNA expression profiles of C57BL/6 to BALB/c and iLCKcreIL-4Rαlox/- to BALB/c, these 
comparisons will identify genes important for mediating protection during L. major 
infection. 
For the comparison involving the iLCKcreIL-4Rαlox/- dataset, a fold change and p-value cut-
off of 1.2 and 0.05 was chosen. This resulted in a sizeable number of genes to work with 
and minimal noise. It was decided to use this set of criteria for both comparisons to obtain 
the lists of differentially expressed genes. 
This study focused on IL-4/IL-13 driven TH1 /TH2 function during L. major infection. Thus, 
genes that are differentially expressed in the presence or absence of IL-4Rα-signaling were 
of interest. The C57BL/6 vs. BALB/c comparison was also of interest as these groups 
represent the resistant and susceptible control groups. The genes in this comparison may 
contribute to the differing susceptibility to Leishmania infection that is seen in the two 
mouse strains. In the iLCKcreIL-4Rαlox/- vs. BALB/c comparison, both these mouse strains 
have a susceptible background. The iLCKcreIL-4Rαlox/- mouse lacks the IL-4Rα on CD4+ T 
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cells, whereas the BALB/c have an active receptor present. The genes from this comparison 
could possibly play a role in TH1 differentiation and or resistance. In addition to these 
comparisons, when overlaying these two comparisons and obtaining the common genes 
from both datasets, these genes adds to the evidence that the microarray data is 
biologically relevant. 
A total of 456 genes were differentially expressed in activated T cells from C57BL/6 mice 
as compared to BALB/c mice, with 46% being up-regulated and 54% being down-regulated 
in the C57BL/6 activated T cells. In contrast, only 17 genes were differentially expressed in 
activated T cells from iLCKcreIL-4Rαlox/- mice as compared to BALB/c mice, with 70% being 
up-regulated and 30% being down-regulated in the iLCKcreIL-4Rαlox/- activated T cells. 
Interestingly, four genes (Gdpd3, CCR5, Otud6b and H2-T10) were differentially expressed 
with the same up- or down-regulatory patterns in the C57BL/6 and the iLCKcreIL-4Rαlox/- 
activated T cells as compared to BALB/c activated T cells.  Of these genes, it is known that 
CCR5 plays an important role in the differentiation process, in that it aids in the formation 
of the immunological synapse.  The integrity of the immunological synapse is strengthened 
by the presence of CCR5 and aids in the differentiation process.  
An important step in the biological interpretation of the data was to confirm that the IL-
4Rα expression profile. Activated T cells from three week infected lymph nodes were 
subjected to transcriptional profiling. It was observed that littermate control IL-4Rαlox/-, 
global knockout IL-4Rα-/- and iLCKcreIL-4Rαlox/- activated T cells have significantly reduced 
expression of IL-4Rα when compared to activated T cells from susceptible BALB/c mice. 
These results confirms the dosage effect of the IL-4Rα alleles, in that BALB/c mice have 2 
functioning alleles of the receptor compared to the knockouts that have only one (IL-
4Rαlox/-). In the global knockout IL-4Rα-/- mRNA expression of the IL-4Rα receptor was still 
observed, even though the gene is not making a functional IL-4Rα protein.  A possible 
hypothesis for this observation is the detection algorithm used for Affymetrix exon array 
image analysis, which calculated overall gene expression by taking an average across all 12 
exons of the IL-4Rα, even though exons 7, 8 and 9 were deleted.  
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It was determined that 41% of the differentially expressed genes in the C57BL/6 and 
iLCKcreIL-4Rαlox/- activated T cells mapped to Leishmania major response (Lmr) loci. This 
enrichment was found to highly statistically significant in C57BL/6 vs. BALB/c comparative 
analysis, but not for the iLCKcreIL-4Rαlox/- vs. BALB/c analysis. 
The strength of the microarray data was confirmed by the appearance of many genes that 
formed networks and were involved in pathways. These known networks / pathways 
included cellular growth and proliferation; cell-mediated immune response; cell signaling; 
inflammatory response; cell-to-cell signaling and interaction and cell death. The top 
associated networks for the two comparisons, C57BL/6 vs. BALB/c and iLCKcreIL-4Rαlox/- 
vs. BALB/c, shows a trend in that similar networks have high scores amongst the 
comparisons and play a role in resistance during L. major infections. In addition, we also 
observed that the molecules from the network analysis have a number of interactions with 
other genes. For the C57BL/6 vs. BALB/c network analysis, we observed various 
interactions including interactions between IL-4, STAT5, TNF, JAK, SlamF7 and Ephx1. 
These genes are in particular of interest as they are in some way associated to T helper 
differentiation. The network analysis for the iLCKcreIL-4Rαlox/- vs. BALB/c comparison also 
yielded interactions between IL-4, CCR5, H2-T10 and STAT5. These genes from the 
networks mentioned above all have roles in the T helper differentiation which relates to 
some of the objectives of the thesis. 
The investigation of how these molecules from the network analysis associated with TH2 
and TH1 molecules followed next. The TH1 molecules selected to show association to was, 
IFN-γ, TNF, IL-12, IL-18 and STAT4; for the TH2 molecules association to IL-4, IL-13, and 
IL-6, IL-2, STAT6 and GATA3 was shown. A number of genes have associations with both 
TH1 and TH2 molecules, with a few genes interacting with the regulatory molecules, IL-10 
and TGF-β. The last strategy was to identify candidate genes that utilized the gene ontology 
terms associated with known marker genes (proliferation, activation, presentation and 
recruitment). Candidate genes were identified as putative markers of TH1 / TH2 and/or 
resistance vs. susceptibility during L. major infection during the acute phase of the disease.  
It was hypothesized that differentially expressed genes (fold change cut-off of 1.2 and a p 
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value of < 0.05) that were identified should display a number a qualities.  These included, 
the genes should be located on known Leishmania resistance or susceptibility loci; genes 
should be involved in pathways associated to T cell receptor signaling, ie. be involved in 
TH1 / TH2 differentiation; the genes should be involved in the formation of the 
immunological synapse, which aids in the differentiation process or these genes should be 
involved in processes like cell-to-cell signaling and interaction; cellular growth and 
proliferation etc.  A mining strategy was employed to extract and assign functional data to 
the differentially expressed genes and to cluster these genes into focus groups.  The lead 
candidate genes that belonged to more than 50% of the focus functional groups were found 
to be enriched with genes that play significant roles in resistance to L. major. 
  
4.4 Gene expression profiling of regulatory T cells  
The global transcriptional profile of the regulatory T cells obtained from draining lymph 
nodes of iLCKcreIL-4Rαlox/-, IL-4Rαlox/-, IL-4Rα-/-, BALB/c and C57BL/6 mice was assessed 
via microarray. This was performed to elucidate the mechanisms by which signaling via the 
IL-4Rα on CD4+T cells causes susceptibility to L. major in a population of regulatory T cells 
(CD4+CD25+). For the regulatory T cells, it was not possible to obtain a 100% pure 
regulatory T cell population as this population of cells contains a mixed population of cells, 
including activated T cells. To obtain a pure population of regulatory T cells, it would be 
required that the isolated CD4+CD25+ cells be stained intracellularly with FoxP3 and this 
staining procedure would result in the loss of RNA from the cells. Considering that the 
regulatory T cells are a mixed population, it is observed that the differentially expressed 
genes from the regulatory T cell microarray contained genes from the activated T cell 
microarray. 
As discussed previously, the aim of this study was to identify genes and pathways 
associated with IL-4Rα-induced TH1 and TH2 differentiation and how these genes may 
contribute to susceptibility or resistance during L. major infection at three weeks post 
infection. Pre-microarray quantitative RT-PCR data compared favorably with a previous , 
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publication from our group (Radwanska et al., 2007). We proceeded to investigate the 
differentially expressed genes amongst the various experimental groups. 
This was achieved by identifying genes differentially expressed in regulatory T cells and 
various comparisons performed. These included C57BL/6 vs. BALB/c and iLCKcreIL-4Rαlox/- 
vs. BALB/c, amongst others. The same criteria used for obtaining the fold change and p-
values in the activated T cell microarray were implemented for the regulatory T cell 
microarray. Given the few number of differentially expressed genes obtained in the 
comparisons involving the iLCKcreIL-4Rαlox/- dataset from the regulatory T cell microarray, 
a fold change and p-value cutoff of 1.2 and 0.05 was chosen. This allowed for a reasonable 
number of genes to be used for downstream pathway analyses. Furthermore, a quick scan 
of these gene lists showed that the genes obtained were biologically relevant. Lowering the 
fold change cut-off did come at the expense of noise/false positives and this was taken into 
account in the further analyses.  
 A total of 485 genes were differentially expressed in regulatory T cells from C57BL/6 mice 
as compared to BALB/c mice, with 53% being up-regulated and 47% being down-regulated 
in the C57BL/6 regulatory T cells. In contrast, 103 genes were differentially expressed in 
regulatory T cells from iLCKcreIL-4Rαlox/- mice as compared to BALB/c mice, with 52% 
being up-regulated and 48% being down-regulated in the iLCKcreIL-4Rαlox/- regulatory T 
cells. Interestingly, seven genes (A130002I06RIK, C530038F07RIK, FAM115C, GDPD3, 
HIP1, IL4, PSG19) were differentially expressed with the same up- or down-regulatory 
patterns in both the C57BL/6 and the iLCKcreIL-4Rαlox/- regulatory T cells as compared to 
BALB/c regulatory T cells. 
As previously done for the activated T cells, we next investigated the IL-4Rα expression in 
the microarray and whether it was in accordance with the genotype of each strain. The 
expected result is that compared to IL-4Rαlox/- T cells, IL-4Rα-/- and iLCKcreIL-4Rαlox/- T 
cells, should have significantly reduced expression and BALB/c T cells should shower 
higher expression as result of two IL-4Rα alleles as compared to one. This is observed for 
the activated T cells discussed earlier. However, no significant differences in IL-4Rα 
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expression were obtained among the strains for the regulatory T cells. This result was 
further investigated by performing a BLAST analysis (Altschul et al., 1997) to determine 
the region of hybridization of the microarray probe to the IL-4Rα transcript. This revealed 
that the probed used, mapped to exon 11 of IL-4Rα (Mohrs et al., 1999), an exon that is 
unaffected by the IL-4Rα deletion process. Taking this into account, the lack of significant 
differential IL-4Rα expression in the microarray among the strains was not a cause for 
concern. 
It was determined that 30% of the differentially expressed genes in C57BL/6 and 31% in 
iLCKcreIL-4Rαlox/- regulatory T cells mapped to Leishmania major response (Lmr) loci. This 
enrichment was found to highly statistically significant in C57BL/6 vs. BALB/c comparative 
analysis however not for the iLCKcreIL-4Rαlox/- vs. BALB/c analysis. 
The strength of the microarray data was confirmed by the appearance of many genes that 
formed networks and were involved in pathways. These known networks / pathways 
included inflammatory response; cell-to-cell signaling and interaction; development and 
function, immune cell trafficking; cellular development, gene expression and cellular 
growth and proliferation. The network with the highest score across the three comparisons 
was cell-to-cell signaling and interaction. Unlike in the activated T cell microarray, the 
networks did not show similar trends.  
In addition, it was observed that the molecules from the network analysis have a number of 
interactions with other genes. For the C57BL/6 vs. BALB/c network analysis, various 
interactions including interactions between TNF, IFN-β, TNFSF, ifi202b, CD40, SOCS1 and 
SlamF7 was observed. Many of these genes have been published previously to be 
associated with known Lmr loci (Kurey et al., 2009). The network analysis for the iLCKcreIL-
4Rαlox/- vs. BALB/c comparison also yielded interactions between NFK-β, IgG1, Erk, Traf1, 
IL-4 and IL-12. These genes from the networks mentioned above all have roles in the T 
helper differentiation. 
Next to be investigated was how these molecules from the network analysis associated 
with regulatory, TH2 and TH1 molecules. The regulatory molecules selected to show 
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association to was, IL-10, TGF-β and FoxP3. A number of genes were found to have 
associations with the regulatory, TH1 and TH2 molecules. The last strategy was to identify 
candidate genes that utilized the gene ontology terms associated with known marker genes 
(proliferation, activation, presentation, recruitment and homeostasis). In total, sixty one 
genes were identified as putative markers of TH1 / TH2 and/or resistance vs. susceptibility 
during L. major infection during the acute phase of the disease. 
 
A similar mining strategy was employed used for the activated T cell microarray, The lead 
candidate genes that belonged to more than 50% of the focus functional groups were found 
to be enriched with genes that play significant roles in resistance to L. major. 
 
4.5     Identification of candidate genes that may confer protection or susceptibility to 
L. major 
Based on the mining strategies applied for both activated T cell and regulatory T cell 
microarrays, a number of genes were selected as lead candidate genes that may confer 
protection or susceptibility to L. major.  One of these genes was CCR5.  The significant 
biological impact for a number of the DE genes during L. major infection has been 
demonstrated in gene deficient mouse models of cell lines. For example, mice deficient for 
CCR5 displayed skewing towards TH2 differentiation (Wong et al., 2003). Therefore, co-
clustering of DE genes with these “high biological impact” genes may therefore highlight 
which of the DE genes should be selected for further analysis. Of the intersection of DE 
genes, 9 genes were initially selected for further analysis. The standard procedure requires 
confirmation of the differential expression of these genes using quantitative RT-PCR on the 
original RNA sample. If indeed the microarray and PCR results are in agreement, genes can 
then be validated biologically. 
From the comparisons that were performed, C57BL/6 vs. BALB/c and iLCKcreIL-4Rα-/lox vs. 
BALB/c and applying the mining strategy, a number of genes were identified. The study 
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investigated IL-4 driven TH1 / TH2 function during L. major infection. Thus, genes that are 
DE in the presence or absence of IL4Rα signaling were of interest. To home in on these 
genes, the number of overlapping genes in the dataset for the abovementioned 
comparisons was identified. Common genes from the comparisons would be of interest, as 
it would identify how similar the responses are as both C57BL/6 and iLCKcreIL-4Rα-/lox 
mice display a resistant phenotype during L. major infection. The following genes were 
common from the two primary comparisons in the activated T cell microarray, CCR5, Mt2, 
Kdm5d, H2-T10, Gdpd3 and Otud6b.  Common genes from the two primary comparisons in 
the regulatory T cell microarray included, A130002I06RIK, C530038F07RIK, FAM115C, 
GDPD3, HIP1, IL4 and PSG19.  The following three genes were selected to be investigated 
further, CCR5, H2-T10 and Gdpd3.  CCR5 and H2-T10 from the activated T cell microarray, 
where both these genes were up-regulated in C57BL/6 and iLCKcreIL-4Rα-/lox mice and 
GDPD3, as this gene was common to both microarrays and down-regulated in both 
C57BL/6 and iLCKcreIL-4Rα-/lox mice. 
Chemokines function in the recruitment, polarization, activation and differentiation of T 
cells (Murphy 1994, Baggiolini et al., 1997, Yoshie et al., 1997 and Rossi 2000). CCR5 
(Chemokine receptor type 5), also known as CD195, is a protein found on the surface of 
white blood cells and acts as a receptor for chemokines. This receptor is predominantly 
expressed on T cells, macrophages, dendritic cells and microglia. It is known that TH1 and 
TH2 cells have different chemokine receptors. TH1 cells express CCR5, whereas TH2 cells 
are known to express CCR3 (also found on eosinophils and basophils). 
CCR5 was selected as a lead candidate gene to confirm differential expression as observed 
in the respective microarrays and quantitative RT-PCR. This gene was one of the DE genes 
that intersected with two or more of the focus functional groups from the activated T cell 
microarray. CCR5 have multiple roles in the immune response (Kawai et al., 1999 and 
Rabin et al., 1999). Firstly, in the recruitment of cells to the site of inflammation and 
subsequently determines the appropriate immune response by facilitating the 
immunological synapse formation. The formation of the immunological synapse, which is 
an organized structure that forms at the interface between an antigen presenting cell (APC) 
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and a T cell, is facilitated by the initial polarization of a T cell (Wong et al, 2003). A 
prerequisite for signaling through the T cell receptor is the aggregation of lipid rafts at the 
synapse. These lipid rafts are enriched with signaling molecules that serve as platforms for 
signaling pathways. Chemokine receptor function depends on lipid rafts. Once CCR5 is 
activated by CCL4, it will localize to lipid rafts. CCR5 activation is dependent on the 
integrity of the lipid rafts. Wong et al demonstrates when treated with cholesterol 
extracting agents, disruption of the ligand binding and signaling from CCR5 occurs.  
CCR5 also serves as a receptor for a number of inflammatory chemokines, including CCL3 
(MIP-1α), CCL4 (MIP-1β) and CCL5 (Rantes). CCL5 is the ligand for CCR5. Induction of TH1 
responses by bone marrow derived macrophage and dendritic cells can occur through the 
interactions between CCR5 and its ligand, independent of IL12. Thus, chemokines can affect 
T cell differentiation (Rissoan et al., 1999). A previous study has shown that CCR5- mice, 
gave rise to a skewed TH2 cytokine profile (Wong et al., 2003). Therefore, it appears that 
CCR5 is involved in determining the fate of T helper cells. We hypothesize that the 
interaction between CCR5 and CCL5 aids in the initial recruitment of T cells to an inflamed 
popliteal lymph node (during infection with an intracellular parasite L. major) and also aids 
in the differentiation of the TH1 cells. 
Consistent with this hypothesis is the observation that IL-4Rα-deficient T cells from L. 
major infected iLCKcreIL-4Rα-/lox and T cells from WT C57BL/6 mice had a 2-fold higher 
expression of CCR5 and CCL5 when compared to T cells from WT control mice (BALB/c). 
CCR5 was one of the differentially expressed genes observed in the microarray and this 
was confirmed by quantitative RT-PCR. CCR5 was found to be expressed at 4.73 fold higher 
levels in activated T cells and 2.17 fold higher in regulatory T cells from resistant C57BL/6 
mice infected with L. major as compared to WT (BALB/c). CD4+ T cell specific IL-4Rα 
deficient (iLCKcreIL-4Rα-/lox) mice infected with L major expressed a 2 fold higher level of 
CCR5 in both activated T cell and regulatory T cell populations as compared to WT 
susceptible BALB/c. CCL5 was also differentially expressed in microarray and quantitative 
RT-PCR demonstrated that CCL5 was expressed at 2.42 fold higher levels in activated T 
cells and 2.73 fold higher in regulatory T cells from resistant C57BL/6 mice infected with L. 
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major as compared to WT susceptible BALB/c mice. CD4+ T cell specific IL-4Rα deficient 
(iLCKcreIL-4Rα-/lox) mice infected with L major expressed a 1.3 fold higher level of CCR5 in 
activated T cell populations as compared to BALB/c mice.  
H2-T10 (Histocompatibility 2-T region locus 10) was the next candidate gene to investigate 
further as it was one of the DE genes that intersected with two or more of the focus 
functional groups. This gene is a protein coding gene that maps to chromosome 17, and 
forms an integral part of the plasma membrane. H2-T10 was differentially expressed and 
was significantly up regulated in both the resistant C57BL/6 and iLCKcreIL-4Rα-/lox groups 
when infected with L. major. Interestingly, H2-T10 binds the T cell receptor and is 
regulated by IFN-γ type 1 and dendritic cells. H2-T10 is involved in the regulation of three 
genes, FYN, LCK and Vav1. Functional characteristics of these genes are listed in Table A5 
in the appendix. Of interest to this study, FYN, LCK and Vav1 are lipid raft associated 
signaling components that form part of the T cell receptor complex (Dykstra et al., 2003). 
The biological processes associated with H2-T10 include antigen processing and 
presentation as well as immune response. H2-T10 may not be directly linked to the 
formation of the immunological synapse, however, it regulates three genes that have a 
direct interaction with the T cell receptor and the lipid raft associated signaling 
components. Currently there are no gene deficient mouse models available.  
The cellular and subcellular location of FYN is the immunological synapse, membrane rafts, 
and plasma membrane.  It is located on chromosome 10 and is involved in G-protein 
coupled receptor signaling and T cell receptor signaling. Its biological processes include, T 
cell co-stimulation and activated T cell proliferation.  FYN is known to regulate CD3 TCR 
and is regulated by TCR, CD3 and FYN.   
The cellular and subcellular location of LCK is immunological synapses, membrane 
compartments, membrane rafts, and plasma membrane.  It is located on chromosome 4 and 
is involved in T cell receptor signaling, IL-2 signaling and NFkβ signaling. Its biological 
processes include positive regulation of T cell receptor signaling, T cell co-stimulation, 
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proliferation, apoptosis and T cell differentiation.  LCK is known to be regulated by CD3, 
TCR and binds CD4 and CD3. 
The cellular and subcellular location of VAV1 is the membrane rafts, cytoplasmic fraction 
and plasma membrane.  It is located on chromosome 17 and is involved in CD28 signaling 
in T helper cells, T cell receptor signaling and PKCθ signaling in T lymphocytes. Its 
biological processes include proliferation, cell development, immune response regulating 
cell surface receptor signaling, regulation of cell adhesion, T cell activation, T cell co- 
stimulation and T cell differentiation.  VAV1 is known to regulate RAC1, CDC42 and is 
regulated by TCR, CD3 and CD28. 
Gdpd3 (Glycerophosphodiester phosphodiesterase domain containing 3) is a protein 
coding gene which maps to chromosome 7 and is located in lmr21, near the Dice 2 locus. 
This locus is involved in glycerophospholipid metabolism. Gdpd3 forms an integral part of 
the membrane and its molecular function is glycerophosphodiester phosphodiesterase 
activity. It is known that Gdpd3 interacts with cullin2 (CUL2) (Bennet et al., 2010). Cullin2 
is involved in the adaptive immune system and antigen processing, ubiquitination and 
proteosome degradation. Currently there are no gene deficient mouse models available for 
cullin2 only cell lines. In addition, cullin2 is also involved in the negative regulation of the 
Jak-Stat (Janus tyrosine kinase-signal transducer and activator of transcription) signaling 
pathway. This signaling pathway aids in mediating the transduction of information 
between cells that are essential for development and its primary role is cell proliferation. 
Functional characteristics of Gdpd3 are listed in Table A5 in the appendix. Gdpd3 was 
selected as a candidate gene as it intersected with two or more of the focus functional 
groups. This gene was observed to be significantly down regulated in the resistant 
C57BL/6 and iLCKcreIL-4Rα-/lox groups when infected with L. major for three weeks. 
CCR5 was selected as one of the lead candidate genes.  From the results obtained in this 
study, we observed an up regulation of CCR5 in C57BL/6 and iLCKcreIL-4Rαlox/-, CD4+ T cell 
knockout mice when compared to the susceptible BALB/c mice.  It was observed that even 
on a susceptible background, when IL-4Rα signaling is omitted on CD4+ T cells only, CCR5 
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is up regulated at mRNA level (quantitative RT PCR) similar to that of resistant C57BL/6 
mice.  It is also known that CCR5 plays an important role in the formation of the 
immunological synapse, hence aiding in the TH1 / TH2 differentiation process.  We 
therefore hypothesize that in C57BL/6 and iLCKcreIL-4Rαlox/- (BALB/c mice with a deletion 
of IL-4Rα signaling on CD4+ T cells only), there is a possible difference in the composition 
and integrity of the immunological synapse, resulting in the differential altered induction of 
TH1 / TH2 differentiation.  The gens that support this hypothesis are Gdpd3, H2-T10 and 
CCR5.  These genes are involved in pathways such as lipid metabolism, raft formation, 
antigen presentation and T helper cell differentiation.  These genes are described in detail 
above and cited by literature to support this hypothesis. 
 
4.6 Validation of candidate genes 
In addition to following the mining strategy to obtain DE genes, a few other gens were 
selected to for quantitative RT-PCR validation. Following identification of candidate genes, 
the standard procedure is to confirm the differential expression of the genes by 
quantitative RT-PCR on the original RNA sample. If the microarray and PCR results are in 
agreement, genes are validated biologically. The following genes were evaluated to check 
conformity, IL-18r1, STAT4, Rnf130, Rapgef4, CCR5 and CCL5. These genes were selected 
based on its relevance to TH1 / TH2 differentiation and being part of the main focus groups 
obtained when implementing the mining strategy. 
IL-18r1 expression by quantitative real time PCR and the differential expression of the 
receptor by microarray, similar trends of expression amongst the various knockout groups 
(iLCKcreIL-4Rαlox/-, IL-4Rαlox/-, IL-4Rα-/-) and its controls (BALB/c and C57BL/6) were 
observed. A slightly elevated level of IL-18r1 expression in the resistant control, C57BL/6 
in the activated T cell population was observed when compared to the other BALB/c mice. 
From the PCR data the elevation is not significantly higher, although in its microarray of the 
activated T cells, significance is shown. This receptor is selectively expressed on murine 
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TH1 cells but not TH2 cells (Xu et al., 1998), is involved in the T helper differentiation 
pathway and can thus be used as a surface marker to distinguish TH1 cells from TH2 cells.  
STAT4 expression by quantitative real time PCR and the differential expression of the 
transcription factor by microarray showed similar trends of expression in the quantitative 
real time PCR data from the activated T cell population amongst the various knockout 
groups, however we observe a significantly higher expression of STAT4 was observed in 
the resistant C57BL/6 group than in the activated T cell microarray. STAT4 expression 
appears to be elevated in the global IL-4Rα-/- mice from the regulatory T cell PCR data, 
however, this is not seen in the microarray. STAT4 binds IFN-γ and also plays a role in the 
T helper cell differentiation pathway (Hoey et al., 2003). Ramp3 expression by quantitative 
real time PCR and the differential expression of the receptor by microarray showed similar 
trends of expression amongst the various knockout groups (iLCKcreIL-4Rαlox/-, IL-4Rαlox/-, 
IL-4Rα-/-) and its controls (BALB/c and C57BL/6). In the activated T cell microarray a 
significantly higher expression of this gene in the global IL-4Rα-/- mice was observed when 
compared to the susceptible BALB/c control. In the regulatory T cell population similar 
expression of Ramp3 across all the groups for both the quantitative real time PCR and the 
microarray was observed. Ramp3 is primarily involved intracellular protein transport, 
receptor-mediated endocytosis, regulation of G-protein coupled receptor protein signaling 
pathway and protein transport (Kuwasako, et al., 2008).  
A significantly decreased level of Rnf130 in resistant C57BL/6 mice was observed when 
compared to the susceptible BALB/c control in the activated T cell population. This 
observation was seen in both the quantitative real time PCR data as well as in the 
microarray data. The knockout groups, iLCKcreIL-4Rαlox/-, IL-4Rαlox/-, IL-4Rα-/- expressed 
equivalent levels of Rnf130 when compared to the BALB/c control in the activated T cell 
data. Equivalent expression levels of Rnf130 were observed for all the groups in the 
regulatory T cell population from the quantitative real time PCR data as well as the 
microarray data. This gene is regulated by STAT4 which is a transcription factor for TH1 
differentiation.  
156 
 
For Rapgef4 expression, the resistant C57BL/6 mice consistently expressed elevated levels 
of Rapgef4 when compared to the susceptible BALB/c mice. This was observed in the 
quantitative PCR data as well as in the microarray data in both activated and regulatory T 
cells. Both iLCKcreIL-4Rαlox/- and global knockout IL-4Rα-/- expressed higher levels of this 
gene in the quantitative PCR data for both cell populations when compared to the 
susceptible BALB/c control. It can thus be deduced that Rapgef4 has a possible role in 
resistance to L. major and that the absence of IL-4Rα may play a role in the switch from a 
susceptible TH2 response to a resistant TH1 response.  
IL-18r1, STAT4, Rnf130, Rapgef4 were selected to perform validation quantitative RT PCR 
amongst the other genes, CCR5 and CCL5 on because of its possible role TH1 / TH2 
differentiation. 
 
4.7 Conclusion and future work 
The study aimed to identify the gene expression patterns in CD4+ T cells that are associated 
with resistance or susceptibility to L. major, using a transcriptomics approach.  
The specific objectives of this study were to (1) perform a minimum of three comparative L. 
major infections comprising from iLCKcreIL-4Rαlox/-, IL-4Rαlox/-, IL-4Rα-/-, BALB/c and 
C57BL/6 mice at 3 weeks post infection; (2) isolate activated and regulatory T cells at three 
weeks post infection; (3) purify total RNA isolated from activated and regulatory T cells 
and profile the gene expression of these by DNA microarray; (4) analyze the microarray 
using bioinformatics to identify genes and pathways important for host protection or 
disease progression and (5) validate the microarray results by quantitative RT- PCR. 
For this study, all of the specific objectives were met. In total, three independent biological 
experiments were completed and the activated and regulatory T cells were isolated to both 
high purity and yield. The RNA was successfully extracted from the T cells and was linearly 
amplified to generate cDNA. Pre-validation quantitative real time PCR and phenotypic data 
indicated that the biology of the experiments were of a high standard. Transcriptional 
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profiling by microarray was used to assess the differences in activated and regulatory T 
cells isolated from the various groups (iLCKcreIL-4Rαlox/-, IL-4Rαlox/-, IL-4Rα-/-, BALB/c and 
C57BL/6).  
Various comparisons from both the activated T cell and regulatory T cell microarrays were 
explored and in addition a mining strategy was developed to generate a list of differentially 
expressed genes. Functional data of the DE genes that were clustered in the “focus” groups 
based on their gene ontology associations, Babelomics / IPA analysis and previously 
published functional roles was reviewed. Candidate genes belonging to two or more of the 
focus groups was then selected for further analysis. The rationale for selecting genes which 
intersected with two or more (ie >50%) of the focus functional groups, was that this 
strategy may increase the probability of selecting candidate genes which have a significant 
biological impact on the resistance of L. major infections. Differentially expressed genes 
that intersected with two or more functional groups were found to be enriched for these 
genes which have already been described in the literature to play a significant role in 
resistance to L. major.  
Following identification of candidate genes, standard procedure is to confirm the 
differential expression of the genes by quantitative RT-PCR on the original RNA sample. A 
few genes where selected to be validated using quantitative RT-PCR. Good correlation was 
observed between the quantitative PCR data and the microarray data. The strong overlap 
of the microarray data and the validation quantitative PCR data supports the strength of 
the microarray experiments and the potential use of the data to identify novel genes 
important during L. major infection.  
The study hypothesized that the integrity of the immunological synapse and pathways 
related to it, including lipid metabolism and raft formation aid in the T helper cell 
differentiation. A number of pathways and networks for this hypothesis were enriched in 
our datasets. Differentially expressed genes were also found to be linked to known Lmr loci 
which further confirmed that the microarrays were of biological relevance. We also further 
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hypothesize that signaling via the IL-4Rα may change the integrity and composition of the 
immunological synapse resulting in T helper cell differentiation. 
Future experiments would include in vitro siRNA knock-down experiments. This entails 
knocking down the candidate gene with siRNA in either bone marrow derived 
macrophages or thioglycollate-elicited peritoneal macrophages infected with L. major and 
then stimulating the cells with either IL-4 and IL-13 ( TH2) or IFN-γ and LPS (TH2). The 
expression of known TH1 and TH2 markers will be assessed to determine whether the 
absence of the candidate gene results in an altered expression profile.  
Lead candidate genes that induce an altered TH1 or TH2 phenotype in the in vitro siRNA 
experiments will be validated in vivo using gene deficient mice. This entails infecting mice 
deficient for the candidate gene with L. major and then assessing the disease phenotype. 
Mice lacking the candidate genes associated with TH2 are expected to be resistant to 
infection as TH2 differentiation are associated with enhanced disease severity ( Radwanska 
et al., 2007). In contrast, mice lacking the candidate genes associated with TH1 are 
expected to be susceptible to infection as TH1 are known to play a protective role during 
infection (Radwanska et al., 2007). 
In conclusion, this study serves as a basis for the identification of novel genes associated 
with susceptibility and or resistance to L. major infection when IL-4Rα is not present of 
CD4+ T cells. Differentially expressed genes were hypothesized to play an important role in 
the formation and integrity of the immunological synapse, thereby aiding in the 
differentiation process. The ultimate aim of this work may be extrapolated to humans and 
mechanisms of controlling L. major infection may be identified so as to improve the quality 
of life of the patients suffering from the disease. 
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Appendix A 
General reagents 
Anaesthetic 
1.2 ml Anaket-V (100 mg/ml) (Centaur labs, 
Isando) 
0.8 ml Rompun (2 %) (Bayer, Germany) 
8.0 ml PBS (1X) 
FACS Buffer 
0.1% BSA (Roche) 
0.05% NaN3 (Merck) 
Made up in 1X PBS 
Phosphate Buffered Saline (PBS 10X) 
80g NaCl (1.37M) 
2g KCl (0.03M) 
14.4g H2PO4 (0.01 M) 
2.4g KH2PO4 
Dissolve in 1 L ddH2O 
 
Red cell lysis buffer 
5 mM EDTA 150 mM NaCl 
10 % glycerol 25 mM Tris-Cl pH 7.5 
0.1 % SDS 1 % Triton –X 100 
0.5 % Non idet P-40 0.5 % Deoxycholate 
5 mM PMSF 
Make to 1L with ddH2O 
 
Blocking Buffer 
20g Milk powder (spar instant) (2 %) 
Make up to 1 L with 1X PBS 
Coating Buffer 
10 ml 10x PBS 
8g BSA (Merck) 
Make to 1L in ddH2O and pH 9.5 
 
Dilution Buffer 
10g BSA (1 %) (Roche) 
0.2g NaN3 (0.02 %) (Merck) 
Make up to 1L with 1X PBS 
 
Substrate Buffer 
0.2g NaN3 (0.02 %) 
97 ml di-ethanolamine 
0.8g MgCl2.6H2O 
700 ml ddH2O 
Adjust the pH to 9.8 and make up to 1 L with 
ddH2O 
Washing buffer 
20g KCL 20g KH2PO4 
144g Na2HPO4.H2O 800g NaCl (Merck-BDH) 
50 ml Tween 20 (Sigma) 100 ml 10 % NaN3 
(Merck) 
Make up to 5 L with ddH2O 
Appendix B: Antibody details  
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The gating strategies of cellular quantifications in the popliteal lymph node in Chapter 3 
are given below. 
 
Table 23 List of FACS antibodies 
Antibody Conjugation Dilution factor 
CD4 PerCP 1:640 
CD44 FITC 1:320 
CD62L APC 1:1280 
CD4 FITC 1:1280 
CD25 Biotin 1:320 
CCR5 PE 1:100 
FoxP3 PE 1:50 
7AAD   1:1000 
Rat serum   1% 
FcγRII/III   1:325 
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Table A.1. Differentially expressed genes in C57BL/6 vs BALB/c, (FC >1.2, p < 0.05) in 
activated T cell microarray (Number of genes = 456). 
Probe_IDs Gene_ID 
Regulation 
in C57BL/6 
vs. BALB/c 
p-value Lmr locus 
6964245 Gdpd3 -63.44 6.5923E-05 Lmr21 
6855022 H2-Ea -58.65 0.01658462   
6753067 Ctse -24.96 0.00158577 Lmr20 
6901952 Gbp1 -14.09 0.00507624   
6889893 Scg5 -7.63 0.00097295 Lmr14 
6788290 Il4 -7.15 0.00452007 Lmr15 
6764289 Ifi202b -7.11 0.00632603 Lmr8* 
6813887 Ctsl -6.99 0.00281704   
6980101 Cd209d -6.86 0.02486814   
6755378 Kmo -6.39 0.00733372 Lmr8 
6935701 Alox5ap -6.16 0.01825812   
6960834 Siglech -6.03 0.0039643 Lmr21 
6993138 Ccr9 -5.34 0.0005895   
6905419 F630111L10Rik -5.31 0.03591767 Lmr11 
6763706 Atp1b1 -5.13 0.00033475 Lmr8 
6844387 Olfr164 -5.12 0.00931687 Lmr23 
6905408 P2ry14 -5.07 0.04572455 Lmr11 
6818958 Rnase6 -4.95 0.04265478   
6876735 Kynu -4.61 0.02071858   
6939130 Ociad2 -4.59 0.01928861   
6751535 Ramp1 -4.43 0.00914693 Lmr20 
6861850 Tcf4 -4.37 0.03128071 Lmr13 
6991264 Ctsh -4.15 0.01504898   
6780570 Havcr1 -3.89 0.02588761 Lmr15 
6849761 Dnahc8 -3.76 0.01815916 Lmr1 
6780777 Rnf130 -3.66 0.04996613 Lmr15 
7015521 Cybb -3.61 0.02243947   
6798285 Pld4 -3.58 0.0206608   
6837008 Csf2rb2 -3.53 0.00906494   
6890312 Ttbk2 -3.43 0.00224024 Lmr14 
6988855 Cadm1 -3.31 0.0144072 Lmr2* 
6959584 Tyrobp -3.30 0.01386917 Lmr21 
6809655 Cd180 -3.27 0.01598122   
6911337 Lyn -3.16 0.04123993 Lmr9* 
6980091 Cd209a -3.02 0.04885126   
6760642 Col6a3 -2.89 0.02927433 Lmr20 
6887854 Chn1 -2.79 0.00034702   
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6907714 Sycp1 -2.71 0.00445272 Lmr11 
6892964 Pltp -2.70 0.04218833 Lmr16 
6789325 Cd68 -2.70 0.01782912 Lmr15 
6876238 Angptl2 -2.60 0.0049717   
6990952 Bckdhb -2.60 0.03129954   
6908745 Rwdd3 -2.54 0.00569991 Lmr11 
6849968 H2-Eb1 -2.54 0.04733397 Lmr1 
6880718 Sqrdl -2.53 0.00920881 Lmr14 
6784345 Grn -2.50 0.01547731   
6969874 Art2a -2.50 0.04605417   
6854393 Fahd1 -2.47 0.01324762 Lmr1 
6998900 Tdgf1 -2.43 0.03240203   
6804405 Grhl1 -2.39 0.00198439 Lmr22 
6755630 Sccpdh -2.38 0.04776039 Lmr8 
6871874 Gcnt1 -2.37 0.02454751   
6907652 Slc22a15 -2.37 0.00162074 Lmr11 
6870697 Atrnl1 -2.37 0.00878645   
6868041 Cybasc3 -2.36 0.01036561   
6865551 Ppic -2.32 0.01483366 Lmr13 
6762804 Rgs18 -2.31 0.02247044 Lmr8 
6782919 Ccl8 -2.28 0.01361971 Lmr15 
6905422 P2ry13 -2.23 0.02555837 Lmr11 
6983115 Zfp868 -2.22 0.00415558 Lmr10 
6865902 2010002N04Rik -2.21 0.02912583 Lmr13 
6782105 Mgl1 -2.18 0.02506773   
6954269 Hpgds -2.16 0.02895954 Lmr4 
6873111 Blnk -2.14 0.01919636   
6800913 Polr2h -2.14 0.02482039 Lmr23 
6790655 Scpep1 -2.14 0.04942001   
6851103 Kat2b -2.13 0.01181798 Lmr1 
6870104 As3mt -2.12 0.01481824   
6878810 Olfr1094 -2.12 0.04049741   
6791914 Cd79b -2.11 0.02859897   
6850017 H2-DMb1 -2.10 0.00488079 Lmr1 
6927227 2810405K02Rik -2.07 0.00578993   
6914190 Tlr4 -2.07 0.03831536   
6817396 Adk -2.03 0.04470448   
6946785 Gng12 -2.00 0.04521871 Lmr4 
6961991 Hddc3 -1.99 0.02278186 Lmr21 
6758027 Tbc1d8 -1.99 0.04980325 Lmr20 
6918015 Pla2g2d -1.97 0.0261803   
6995526 1110032A03Rik -1.97 0.04089204 Lmr2 
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6955698 Lrig1 -1.97 0.03099483   
6820323 5031414D18Rik -1.95 0.0193377   
6978923 Cdh1 -1.94 0.02713129   
6903088 Hey1 -1.93 0.00129306   
6855202 Ppp1r11 -1.93 0.02711894 Lmr1 
6958059 Ldhb -1.91 0.01779387   
6912577 Polr1d -1.90 0.04378076   
6968126 Arrdc4 -1.90 0.00465251 Lmr21 
6805108 Otud6b -1.89 0.02503586 Lmr9 
7017699 Pls3 -1.89 0.03064641   
6941685 Aldh2 -1.89 0.01761513   
6766063 Adat2 -1.88 0.03333431   
6874631 Phyh -1.86 0.01362147   
6965901 Atp1a3 -1.85 0.02059886 Lmr21 
6966145 Zfp36 -1.84 0.0409055 Lmr21 
6815111 Jmy -1.84 0.01340618   
6792649 Timp2 -1.83 0.0076297   
6848572 Fgfr1op -1.82 0.02431158 Lmr7 
6882611 Phf20 -1.82 0.00081202 Lmr16 
6759549 Ikzf2 -1.80 0.02637114 Lmr20 
6803161 Lgmn -1.79 0.03119906   
6956765 Rassf4 -1.77 0.01963004   
6831800 Csf2rb -1.77 0.01117184   
6960578 Nav2 -1.77 0.03073576 Lmr21 
6789339 Amac1 -1.76 0.01737601 Lmr15 
6861751 D18Ertd653e -1.75 0.0366812 Lmr13 
6977589 Inpp4b -1.74 0.04629778   
6980598 2410022L05Rik -1.72 0.01847857   
6924366 Scp2 -1.72 0.02248478   
6848553 Tagap -1.71 0.04648494 Lmr7 
6812214 Tubb2a -1.71 0.0354927   
6958269 Itpr2 -1.70 0.00341098   
6919417 Tox -1.68 0.04876886 Lmr9 
6954385 Gadd45a -1.68 0.00215183 Lmr4 
6977846 Phkb -1.67 0.04377779   
6754138 Rgs16 -1.67 0.00376459 Lmr8 
7017604 Renbp -1.66 0.01429746   
6996191 Glce -1.63 0.03817523 Lmr2 
6867566 Cpt1a -1.62 0.00232489   
6835984 Mtss1 -1.61 0.00299817   
6971656 Chst15 -1.61 0.0261638 Lmr21 
6980107 Cd209c -1.61 0.00617314   
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6957272 D130058E03 -1.61 0.04692001   
6919320 Penk -1.61 0.02431637 Lmr9 
6900254 Dennd2d -1.61 0.04807682 Lmr11 
6779432 Bcl11a -1.60 0.04357257 Lmr6 
7011377 Ddx26b -1.60 0.04949251   
6933014 Ptpn13 -1.60 0.00268147   
6785762 Nudcd3 -1.58 0.02497472 Lmr6 
6807074 Syk -1.57 0.043697   
6774719 Arid5b -1.57 0.016905 Lmr19 
6849327 Nme3 -1.57 0.00496098 Lmr1 
6958078 St8sia1 -1.56 0.03236801   
6843384 Ttc3 -1.56 0.03983991 Lmr18 
6922026 Ptgr1 -1.55 0.04448142   
6935094 Zcwpw1 -1.55 0.03197834   
6956926 Erc1 -1.55 0.01509309   
6994705 Spa17 -1.55 0.0256844 Lmr2 
6922241 Alad -1.54 0.02551281   
6913133 1700055D18Rik -1.54 0.00701961   
6860430 LOC100042767 -1.54 0.00316635   
6788728 4930412M03Rik -1.54 0.03322737   
6860780 Tnfaip8 -1.53 0.01937005 Lmr13 
6757120 Stau2 -1.53 0.01469778 Lmr20 
6784829 Map2k6 -1.52 0.03913024   
6963422 Swap70 -1.51 0.02156892   
6876219 Ptrh1 -1.50 0.01388439   
6991461 Slc9a9 -1.50 0.0064597   
6968643 Ntrk3 -1.50 0.0312964 Lmr21 
6873476 Calhm2 -1.49 0.01854893   
6874085 4930506M07Rik -1.49 0.04709669   
6849515 Pacsin1 -1.49 0.0075557 Lmr1 
6806219 Fars2 -1.48 0.02197318   
6769204 Ndufs7 -1.47 0.04799513 Lmr19 
6968018 Mef2a -1.46 0.0487577 Lmr21 
6899743 Sv2a -1.46 0.03546496 Lmr11 
6901737 Adh1 -1.46 0.01272266   
6929260 Klhl7 -1.45 0.03069464   
6979439 Plcg2 -1.45 0.03998227   
6827944 Gpr183 -1.44 0.00313854   
6752571 Ccdc93 -1.44 0.02379693 Lmr20 
6769634 Gnptab -1.43 0.00883444 Lmr19 
6776152 4932415G12Rik -1.43 0.01740469 Lmr19 
6960287 Napsa -1.42 0.04542982 Lmr21 
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6964382 Itgax -1.42 0.00868636 Lmr21 
6789741 Serpinf1 -1.42 0.01737644 Lmr15 
6831927 Cby1 -1.41 0.04816391   
6796339 Rdh12 -1.41 0.01254551 Lmr22 
6946931 Vps24 -1.40 0.03604998 Lmr4 
6770013 Eea1 -1.40 0.01541705 Lmr19 
6800060 Ahr -1.40 0.02449899 Lmr22 
6890193 Ccdc32 -1.39 0.00408642 Lmr14 
6950397 8430419L09Rik -1.39 0.01696055   
6840199 Lpp -1.38 0.01271137 Lmr12 
6909792 Dapp1 -1.38 0.02904414   
6843184 Ifngr2 -1.37 0.02228764 Lmr18* 
6784236 Atp6v0a1 -1.36 1.6143E-05   
6838754 Calcoco1 -1.36 0.03439407   
6767402 Sesn1 -1.36 0.0178282   
6892384 Edem2 -1.36 0.03287585 Lmr16 
6847824 4932438H23Rik -1.36 0.01130555 Lmr18 
6887179 Dpp4 -1.36 0.03912838   
6847748 Tiam1 -1.35 0.017937 Lmr18 
6882499 a -1.34 0.01621417 Lmr13* 
6975064 Fut10 -1.34 0.0178798 Lmr10 
6765460 Cr2 -1.34 0.04972229 Lmr20 
6840629 Heg1 -1.34 0.0485809 Lmr12 
6834975 Rnf19a -1.34 0.02107743   
6792650 RP23-394O9.3 -1.33 0.03040018   
6869027 Jak2 -1.33 0.03823321   
6754776 Brp44 -1.32 0.04305995 Lmr8 
6983608 Smad1 -1.32 0.01569378   
6992490 Epm2aip1 -1.32 0.04386657   
6910088 Hs2st1 -1.32 0.01992169   
6989553 Hexa -1.32 0.00428176 Lmr2 
6899016 Arhgef11 -1.31 0.00314213 Lmr11 
6957144 Lag3 -1.31 0.0428661   
6993465 Endod1 -1.31 0.03284209 Lmr17 
6831157 Phf20l1 -1.30 0.04118845   
6780443 Ebf1 -1.30 0.00193787 Lmr15 
6929655 Khk -1.30 0.02175911   
6884277 Tpd52l2 -1.30 0.00395644   
6794059 Rnaseh1 -1.30 0.03558572 Lmr22 
6938678 Tlr1 -1.30 0.0179491   
6804033 Wdr60 -1.29 0.02515024   
6949473 Fbxl14 -1.29 0.03827057   
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6783330 Rnf43 -1.29 0.02758997 Lmr15 
6810333 Esm1 -1.29 0.02181983   
6783626 Mbtd1 -1.29 0.04412346   
6875961 Mrps2 -1.29 0.00908533   
6823742 Hacl1 -1.28 0.04367946   
6954638 Tgoln1 -1.28 0.0119932 Lmr4 
6849992 Wdr46 -1.27 0.02327175 Lmr1 
6934662 0610007L01Rik -1.27 0.02883146   
7015255 Mid1 -1.27 0.04315216   
6857431 Strn -1.26 0.01562701   
6876943 Kif5c -1.26 0.01426185   
6906433 D930015E06Rik -1.26 0.04360848 Lmr11 
6774336 Sgpl1 -1.26 0.01659704   
6885070 Pip4k2a -1.26 0.00773225   
6976609 Ddx60 -1.26 0.00477551 Lmr10 
6838349 Senp1 -1.26 0.01173002   
6772763 Taar7a -1.25 0.01469976   
6861711 Slmo1 -1.25 0.04893485 Lmr13 
6796331 Arg2 -1.25 0.03292034 Lmr22 
6931790 Srd5a3 -1.25 0.03587391   
6871499 Dak -1.25 0.0334434   
6868055 A430093F15Rik -1.24 0.00500853   
6926502 Fhad1 -1.24 0.03466988   
6859781 Wdr33 -1.24 0.003683 Lmr13 
6863417 6030446N20Rik -1.23 0.00523553   
6771259 D930020B18Rik -1.23 0.04349905 Lmr5 
6752848 Mgat5 -1.23 0.01930707 Lmr20 
6798601 Ncoa1 -1.23 0.02461384 Lmr22 
6899967 Trim45 -1.22 0.02302552 Lmr11 
6790621 Msi2 -1.22 0.04944914   
6917069 Gnl2 -1.22 0.02969357   
6765186 Rps6kc1 -1.22 0.00666749 Lmr20 
6837105 Csnk1e -1.22 0.04659457   
6868371 Gna14 -1.21 0.02738894   
6992887 Exog -1.21 0.04574609   
6914007 Orm1 -1.20 0.00331422   
6823653 Il17rb -1.20 0.04861021   
6788862 Ulk2 -1.20 0.04080512 Lmr15 
6882397 Dnmt3b -1.20 0.04275656 Lmr14 
6839008 Cluap1 -1.20 0.02654342 Lmr23 
6991777 Cep70 -1.20 0.02283281   
6767631 Hace1 -1.20 0.02091835   
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6791881 Limd2 1.20 0.03539809   
6971359 Zfp689 1.20 0.0228968 Lmr21 
6934892 Stx1a 1.20 0.0372897   
6918125 Padi2 1.20 0.0102547   
6844291 Med15 1.21 0.01790483 Lmr23 
6946018 AI854703 1.21 0.0369642   
6950257 Tas2r117 1.21 0.04993896   
6931181 Pgm1 1.21 0.04371763   
6788595 Olfr30 1.21 0.02641861 Lmr15 
6863323 Esco1 1.22 0.02036344   
6764089 Ly9 1.23 0.01675059 Lmr8 
6976975 Tm6sf2 1.23 0.04117926 Lmr10 
6753033 Lgtn 1.24 0.02806524   
6933512 Tpst2 1.24 0.03163461   
6787741 Nipal4 1.25 0.04377136 Lmr15 
6933675 Pxn 1.25 0.01921934   
6836341 Sla 1.25 0.01222784   
6791171 Tbx21 1.25 0.0377593   
6983172 Armc6 1.25 0.04338844 Lmr10 
6798153 Rcor1 1.26 0.04960617   
6785463 Npb 1.26 0.00233673   
6901084 Tram1l1 1.27 0.0209641 Lmr11 
6874947 Itih5 1.27 0.04200181   
6832256 Bik 1.27 0.04788735   
6856365 A930025A13Rik 1.27 0.02786781   
6803895 Akt1 1.27 0.00868045   
6871903 Ostf1 1.27 0.03951073   
6813094 Susd3 1.28 0.02561303   
6984071 Snx20 1.28 0.02237282   
6887089 Rbms1 1.28 0.01839074   
6892380 Trpc4ap 1.29 0.04093896   
6934902 Tbl2 1.29 0.0293296   
6963898 2610020H08Rik 1.30 0.02873141   
6891898 Napb 1.30 0.01708198 Lmr14 
6848179 Dscam 1.30 0.01806987 Lmr18 
6893556 Zbp1 1.30 0.00922888   
6925590 Txlna 1.30 0.0059244   
6802507 Pomt2 1.31 0.01442624 Lmr22 
6790581 Olfr462 1.32 0.02214632 Lmr15 
6880776 Sema6d 1.32 0.03081683 Lmr14 
6905421 Gpr87 1.32 0.00236886 Lmr11 
6915559 Fggy 1.33 0.0153838   
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6852389 2410091C18Rik 1.34 0.02472063   
6942441 Hip1 1.34 0.00856514   
6991942 9630041A04Rik 1.34 0.02906521   
6963558 Arntl 1.35 0.00597454   
6996127 Lrrc49 1.35 0.04661955 Lmr2 
6931321 Nsun7 1.36 0.01004226   
6887079 Cd302 1.36 0.01519311   
6893279 Nfatc2 1.37 0.0389197 Lmr16* 
6992172 Dusp7 1.37 0.01127009   
6884267 Lime1 1.38 0.00532311   
6798392 Vipr2 1.38 0.04682953   
6768853 Adora2a 1.39 0.03268465 Lmr19 
6966328 Usf2 1.40 0.02724905 Lmr21 
6953800 Nod1 1.41 0.04516387 Lmr4 
6962107 Sh3gl3 1.41 0.04095174 Lmr21 
6977692 Lphn1 1.41 0.04398454   
6917063 9930104L06Rik 1.41 0.02005684   
6883125 Mmp9 1.41 0.03582836   
6945786 Zyx 1.41 0.04431665 Lmr4 
6774020 Man1a 1.41 0.04041668   
6749392 Stat4 1.42 0.01936232 Lmr20 
6868110 Ms4a4d 1.42 0.00574496   
6790928 Wfikkn2 1.43 0.02793603   
6987446 Zfp809 1.43 0.03514745 Lmr2 
6917656 Paqr7 1.43 0.04575547   
6893186 Ube2v1 1.43 0.03408674   
6758588 Obfc2a 1.44 0.03515568   
6992878 Acaa1a 1.44 0.03055147   
6981573 Wrn 1.45 0.04127672 Lmr10 
6849241 Dcpp1 1.45 0.03906687 Lmr1 
6862448 Pard6g 1.45 0.00117398   
6850786 Ccnd3 1.45 0.01200664 Lmr1 
6885431 Tmem141 1.45 0.03993847   
6769366 Chst11 1.45 0.04328637 Lmr19 
6791921 Ern1 1.46 0.01863611   
6919885 Otud6b 1.46 0.03193141 Lmr9 
6913975 Bspry 1.46 0.03766598   
6852849 Cript 1.46 0.00234591   
6953929 Vopp1 1.46 0.03848534 Lmr4 
6775472 Gna15 1.47 0.01729143 Lmr19 
6892285 Cdk5rap1 1.47 0.03742276 Lmr16 
6817616 4931406H21Rik 1.47 0.03664528   
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6844407 Olfr170 1.48 0.04161195 Lmr23 
6919003 Tnfrsf25 1.48 0.04864592   
6806893 A830005F24Rik 1.48 0.04067765   
6854384 Gfer 1.48 0.03765385 Lmr1 
6978736 Cmtm3 1.49 0.04763099   
6893057 Sulf2 1.49 0.02793558   
6994883 Crtam 1.50 0.02214225 Lmr2 
6875038 Il2ra 1.50 0.04352504   
6998584 Abhd14a 1.51 0.00850314   
6976956 Lpar2 1.51 0.04966683 Lmr10 
6954982 Hk2 1.51 0.00157301 Lmr4 
6956965 Cecr5 1.54 0.00467121   
6958974 Pglyrp1 1.55 0.00619044 Lmr21 
6907945 Chi3l3 1.55 0.0212381 Lmr11 
6932336 Afp 1.55 0.01156338 Lmr3 
6972990 Ube2m 1.55 0.0326654 Lmr21 
6975307 Tmem66 1.56 0.00253581 Lmr10 
6860710 Eno1 1.57 0.02514762   
6968836 Fsd2 1.57 0.0093477 Lmr21 
6810682 Calml3 1.58 0.04816957   
6958905 Slc1a5 1.59 0.00273613 Lmr21 
6881123 Slc20a1 1.59 0.02939269 Lmr14 
6868216 Olfr1469 1.60 0.04894665   
6959557 Zfp260 1.61 0.04204331 Lmr21 
6750519 Il8rb 1.61 0.03039108   
6844400 Olfr168 1.61 0.02375756 Lmr23 
6945837 Olfr435 1.62 0.0076167 Lmr4 
6760042 Fam124b 1.62 0.03609505 Lmr20 
6872250 Tjp2 1.63 0.04661669   
6858871 Cables1 1.63 0.02399719   
6959674 Gm6725 1.65 0.04515151   
6766839 Themis 1.66 0.04995736   
6918177 B830004H01Rik 1.66 0.01104493   
6907137 Tnfaip8l2 1.66 0.04972191 Lmr11 
6990167 Rora 1.66 0.02735123   
6963608 Pde3b 1.66 0.00954652   
6754537 Tnfsf18 1.67 0.006713 Lmr8 
6953443 Igf2bp3 1.67 0.01916275 Lmr4 
6848721 D17Ertd663e 1.68 0.01322297   
6957428 Klri2 1.68 0.03230592   
6878038 Rapgef4 1.69 0.00644244   
6888569 Olfr1197 1.69 0.03123225   
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6779827 Nsg2 1.71 0.02860555 Lmr6 
7013153 Cypt2 1.71 0.03034799   
6771052 Ifng 1.72 0.0473049 Lmr5* 
6807609 2010111I01Rik 1.72 0.02133265   
6814043 Zfp85-rs1 1.73 0.02001141   
6932118 Stap1 1.74 0.02568874 Lmr3 
6858910 Ttc39c 1.74 0.00947665   
6769481 Btbd11 1.76 0.02181908 Lmr19 
6981182 Hgsnat 1.78 0.02052178 Lmr10 
6852438 Cyp1b1 1.78 0.02248427   
6970164 Gvin1 1.78 0.02180314   
6854341 Dnase1l2 1.79 0.00212067 Lmr1 
6878794 Olfr1036 1.80 0.00262062   
6888668 Olfr1259 1.82 0.02966071   
6792107 Fam20a 1.82 0.00617188   
6868511 BC016495 1.85 0.01720217   
6921381 Coro2a 1.86 0.00683686   
6868243 Olfr1505 1.86 0.04501316   
6890699 Kcnip3 1.86 0.04194681 Lmr14 
6963114 Olfr618 1.87 0.02262087   
6888413 Olfr1040 1.87 0.03072553   
6926021 Sepn1 1.89 0.01078634   
6855087 Tnf 1.89 0.00556036 Lmr1* 
6950115 Klrb1f 1.89 0.02842606   
6769357 Txnrd1 1.90 0.01484215 Lmr19 
6871117 Ctsw 1.92 0.03562476   
6754027 Fam129a 1.93 0.02879366 Lmr8 
6868176 Fam111a 1.93 0.01922008   
6873060 Cyp2c40 1.95 0.0373028   
6888898 Cd82 1.95 0.01203409   
6814055 Zfp87 1.96 0.01992911   
6822297 Clybl 1.97 0.02862278   
6845444 Slc15a2 1.97 0.03229823 Lmr12 
6845435 Cd86 1.99 0.03660526 Lmr12 
6868091 Ms4a4c 2.00 0.01958345   
6820472 Epsti1 2.00 0.00120701   
6814044 Zfp874 2.00 0.03118594   
6913042 Glipr2 2.02 0.03575521   
6748893 Il18rap 2.04 0.02706447 Lmr20 
6763572 Fasl 2.04 0.02340819 Lmr8 
6957025 Klrg1 2.08 0.01842798   
6850345 Olfr130 2.10 0.00351156 Lmr1 
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6748889 Il18r1 2.12 0.01945442 Lmr20 
6968781 Furin 2.12 0.01724665 Lmr21 
7000764 9330169L03Rik 2.17 0.04907309   
6849091 Zfp52 2.23 0.01596919 Lmr1 
6882538 Acss2 2.24 0.00460851 Lmr16 
6977108 Zfp617 2.25 0.00381266 Lmr10 
6780551 Havcr2 2.26 0.00260582 Lmr15 
6761691 Dbi 2.26 0.0422967 Lmr20 
6836829 Dgat1 2.28 0.02975661   
6836723 Ly6i 2.30 0.04980991   
6797585 Serpina3f 2.36 0.00641612   
6954415 Il12rb2 2.37 0.00985311 Lmr4 
6764093 Slamf7 2.39 0.00391687 Lmr8 
6970166 Gm4759 2.39 0.00898416   
6790288 Ccl5 2.43 0.02554016 Lmr15 
6940658 Abcg3 2.46 0.00204207   
7015995 Zfp300 2.49 0.04242324   
6857435 Eif2ak2 2.56 0.00351408   
6901957 Gbp2 2.57 0.00074727   
6831538 Ly6e 2.65 0.00904188   
6806034 Serpinb6b 2.71 0.03184738   
6825872 Cysltr2 2.72 0.02299229   
6815542 Marveld2 2.72 0.01591547   
6954418 Il23r 2.90 0.0159262 Lmr4 
6939338 Hopx 3.30 0.02732588   
6957421 Klrc2 3.31 0.01114157   
6968871 Hdgfrp3 3.33 0.03857217 Lmr21 
6826179 Dnajc15 3.63 0.0199817   
6823429 D14Ertd449e 3.63 0.00171368   
6963907 Tmem159 3.65 0.01373536   
6905746 Lxn 3.68 0.00478389 Lmr11 
6764246 Ifi204 3.93 0.03175784 Lmr8* 
6831959 Apobec3 4.06 0.01570741   
6993154 Ccr5 4.73 0.00109599   
6878045 Rapgef4 5.45 0.00780361   
6899171 Gon4l 5.45 0.01420384 Lmr11 
6970066 AI451617 8.03 0.03235411   
6957423 Klrc1 11.76 0.00069355   
6855155 H2-T10 16.61 0.0075139 Lmr1 
6970053 Trim12 37.84 0.00166596   
6992174 Rpl29 47.05 0.01240538   
* published candidate gene in Lmr locus 
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Table A.2. Differentially expressed genes in iLCKcreIL-4Rα-/lox vs BALB/c, (FC >1.2, p < 
0.05) in activated T cell microarray (Number of genes = 17). 
Probe_IDs Gene_ID 
Regulation in 
iLCK vs. 
BALB/c 
p-value Lmr locus 
6964245 Gdpd3 -76.25 0.000021 Lmr21 
6957472 Tas2r104 -2.40 0.033647   
6964160 Il4ra -2.38 0.006111 Lmr21* 
6889440 A130004G07Rik -2.06 0.028503   
6805108 Otud6b -2.02 0.024273 Lmr9 
6993154 Ccr5 1.93 0.045993   
6890837 Il1a 1.99 0.009904 Lmr14 
6791347 Krtap1-5 2.02 0.036811   
6780732 Olfr10 2.03 0.023253 Lmr15 
6923155 Mrpl48 2.07 0.032981   
6828417 Rpl37 2.14 0.032996   
6978290 Mt2 2.37 0.033796   
6855166 H2-T3 2.79 0.004422 Lmr1 
7023069 Kdm5d 12.23 0.002277   
6855155 H2-T10 33.32 0.000137 Lmr1 
7023079 Ddx3y 38.22 0.000899   
7023072 Eif2s3y 44.52 0.000680   
* published candidate gene in Lmr locus 
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Table A.3. Differentially expressed genes in C57BL/6 vs BALB/c (FC >1.2, p < 0.05) in 
regulatory T cell microarray (Number of genes = 485). 
Probe_I
Ds 
Gene_ID 
Regulation in C57BL/6 
vs. BALB/c 
p-value Lmr locus 
5090722 GDPD3 -10.90 0.024798618 Lmr21 
4390451 H2-D1 -9.63 0.019308612 Lmr1 
2140639 CTSE -5.91 0.035493231 Lmr20 
650601 IFI202B -5.61 0.037002387 Lmr8* 
5690246 GBP1 -4.99 0.009930821   
1170400 C530038F07RIK -2.78 0.00147442   
7380725 MRPL14 -2.74 2.98713E-05 Lmr1 
3710678 1110032A13RIK -2.74 0.04384901   
3400504 8430419L09RIK -2.71 0.048482916   
2940544 LOC672474 -2.70 0.000700868   
5820767 4930477M19 -2.68 0.001540044   
1570095 LOC242459 -2.31 0.033473978   
6110278 LOC333685 -2.24 0.000186438   
5870367 LOC666403 -2.21 0.00801494   
5290546 CTSE -2.21 0.007293356 Lmr20 
6420561 ADI1 -2.20 0.017263467 Lmr22 
1710196 LOC100048583 -2.08 0.034520971   
1090671 INPP4B -2.04 0.010573464   
4560626 GLO1 -2.00 0.02252529 Lmr1 
6290338 TLR4 -1.95 0.046564514   
4860035 CRIPT -1.93 0.003017595   
7040195 GPR83 -1.93 0.039411024 Lmr17 
1300445 IL4 -1.92 0.016736936 Lmr15 
7400739 ACSL5 -1.90 0.010929393   
5910181 LOC638034 -1.88 0.030928467   
2940064 INPP4B -1.88 0.002609918   
3130646 ZFP36L1 -1.81 0.00066302 Lmr22 
670014 TRAPPC2L -1.79 0.0224206   
7610750 LOC381157 -1.78 0.041431587   
6590451 CC2D2A -1.75 0.003731041   
6980274 HMGA1 -1.74 0.024133771 Lmr1 
2470220 POLR2F -1.74 0.048306506   
6620446 IL27RA -1.73 0.04211852   
4890100 LOC100047674 -1.70 0.035618938   
4900475 LOC100046025 -1.70 0.014855695   
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4040424 TOR1AIP1 -1.70 0.014993998 Lmr8 
1580468 5730481H23RIK -1.69 0.02915888   
4010243 RAMP1 -1.64 0.005159457   
3290605 SLC2A9 -1.64 0.037058254   
6100132 2610024H22RIK -1.61 0.022219483   
6510445 PPP1R11 -1.61 0.028245279 Lmr1 
4290739 PLEKHK1 -1.60 0.027212147   
610274 FADS1 -1.59 0.004807787   
4390286 LOC386513 -1.59 0.012638243   
6860598 AI449175 -1.59 0.009843749   
3830601 ENO3 -1.58 0.030989417 Lmr15 
1770458 SLAMF1 -1.58 0.016677494 Lmr8 
6450438 STK38L -1.58 0.034521683   
2340121 AP1B1 -1.57 0.041230675 Lmr6 
2000228 FUT10 -1.57 0.001973673 Lmr10 
6220603 RWDD3 -1.57 0.047272654 Lmr11 
3710086 LOC544988 -1.56 0.009385961   
3170435 CAMK4 -1.55 0.021686593 Lmr13 
6270327 GRHL1 -1.55 0.01119788 Lmr22 
1740626 MRPS10 -1.54 0.02542475 Lmr1 
6580373 LOC280487 -1.54 0.020891857   
2140368 1500001E21RIK -1.54 0.010420728   
1090767 ENO2 -1.53 0.032946981   
2190086 PDZK8 -1.52 0.011499518   
540131 RCN1 -1.52 0.033452958 Lmr14 
2000121 VDAC2 -1.52 0.001817328   
4860133 C230096C10RIK -1.52 0.010470679   
7330189 ADCY7 -1.52 0.041610608   
4570670 STAU2 -1.52 0.019121112 Lmr20 
5090400 CUGBP1 -1.51 0.036168354   
3850112 DNAHC8 -1.51 0.005987084 Lmr1 
6400706 RABGAP1L -1.51 0.024656866 Lmr8 
2900441 5133400G04RIK -1.50 0.043019916   
5690139 MANBA -1.50 0.008523954   
770162 E2F2 -1.50 0.029303533   
6940136 MLLT4 -1.49 0.009243437   
4890634 TAF5L -1.49 0.013085506   
5810398 RNASE4 -1.49 0.031790411   
6900044 LAT -1.49 0.045714583 Lmr21 
4490082 LOC385289 -1.49 0.044087386   
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3390020 PCCB -1.49 0.02400995   
360204 SLC35A4 -1.48 0.018541575 Lmr13 
110630 EBPL -1.47 0.007603217   
2350669 2810046L04RIK -1.46 0.043783703   
5420170 GBP6 -1.46 0.039948889   
5080132 CUGBP1 -1.46 0.011829162   
2710639 H2-T24 -1.45 0.004500366   
3060224 PDZD8 -1.45 0.049874362   
1570544 C730026O12RIK -1.45 0.038956773   
2070243 ALDH5A1 -1.45 0.018901103   
4850142 PHF20 -1.45 0.018139278 Lmr16 
2810369 0710001D07RIK -1.45 0.049608301   
7050397 NTN4 -1.44 0.048365914 Lmr19 
7160079 SCL000408.1_6 -1.44 0.049909786   
3870370 D8ERTD738E -1.44 0.03884528   
1300079 LOC381471 -1.44 0.019445636   
1980343 COL6A3 -1.43 0.018212434 Lmr20 
5360647 RNASEN -1.43 0.04382817   
5270164 FUT10 -1.43 0.004294804 Lmr10 
4830156 9630041B11RIK -1.43 0.004080547   
5700722 ECE1 -1.43 0.009928606   
6020398 ETS1 -1.43 0.020326955 Lmr2 
3940050 1500010G04RIK -1.43 0.00927059   
4810056 H13 -1.42 0.01174552 Lmr14 
4290593 FVT1 -1.42 0.006155602   
3290246 CRBN -1.42 0.01665948   
5720021 4930540L03RIK -1.41 0.02814004   
4560731 1110014O20RIK -1.41 0.027723991   
6900133 MTSS1 -1.41 0.02288777   
6220669 4930505D03RIK -1.41 0.019976874   
4730767 LOC436539 -1.40 0.037887311   
3940528 LOC386446 -1.40 0.015148263   
4560148 1810027O10RIK -1.40 0.031155869   
5670128 FAM105A -1.39 0.00704101   
2600424 SQRDL -1.39 0.000364941 Lmr14 
2600156 A630004K05RIK -1.39 0.045205132   
6450403 2410005O16RIK -1.39 0.045834941   
670707 TTC3 -1.38 0.027915306 Lmr18 
6580768 2810416G20RIK -1.38 0.007046061   
3840575 LOC677008 -1.38 0.020398964   
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4210477 MAPBPIP-PENDING -1.38 0.041666816   
5390019 PLA2G4B -1.38 0.048352887 Lmr14 
1580161 DNAJC10 -1.38 0.036176421   
6580347 LPHN1 -1.38 0.038750768   
5260382 FDXR -1.37 0.044992019   
5820647 FDXR -1.37 0.039286106   
4610246 OCIAD1 -1.37 0.025574963   
2190615 2310045K21RIK -1.36 0.014134114   
3420242 LOC674611 -1.36 0.038478121   
4640070 FTO -1.36 0.03289406   
3420544 PMEPA1 -1.36 0.009140799 Lmr16 
1770669 TSSC1 -1.36 0.030062093 Lmr22 
3170195 FUT10 -1.36 0.003348306 Lmr10 
4640093 TCRB-V8.3 -1.36 0.032950374   
5260278 ETS1 -1.35 0.002282727 Lmr2 
6520451 ANGPTL7 -1.35 0.01881548   
610086 LOC381904 -1.35 0.010117351   
1580088 CCND2 -1.35 0.01496842   
1030243 9430038I01RIK -1.35 0.024037325   
5220639 EDEM2 -1.34 0.048744879 Lmr16 
3400630 ANGPTL2 -1.34 0.007310436   
7000315 BC002216 -1.34 0.032163981   
5090739 CLEC16A -1.33 0.041641748   
2750414 VAV3 -1.33 0.024013586 Lmr11 
2450528 SAMD10 -1.32 0.025587028   
6220750 TOE1 -1.32 0.008732543   
1500364 STK35 -1.32 0.019104287 Lmr14 
7320181 SLC39A11 -1.32 0.044444985   
5720674 1110002L01RIK -1.32 0.037115676   
3990630 PDCD4 -1.32 0.046919629   
2230133 DDX24 -1.31 0.04851923   
6520360 CD3E -1.31 0.036519391 Lmr2 
1690189 E2F6 -1.31 0.025716108 Lmr22 
160040 A930005G04RIK -1.31 0.014164717   
6280753 9430028F23RIK -1.31 0.001837776   
6280270 1700022C21RIK -1.31 0.020763507   
4480333 PPIC -1.31 0.04493856 Lmr13 
1300437 FAM115C -1.31 0.013639261 Lmr4 
3830338 TCP11L2 -1.30 0.042799203 Lmr19 
380438 TSHZ3 -1.30 0.006484261 Lmr21 
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1470202 ELK3 -1.30 0.046532803 Lmr19 
1300619 A130065C03RIK -1.30 0.02658408   
6110519 ELK3 -1.30 0.008409067 Lmr19 
6200682 HEXIM2 -1.29 0.002015059   
2750079 AKAP1 -1.29 0.033674174   
7650086 TMEM136 -1.29 0.033063144   
7200048 1700054N08RIK -1.29 0.023817552   
650626 RWDD3 -1.29 0.049359179 Lmr11 
6350193 TBC1D4 -1.29 0.030333667   
6860102 KLHDC4 -1.29 0.039347912   
670646 1700052K11RIK -1.29 0.028165941   
4670753 CD97 -1.28 0.015257937   
4480519 HERC4 -1.28 0.036303331   
1440079 6030413C11RIK -1.28 0.030218924   
3870202 B3GALT4 -1.28 0.027408449 Lmr1 
6200400 SNX27 -1.28 0.010391671   
6290332 PLEKHA8 -1.28 0.017299954 Lmr4 
650706 9030025P20RIK -1.28 0.0344097   
5960673 PHF20 -1.28 0.047878753 Lmr16 
6450291 KCTD10 -1.27 0.019887025   
6370672 ADAM26A -1.26 0.011277176 Lmr10 
5720059 PAPOLA -1.26 0.048800973   
7510315 TRIM33 -1.26 0.02479773 Lmr11 
2370592 ABLIM1 -1.26 0.026356127   
7100300 TMC6 -1.26 0.030413505   
6510333 SFRS1 -1.26 0.016147285   
3170092 SCL0001233.1_26 -1.26 0.037647551   
870068 TRBV30_X16695_T_CEL
L_RECEPTOR_BETA_VA
RIABLE_30_160 
-1.26 0.009105639 
  
6420722 NME3 -1.26 0.008349652 Lmr1 
2630735 LOC100045737 -1.26 0.031891269   
6770368 LOC276878 -1.26 0.007470219   
990692 TMOD3 -1.25 0.026816201   
3850017 TGFBR1 -1.25 0.01486183   
5340598 INTS10 -1.25 0.022433746 Lmr10 
7040750 LRBA -1.25 0.032166043   
1010703 ATP6V0E2 -1.25 0.038668493 Lmr4 
3850114 4930505D03RIK -1.25 0.046976285   
4220091 NRADD -1.24 0.024908899   
3400471 JAK1 -1.24 0.033133559   
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5130523 B230399E16RIK -1.24 0.001774212   
4670528 PPP2R4 -1.24 0.005651688   
7200491 1110007A13RIK -1.24 0.028261492   
5870192 AOF1 -1.24 0.005355389   
4780050 CBLC -1.24 0.025048325   
4830717 NSDHL -1.24 0.029382761   
1230307 TRMT2B -1.24 0.020298989   
3140543 GNA-RS1 -1.24 0.012779433   
1690292 BC094916 -1.23 0.040691424   
5670468 SH3MD4 -1.23 0.040028112   
2570220 VGLL1 -1.23 0.016045139   
2490333 EDEM2 -1.23 0.009839398 Lmr16 
240343 TBC1D15 -1.23 0.041189792 Lmr19 
4390037 SOX9 -1.23 0.036892602   
3140102 PAOX -1.23 0.045331407   
3360349 ZMIZ2 -1.23 0.00541049 Lmr6 
1010600 AIFM1 -1.22 0.019341269   
6480377 AOF1 -1.22 0.026123917   
2260594 OLFR1403 -1.22 0.004016447   
6350537 APOA2 -1.22 0.010781362 Lmr8 
6250195 SFXN3 -1.22 0.028025785   
3370026 E430039K24RIK -1.22 0.012790774   
4540561 CHGB -1.22 0.031031417 Lmr14 
270274 POLR1A -1.22 0.032432816 Lmr4 
70201 PRPF31 -1.22 0.023856648   
2600187 IQCF1 -1.21 0.024840048   
3940593 C630004H02RIK -1.21 0.047714644   
7210392 COL6A3 -1.21 0.007551684 Lmr20 
7550603 SORBS2 -1.21 0.015383469 Lmr10 
4180767 3632411M23RIK -1.21 0.007496129   
2710138 N4BP2 -1.21 0.009651222   
3870743 1810008A18RIK -1.20 0.03501973 Lmr19 
6130300 CTNNBL1 -1.20 0.027846661 Lmr16 
7050524 D630016F07RIK -1.20 0.006363115   
7400709 LOC381129 -1.20 0.015091714   
4850692 9930004G02RIK 1.20 0.002983825   
3140037 5930437C20RIK 1.20 0.019241074   
5340176 6720451B11RIK 1.20 0.033383514   
5360632 DOCK5 1.20 0.007116738   
6060554 CPEB4 1.20 0.035824136 Lmr6 
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6290411 PANK1 1.20 0.005339989   
4150767 LOC100041194 1.21 0.042664927   
50093 LOC238966 1.21 0.043510544   
7570768 PSG19 1.21 0.02765374 Lmr21 
7100477 KCNJ4 1.21 0.008280216   
5310446 TRDMT1 1.21 0.046759978   
4220193 PGPEP1 1.21 0.023008928 Lmr10 
2750746 SLC30A4 1.21 0.017398286 Lmr14 
6130328 PLSCR1 1.21 0.047667773   
1990437 STAC3 1.21 0.046117174   
2490044 CRTAM 1.22 0.039322567 Lmr2 
6650184 GSTT2 1.22 0.027776428 Lmr19 
5340221 AU018091 1.22 0.020180455   
60358 LOC383062 1.22 0.032036643   
4210196 EDNRB 1.22 0.023332755   
7380075 LOC240871 1.22 0.024071424   
1340500 AW125391 1.22 0.019646487   
1710202 PSMG2 1.23 0.024528816 Lmr13 
2680382 GP1BB 1.23 0.001604651   
1230608 TTC9C 1.23 0.019023829   
4540327 SYNGR3 1.23 0.004652134 Lmr1 
4290253 GALNT10 1.24 0.041446472 Lmr15 
7400707 EPS8L1 1.24 0.021115448   
3190020 4930579C12RIK 1.24 0.002588221   
70468 MOSC2 1.24 0.048665022   
3130100 PARG 1.25 0.041510856   
360706 BC117090 1.25 0.013963372   
7050139 TAAR8A 1.25 0.044076295   
3800722 KLF8 1.25 0.016456135   
1980682 ARV1 1.25 0.015971002   
6900600 H2AFJ 1.26 0.002570242   
3710152 SH3GL3 1.26 0.025345144 Lmr21 
2070270 HIP1 1.26 0.046417147   
6550392 UNC119B 1.26 0.01901874   
3400521 9930108O06RIK 1.26 0.047645819   
5560167 DNAJB4 1.27 0.022221979   
4120093 LOC100045840 1.27 0.032550651   
60762 FBXO3 1.27 0.041090099   
7100681 LOC383466 1.28 0.013199973   
2100386 NDUFB10 1.28 0.024814651 Lmr1 
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5890437 SNX13 1.28 0.019126507 Lmr22 
2100605 PCM1 1.28 0.047055812 Lmr10 
520100 5031439A09RIK 1.28 0.020857168   
1690368 LOC547380 1.28 0.014571145   
6110114 TEX261 1.28 0.028117032 Lmr4 
870288 4921513D23RIK 1.29 0.04623151   
1300040 ADH5 1.29 0.04919657   
6290768 CD52 1.29 0.038237705   
4900520 1500001L15RIK 1.29 0.034316996   
6250689 MT-ND4 1.30 0.026020681   
5090039 ACOX1 1.30 0.045455062   
7100674 LY96 1.30 0.015679792 Lmr20 
4920382 DDX17 1.30 0.020549092   
1570446 MRPL19 1.31 0.033200661 Lmr4 
2760484 ABCC1A 1.31 0.029167696   
4150593 MXD1 1.31 0.043109957   
6400347 LOC624610 1.31 0.001779167   
1580338 TXNRD1 1.31 0.039680398 Lmr19 
6940672 RAD23B 1.31 0.034171486   
540402 GPN2 1.31 0.034722242   
5890056 MAN2B1 1.31 0.037214809   
6130075 NDRP 1.32 0.026042801   
5090754 DUS2L 1.32 0.025081553   
2900255 WSB2 1.32 0.035115085   
6060731 LOC100047840 1.32 0.043446927   
7210458 CDK5R1 1.32 0.047191861 Lmr15 
5550035 RRAD 1.32 0.029033338   
1010008 NUDT7 1.32 0.006776351   
5820619 ZFP160 1.32 0.029018298 Lmr1 
6330195 CAMK2N1 1.33 0.045786274   
2710735 FLYWCH2 1.33 0.006555428 Lmr1 
6110138 2210410E06RIK 1.33 0.024750914   
5360474 PI4K2B 1.34 0.020318225   
5080632 NUP88 1.34 0.010152987 Lmr15 
2000035 D530024B08RIK 1.34 0.036760533   
4640500 ART2A 1.34 0.02096064   
3120328 ITGB1BP1 1.34 0.037562707   
3130433 TTC27 1.34 0.020314903   
460528 2010015J01RIK 1.34 0.026535711   
4250280 NAPRT1 1.35 0.047657669   
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3420528 4933407N01RIK 1.35 0.025657702   
1500301 TUBA8 1.35 0.032855854   
4040671 CHD9 1.35 0.028168438   
3420615 ASCC2 1.36 0.002006052 Lmr6 
2490072 TLR11 1.36 0.021433063   
5810274 TMBIM4 1.37 0.033728631 Lmr5 
4180471 NT5E 1.37 0.011403616   
3710672 2810436B12RIK 1.37 0.019603565   
4070019 SIDT2 1.37 0.044435618 Lmr2 
3310176 USP21 1.38 0.035360067 Lmr8 
4290180 CASP4 1.39 0.030818504 Lmr2* 
4290100 HPCAL1 1.39 0.046953803   
4280458 COPS2 1.39 0.006530682 Lmr14 
3120020 PDXDC1 1.39 0.026921925 Lmr23 
3870278 MCART1 1.39 0.005392499   
5810292 5830417I10RIK 1.40 0.047383896   
1660367 SMOX 1.41 0.011181575 Lmr14 
3360068 5830417I10RIK 1.41 0.016646312   
5420739 FES 1.41 0.033390801 Lmr21 
6380148 FBXO34 1.41 0.03972668   
4890192 LPIN1 1.42 0.018296436 Lmr22 
6760286 EG668139 1.43 0.009699956   
6220170 RPGR 1.43 0.010581347   
4390576 AI451617 1.43 0.009262019   
290286 CHM 1.43 0.029111641   
3420600 CPM 1.44 0.003043826   
2570451 MRPS23 1.45 0.029122535 Lmr15 
6480735 RBM13 1.45 0.047349991   
4590093 5830417I10RIK 1.46 0.009591583   
6110551 AHCY 1.46 0.032503065 Lmr16 
5690603 BTBD11 1.46 0.048054463 Lmr19 
1110138 ANKRD27 1.46 0.009871775 Lmr21 
270341 EMB 1.46 0.039455086   
5360307 4732457N14 1.47 0.034424669   
4560504 MRPS7 1.47 0.016922055   
1980048 GIMAP5 1.47 0.041462774 Lmr4 
5080286 NSG2 1.47 0.016557321 Lmr6 
6620577 MS4A4C 1.48 0.04808842   
4640328 2610307O08RIK 1.48 0.007365826   
4610095 DNAJC3 1.49 0.003163988   
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4780066 CSRP1 1.49 0.022191048 Lmr8 
5690370 SCL0001032.1_178 1.49 0.010566723   
4050369 HSD11B1 1.50 0.024646992 Lmr20 
1230241 4631422C13RIK 1.51 0.006152361   
4150370 E030040G24RIK 1.51 0.029972007   
540048 XPNPEP1 1.51 0.015932937   
1170343 MINA 1.51 0.011762041 Lmr12 
4060270 2410078J06RIK 1.52 0.039265675   
7200750 PUSL1 1.53 0.001825142   
780504 NDE1 1.54 0.040856985 Lmr23 
2970136 LNP 1.54 0.018242142   
6650440 LY6K 1.54 0.037047718   
4890113 LOC100045567 1.55 0.014356072   
6660039 MAD 1.55 0.03811996   
4810630 9430032E06RIK 1.55 0.013389065   
7150243 BDH1 1.55 0.004319045 Lmr12 
6200386 LOC433801 1.56 0.033909651   
1990500 9930105H17RIK 1.56 0.036912428   
5550066 4933426K07RIK 1.57 0.001191276   
6590139 1700047I17RIK1 1.57 0.03502075   
2490068 FGFR1OP2 1.58 0.016927008   
5420685 NUDT7 1.58 0.012308105   
4220189 APOB48R 1.58 0.032933779   
1030682 SLC11A2 1.59 0.03049791   
5690148 TOR1AIP2 1.59 0.01576437 Lmr8 
3990246 AHCY 1.60 0.01290993 Lmr16 
20438 SCL0002022.1_2978 1.61 0.001511742   
7160202 ACADL 1.62 0.025688782 Lmr20 
5130593 2310042D19RIK 1.62 0.002805166   
6200646 4930473A06RIK 1.62 0.015535425   
3060600 RAB6B 1.63 0.031977113   
6020445 1700047I17RIK1 1.63 0.046863752   
3440646 PRKCB 1.63 0.010168998   
2900373 1190002H23RIK 1.63 0.017258082   
4480148 BTBD11 1.64 0.017104964 Lmr19 
5890458 PIK3R4 1.64 0.006750345   
3060326 3830402I07RIK 1.65 0.017607319   
940278 SCLY 1.65 0.046328078 Lmr20 
5560465 MTDNA_ATP8 1.65 0.027583464   
1170446 MTMR6 1.65 0.00887721   
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2480382 NOL10 1.66 0.040518108 Lmr22 
2260301 CCDC46 1.67 0.00937484   
2850398 ASB2 1.67 0.003971032   
3990435 MGMT 1.67 0.009106333 Lmr21 
6380379 PON2 1.68 0.000177964   
6900546 CCL25 1.69 0.012480945   
3890328 OAS1G 1.69 0.02280121   
1990639 APAF1 1.70 0.011028229 Lmr19 
2000747 TNFRSF4 1.70 0.043583137   
1400204 ARHGAP26 1.71 0.029544345 Lmr13 
4850082 ENPP5 1.71 0.005078858 Lmr1 
2260427 A130002I06RIK 1.72 0.036483142   
6980672 BTLA 1.73 0.016309666 Lmr12 
4780437 VTI1B 1.73 0.041324109 Lmr22 
6110193 CHD4 1.73 0.03132145   
1090291 XRCC4 1.75 0.002487976   
3450167 SNX10 1.75 0.021092114 Lmr4 
7610669 GMFB 1.76 0.017999382   
940639 CCNDBP1 1.77 0.008675382 Lmr14 
5690301 GABARAPL1 1.78 0.032336904   
2030593 HSPA8 1.78 0.014663134   
1980255 ITPA 1.78 0.011349603   
270719 2510049I19RIK 1.79 0.034088354   
3130292 IDB2 1.79 0.045785157   
3940348 DNAJB13 1.80 0.006830445   
3520500 1700123O20RIK 1.82 0.016350353   
3370717 GADD45GIP1 1.85 0.013858221   
450735 GVIN1 1.85 0.002936564   
1580021 RPL29 1.87 0.000196768   
4490301 EG637748 1.87 0.025663106   
6060390 RPS2 1.88 0.028355466   
3890767 SV2C 1.90 0.011168715   
650717 LILRB4 1.90 0.045021478   
6940259 CCR2 1.91 0.015777769   
4880639 2810021O14RIK 1.94 0.026336696   
5310722 1200015F23RIK 1.95 0.005566011   
540543 TM7SF3 1.99 0.023425142   
4540082 SERPINA3F 2.00 0.002990713   
6510482 ADAM17 2.01 0.015504837   
5670040 CRYBG3 2.01 0.002354085 Lmr12 
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6370451 OTTMUSG00000016644 2.01 0.049409049   
7050148 G430022H21RIK 2.02 0.028504164   
3440056 RING1 2.03 0.017560926 Lmr1 
450594 KLHL28 2.05 0.008598248 Lmr22 
2630673 PCM1 2.07 0.001666612 Lmr10 
5820709 LOC240921 2.12 0.037860146   
2070014 NFKB2 2.13 0.001936343   
2970088 LOC229810 2.18 0.000896507   
4390131 TMEM66 2.20 0.005448319 Lmr10 
6940386 H2-Q7 2.21 0.01053833   
1070598 ZFP260 2.23 0.028005869 Lmr21 
2940164 RBM13 2.24 0.00238316   
5900370 LOC381140 2.26 0.00031351   
3130630 CDKN1A 2.32 0.043310202 Lmr1 
2690639 NSG2 2.32 0.045807137 Lmr6 
5960102 A530055J02RIK 2.33 0.02743687   
5700754 B3GALT6 2.33 0.019472319   
870279 CABLES1 2.35 0.042016042   
2850082 1200003I07RIK 2.36 0.001536451   
1690753 PRDX2 2.37 0.015271833   
5820739 GP49A 2.39 0.011290857   
6860681 HOPX 2.41 0.01290554   
5670035 HGSNAT 2.42 0.001784441 Lmr10 
4760255 TOR1AIP2 2.45 0.017810617 Lmr8 
5550671 LY6C1 2.50 0.001802893   
3120397 DOCK8 2.52 0.007537909   
6550376 LY6E 2.52 0.035642311   
4780184 LY6E 2.53 0.02959187   
3130692 LOC385279 2.54 0.011645859   
2940367 ART2B 2.55 0.027727146   
5570646 CHCHD4 2.61 0.000398441   
1230341 BHLHB2 2.63 0.014692725   
3460463 MANBAL 2.76 0.008602689 Lmr16 
3060687 RPL29 2.86 0.012504189   
4810747 FSD2 2.87 0.008676776 Lmr21 
2710341 NSG2 2.98 0.025056594 Lmr6 
7210349 APOBEC3 3.16 0.004459444   
7400519 PDRG1 3.28 0.001136237 Lmr14 
4220162 STX11 3.35 0.004076645   
3170703 LOC545056 3.50 0.026846707   
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3930093 LOC100043821 3.65 0.001057309   
5340328 ZFP330 3.72 0.000102911   
5720719 NSG2 4.61 8.76295E-05 Lmr6 
2760445 FSD2 4.70 0.005741936 Lmr21 
4120750 SLC15A2 4.78 0.010990516 Lmr12 
3990427 0610010I05RIK 4.97 0.006394751   
3780736 H2-K1 5.57 0.004748943 Lmr1 
6270682 SLC15A2 6.38 0.034703682 Lmr12 
2060474 RBM28 6.64 0.001308864   
7570196 TRIM59 7.76 0.017881158 Lmr11 
4070402 EG241041 23.31 0.018017417   
* published candidate gene in Lmr locus   
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Table A.4. Differentially expressed genes in iLCKcre IL-4Rαlox/- vs BALB/c, (FC >1.2, p < 
0.05) in regulatory T cell microarray (Number of genes =103). 
Gene_ID 
Regulation in 
iLCK vs. 
BALB/c 
p-value Lmr locus 
GDPD3 -11.91 0.024618405 Lmr21 
THUMPD1 -9.57 0.011774589   
XIST -3.17 0.026669264   
XIST -2.97 0.045401352   
PRCP -2.02 0.001060697   
MINT-PENDING -2.00 0.046669397   
IL4 -1.44 0.023974876 Lmr15 
RUVBL1 -1.38 0.028969522   
GPR108 -1.34 0.049601816 Lmr1 
FAM115C -1.34 0.012431219 Lmr4 
KLK1B21 -1.34 0.004303247 Lmr21 
LOC100043322 -1.32 0.048385903   
SFTPC -1.31 0.004762556   
LOC232787 -1.29 0.041890792   
RTP4 -1.29 0.047850894 Lmr12 
6030413C11RIK -1.29 0.029553113   
C530038F07RIK -1.27 0.026484634   
NOL1 -1.27 0.039322253   
PDZK8 -1.27 0.006383045   
NOL5 -1.27 0.019697414   
MGC60742 -1.26 0.040994501   
GPRC5B -1.26 0.021410928   
LOC385112 -1.25 0.041372333   
ATP6V1G1 -1.25 0.047525362   
CDC42SE1 -1.24 0.00587767 Lmr11 
GLT8D2 -1.24 0.027983617 Lmr19 
GTF2I -1.24 0.014576493   
BCL9 -1.24 0.021921508 Lmr11 
BAK1 -1.24 0.02441454 Lmr1 
LOC382229 -1.24 0.040852124   
SYT11 -1.24 0.025059497   
SLC9A9 -1.23 0.037659302   
BC008163 -1.23 0.014208395   
2310001L23RIK -1.22 0.048581967   
PSMC4 -1.22 0.02332712 Lmr21 
SSX2IP -1.22 0.047109794   
HOXC11 -1.22 0.031121486   
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LOC434960 -1.21 0.004245102   
KLHL36 -1.21 0.042022136   
A530058L02RIK -1.21 0.019124233   
PHLDA3 -1.21 0.020423322 Lmr8 
LOC386468 -1.21 0.031091693   
LOC278666 -1.21 0.03342157   
A730011L01RIK -1.21 0.041748141   
PSCD1 -1.21 0.016155441   
TMEM192 -1.20 0.02138284 Lmr10 
5430405G05RIK -1.20 0.044632704   
SOX13 -1.20 0.016689833 Lmr8 
OLFR166 -1.20 0.032784445 Lmr23 
NOTO -1.20 0.031667968   
LOC100045551 1.20 0.044534953   
NFS1 1.20 0.03442322   
HIP1 1.20 0.040731047   
MAPK10 1.20 0.032763246 Lmr3 
OLFR1265 1.20 0.016775536   
GM382 1.21 0.048012261   
RNF170 1.21 0.014097065 Lmr10 
RRBP1 1.21 0.015055243 Lmr14 
FAM13B 1.21 0.033388671   
2310004H21RIK 1.21 0.023051732   
FZD5 1.21 0.028733743 Lmr20 
IFNGR1 1.21 0.026025191   
A230057G18RIK 1.21 0.047926419   
CDK10 1.21 0.037298392   
1700109H08RIK 1.21 0.023680244   
PNRC2 1.22 0.04875417   
ACSL3 1.22 0.023985667 Lmr20 
PHXR5 1.22 0.026489412   
OLFR324 1.22 0.045263732   
FOXK1 1.22 0.037927825   
ZFP101 1.22 0.006661833 Lmr1 
4631416M11RIK 1.23 0.012774489   
NRIP1 1.23 0.022783099 Lmr18 
4930539E08RIK 1.23 0.004015415 Lmr1 
EG226654 1.23 0.035326704   
4930527B16RIK 1.23 0.037231148   
1700109H08RIK 1.23 0.027231433   
LOC383110 1.23 0.043082262   
LOC381630 1.24 0.01465551   
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PSG19 1.24 0.049276031 Lmr21 
GEM 1.25 0.027616939 Lmr9 
C530020B06RIK 1.26 0.016399936   
TAPBPL 1.26 0.018173748   
2610301B20RIK 1.26 0.048390908 Lmr9 
C130054H24RIK 1.27 0.015147705   
TMBIM4 1.27 0.027018802 Lmr5 
CHIC2 1.29 0.039012089   
LOC100043968 1.29 0.003333294   
RBBP9 1.30 0.03854793 Lmr14 
BRAF 1.32 0.023358506   
TCF12 1.33 0.019801787   
SKIL 1.34 0.03471503 Lmr11 
RGS10 1.35 0.041840761 Lmr21 
TRAF1 1.39 0.021456964   
RGS1 1.46 0.001634603 Lmr8 
SGIP1 1.46 0.039179197   
LOC436541 1.49 0.02906417   
A130002I06RIK 1.58 0.048894278   
LOC277146 1.65 0.0310446   
DDX3Y 1.79 0.01474494   
LOC634171 2.29 0.015808494   
MT-ATP6 2.88 0.014081228   
H2-T10 4.84 0.037054581 Lmr1 
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Table A5 Candidate genes that intersected with two or more functional groups 
(Ingenuity Systems). 
Gene Symbol Gene Name 
Relationship with relevant molecules 
Role in cell Regulate
s Regulated by Binds 
H2-T10 
histocompatibility 2, 
T region locus 22 
LCK, FYN 
and 
VAV1 
lipopolysaccharid
e, dendritic cells 
and IFN type 1 
TCR 
gamma 
delta, 
B2M priming 
LCK 
lymphocyte-specific 
protein tyrosine 
kinase 
No data 
available TCR, CD3 CD4, CD8 
differentiatio
n and 
apoptosis 
FYN 
FYN oncogene 
related to SRC, FGR, 
YES CD3-TCR 
TCR, CD3 and 
FYN 
CBL, 
KHDRBS
1, PTK2 Proliferation 
VAV1 
vav 1 guanine 
nucleotide exchange 
factor 
Rac, 
RAC1, 
CDC42 
TCR, CD3 and 
CD28 
LCP2, 
GRB2, 
ZAP70 Proliferation 
Gdpd3 
Glycerophosphodiest
er 
phosphodiesterase 
domain containing 3 
No data 
available 
Chlorcyclizine, 
perhexiline, 
imipramine 
No data 
available 
No data 
available 
Cul2 Cullin2 
CUL2, 
VHL, 
TGFB1 
CUL2, 
NEDD8,RBX1 
VHL, 
TCEB1, 
RBX1 
Cell cycle 
progression, 
cell 
proliferation 
and G1/S 
phase 
transition 
CCR5 
Chemokine receptor 
type 5 
CCR5, 
Ca2+, 
CCL4 
lipopolysaccharid
e, CCL5, TNF 
CCL4, 
CCL5, 
CCL3 
chemotaxis, 
migration, 
trafficking 
CCL5 Chemokine ligand 5 
CCR5, 
Ca2+, 
TNF 
TNF, 
lipopolysaccharid
e, IFNG 
CCR5, 
CCR1, 
CCR3 
chemotaxis, 
migration, 
activation 
IL-18r1 
Interleukin-18 
receptor 1 
NFkB, 
IFNG, Jnk Il12, IL4, STAT4 
IL18, 
IL18RAP, 
IL37 
function, 
binding, 
cytolysis 
STAT4 
Signal transducer 
and activator of 
transcription 4 
IFNg, 
TNF, 
SOCS3 
IL-12, Interferon 
alpha, IL-2 
IFNg, 
IL12RB2, 
Cytokine 
receptor 
Differentiatio
n, Production 
and 
development 
Rnf130 
ring finger protein 
130 unknown STAT4 
UBE2D3, 
UBE2D1, 
LYSU apoptosis 
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Rapgef4 
Rap guanine 
nucleotide exchange 
factor 
Rap1, 
Ins1, 
Insulin 
Cyclic AMP, 
sulfonylurea 
RIMS2, 
PCLO, 
RAP1A 
binding, 
synaptic 
transmission, 
exocytosis 
HIP1 
huntingtin 
interacting protein 1 
HIP1, 
CASP3 HTT, HIP1, TGM2 
HTT, 
IFT57, 
Clathrin 
Apoptosis, 
cell death and 
activation 
IL-4 Interleukin-4 
STAT6, 
IFNG, 
TNF 
Cd3, CD28, Th2 
cells 
IL4R,  
IL2RG, 
Nfat 
differentiatio
n, 
proliferation, 
expression 
PSG19 
pregnancy specific 
glycoprotein 19 
No data 
available 
RBPJ, NOTCH1 
RBPJ 
No data 
available 
FAM115C 
family with sequence 
similarity 115, 
member C 
No data 
available No data available 
No data 
available 
No data 
available 
A130002106RI
K No data available 
No data 
available No data available 
No data 
available 
No data 
available 
C530038F07RI
K No data available 
No data 
available No data available 
No data 
available 
No data 
available 
 
 
 
 
 
 
 
 
 
 
 
